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ABSTRACT 
Background: Vitamin D deficiency is highly prevalent in African American and 
Hispanic women and there is evidence to show that it can have a deleterious impact in 
pregnancy.  There is also evidence indicating that vitamin D deficiency is associated with 
numerous symptoms such as musculoskeletal pain, poor sleep, and depression but evidence has 
been focused on predominantly non-pregnant participants.  However, whether low levels of 
vitamin D are associated with these and other symptoms during pregnancy is unknown.  What is 
known is that vitamin D deficiency disproportionately affects pregnant minority women, 
therefore, this study was undertaken to understand the impact that vitamin D deficiency has on 
pregnancy symptoms and its potential impact on quality of life. 
Purpose: The main purpose of the study was to determine the following: (1) if there was 
a relationship between vitamin D status, pregnancy symptoms including depressive symptoms 
and sleep disruption, health-promoting behaviors, and quality of life, and (2) if differences 
existed in vitamin D status, pregnancy symptoms including depressive symptoms and sleep 
disruption, health-promoting behaviors, and quality of life between African American and 
Hispanic women.   
Theoretical/Conceptual Framework: The Wilson & Cleary’s Health-Related Quality of 
Life model was used to guide the study.  With this framework, the characteristics of the 
individual (e.g., age, ethnicity) and the environment (e.g., social support and spirituality) impact 
on biological factors (e.g., vitamin D status), symptom status (pregnancy symptoms, depression,
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sleep quality), and functional status (health-promoting behaviors) which all ultimately affect 
overall health-related quality of life. 
Method: The study used a descriptive, cross-sectional design to examine women at 24 to 
32 weeks gestation.  A convenience sample of 125 women from underserved, low-income 
federally qualified health centers serving predominantly African Americans and Hispanics 
participated. The variables assessed included the following: biologic (vitamin D status), 
symptoms of pregnancy (Pregnancy Symptom Inventory, PSI), depression (Edinburgh Postnatal 
Depression Scale-EPDS), sleep quality (Pittsburgh Sleep Quality Index-PSQI), functional status 
(Health-promoting Lifestyles Profile-HPLP), and quality of life (SF-12).   
Data Analysis: Statistical analyses were done using SPSS version 22.0.  Descriptive 
statistics were conducted on all study variables. Independent sample t-tests for continuous 
variables and chi-square tests for categorical variables were used to examine differences between 
those who were vitamin D deficient (< 20 ng/ml) and vitamin D sufficient ( ≥ 20ng/ml).  A 
combination of univariate and multivariable logistic regression analyses were conducted to 
detect if vitamin D as a binary variable predicted pregnancy symptoms, depressive symptoms, 
sleep quality, health-promoting behaviors, and mental and physical quality of life.  A series of 
independent sample t-tests were used to detect ethnic differences between African American and 
Hispanic women on key study variables.  
Results: The majority of the pregnant women were either African American (49%) or 
Hispanic (42%).  They were predominantly either single, living with or not living with their 
partner (71.2%), had an income of less than $40,000 (87.2%), had at least a high school 
education (86.4%), were predominantly on Medicaid insurance (77.6%), had an unplanned 
pregnancy (65.6%), had no history of depression (88%) or anxiety (93.6%), did not have 
 xv 
 
gestational diabetes (86.4%), and had planned to breastfeed (80%).  The sample was 
predominantly multiparous (78.4%).  Overall, the vitamin D deficient group had the following 
characteristics:  they were more likely to be African American, have a lower income, and have 
an unplanned pregnancy, and were less likely to breastfeed.   
Mean vitamin D level for the entire sample was 19.46 ng/ml, 58.4% (n = 73) with 
vitamin D < 20 ng/ml and 41.6% (n = 53) with vitamin D ≥ 20 ng/ml.  The most frequently 
reported symptoms by pregnant women were tiredness, urinary frequency, food cravings, back 
pain, and poor sleep.  The mean pregnancy symptom total score for the deficient vitamin group 
was 36.2 (SD=18) and for the sufficient vitamin D group was 36.3(SD=18.8); thus no differences 
were observed between groups.  The sample had a low incidence of depressive symptoms (6.4%, 
EPDS score > 12 indicates elevated risk for depression), and there was no significant difference 
between deficient and sufficient vitamin D groups [mean = 4.05 (SD = 4.8)] vs mean = 3.62 (SD 
= 4.1)]. 
Overall, the sample had poor sleep quality with a mean PSQI global score of 6.3 where 
good sleep quality is defined as ≤ 5.  There were significant differences in PSQI global scores 
with those being deficient having worse sleep quality (mean = 7.28, SD = 3.6) compared to those 
who were sufficient (mean = 5.1, SD = 2.9) scores [t (122) = 3.68, p < .001].  Overall, women 
practiced healthy behaviors with a mean HPLP total score of 2.59 (SD = 0.4), where a score of 4 
denotes practicing healthy behaviors routinely.  Quality of life scores for mental quality of life 
were better than average with a mean value of 52.19 (SD = 8.6) where a value >50 denotes good 
mental quality of life.  Physical quality of life scores were less than average with a mean score of 
45.45 (SD = 7.6) where a value >50 denotes good physical quality of life. 
Using a binary logistic regression, univariate analyses indicated that only sleep quality 
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and physical quality of life were significantly predicted by vitamin D status.  Patients who were 
deficient of vitamin D were 3.1 (95% CI: 1.292–7.47, p = .012) times more likely to have poor 
sleep quality compared to those who were sufficient.  Despite controlling for other significant 
covariates, the predictive value of vitamin D status on sleep quality remained constant.  
Similarly, those with deficient vitamin D were 5.78 (95% CI: 2.13–15.7, p = .001) times more 
likely to report poor physical quality of life compared to those who were sufficient.   
Overall, ethnic differences were found in sleep quality with African Americans having 
worse sleep (mean = 7.34, SD = 3.5) compared to Hispanics (mean = 5.33, SD = 3.2) [t(112) = 
3.18, p = .002].  Although African Americans were likely to report more depressive symptoms 
(mean = 4.63, SD = 5.2) than Hispanics (mean = 2.42, SD = 3.3), these values do not reflect 
depressive states.  Finally, vitamin D levels were lower in African Americans (mean = 17.02, SD 
= 8.3) compared with Hispanics (mean = 21.13, SD = 7.4) [t(113) = -2.77, p = .006].  
Conclusions:  This study confirmed that vitamin D deficiency is highly prevalent in a 
minority pregnant population and provided evidence that deficient vitamin D status could 
contribute to worse symptomology in pregnancy.  It also provided some evidence that vitamin D 
status may impact sleep quality and quality of life which needs to be investigated further.  
Although the pregnancy symptoms, depressive symptoms, and health-promoting behaviors were 
not significantly predicted by vitamin D status, there were several important findings.  It was 
evident that sleep quality and physical quality of life were significantly predicted by vitamin D 
status.  After controlling for significant covariates, being vitamin D deficient significantly 
predicted poorer sleep quality and physical quality of life. Furthermore, the ethnic differences 
found between African American and Hispanic pregnant women were vitamin D, sleep quality, 
and depressive symptoms with a trend toward significance in regards to physical quality of life.    
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Implications for Nursing Practice:  It is clear that vitamin D deficiency is a significant 
problem in pregnant women, especially in at-risk populations.  Nursing has an important role in 
providing the education and advocacy for screening pregnant women for vitamin D status and 
supplementing according to clinical practice guidelines.  Based on the current study findings, 
sleep disruption and poorer physical quality of life may be problematic in underserved pregnant 
women who are vitamin D deficient.  The potential for a future study to examine whether 
supplementation can improve symptomology, quality of life, and health outcomes is essential.  
The beneficial effects of vitamin D supplementation to alleviate symptoms, prevent pregnancy 
complications, and enhance overall quality of life need further study with well-designed clinical 
trials.
 1 
 
CHAPTER ONE 
 
PROBLEM STATEMENT 
 
 Pregnancy is a period of transition for women which includes not only physical 
alterations but psychological and hormonal changes.  Women may respond differently to this 
transition depending upon their previous life experiences, existing comorbid conditions, and the 
support available to them during this time (Kamysheva, Skouteris, Wertheim, Paxton, & 
Milgrom, 2010; Kamysheva, Werheim, Skouteris, Paxton, & Milgrom, 2009; Nazik & Eryilmaz, 
2013; Wallace, Boyer, & Holm, 1986).   Oftentimes, symptoms are manifested during pregnancy 
due to the physical and psychological alterations and may include: fatigue, low back pain, 
increase urinary frequency, breast pain, nausea, vomiting, and poor sleep (Kamysheva et al., 
2009; Nazik & Erylmaz, 2013; Foxcroft, Callaway, Byrne, & Webster, 2013; Skouteris, 
Wertheim, Germano, Paxton, & Milgrom, 2009).   
It has been reported that increased physical symptoms in the second trimester of 
pregnancy are correlated with higher depressive symptoms (Kamysheva et al., 2010).  
Depression in pregnancy has devastating effects not only on maternal outcomes but on fetal 
outcomes as well (Bowen, 2006; Gavin, Gaynes, Lohr, Meltzer-Brody, Gartlehner, & Swinson, 
2005; Muzik & Borovska, 2010).  Recently, low vitamin D has been associated with depression 
in pregnant and postpartum women (Huang, Arnold, Qui, Miller, Williams, &Enguobahrie, 
2014; Cassidy-Bushrow, Peters, Johnson, Li, & Rao, 2012; Robinson et al., 2014; 
Brandenburg,Vrijkotte, Goedhart, & Eijsden, 2012;
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Gur, Genc, Eskicioglu, Kurtulmus, & Guclu, 2015; Nielsen et al., 2013).  Vitamin D 
supplementation has been reported to improve depressive symptomology in non-pregnant 
women (Spedding, 2014) and one trial in Iran examined improved depressive symptom scores 
with vitamin D supplementation in pregnant women (n=169) at 38-40 weeks gestation, 4 and 8 
weeks postpartum (Vaziri et al., 2016).  Vitamin D deficiency has also been associated with 
fatigue, low back pain (musculoskeletal pain), pelvic floor disorders, poor sleep, and depression 
in women (Knutsen, Brekke, Gjelstad, & Lagerlov, 2010; Foxcroft et al., 2013; Lodh et al., 
2015; Cassidy-Bushrow et al., 2012; Huang et al., 2014; Le Goaziou et al., 2014; Badalian & 
Rosenbaum, 2010; Parker-Autry, Markland, Ballard, Downs-Gunn, & Richter, 2012). Studies 
have suggested that supplementation may be beneficial in alleviating some of these symptoms in 
non-pregnant women (Schreuder, Bernsen, & Van der Wouden, 2012; Huang, Shah, Long, 
Crankshaw, & Tangpricha, 2013; Arvold et al., 2009; Khoraminya, Tehrani-Doost, Jazayeri, 
Hosseini, & Djazayery, 2013).  Whether vitamin D level is associated with pregnancy symptoms 
has not been studied and is the focus of this proposed study.    
The National Health and National Examination Study (NHANES) has reported data 
regarding vitamin D levels in non-pregnant childbearing women.  For non-Hispanic Black 
women, 99% had vitamin D levels <30 ng/ml and of those women, 86% had vitamin D levels < 
20 ng/ml.  For Hispanic women, 93% had levels <30 ng/ml and of those women, 60% had 
vitamin D levels <20ng/ml (Ginde, Sullivan, Mansbach, Carmargo, 2010).  Another NHANES 
study reported a mean vitamin D of 14.8 ng/ml for non-pregnant African American women and a 
mean vitamin D of 19.5 ng/ml for Hispanic women compared with a mean vitamin D of 25.6 
ng/ml for White women (Gutierrez, Farwell, Kermah, & Taylor, 2011).  Studies have shown that 
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vitamin D deficiency is very common in pregnant women, particularly in African American 
women with a mean vitamin D of 15.6ng/ml and Hispanic women with a mean vitamin D of 22.4 
ng/ml in a NHANES cohort of 928 pregnant women (Ginde et al., 2010).  An important 
consideration, in regards to the high incidence of vitamin D deficiency in pregnant women, are 
the associated adverse obstetric and fetal outcomes (Wagner, Taylor, Dawodu, Johnson, & 
Hollis, 2010; Aghajafar et al., 2013; Urrutia & Thorp, 2012). 
There is evidence to show there are vitamin D receptors (VDR) on the reproductive 
tissues including the placenta, suggesting that vitamin D may play an important part of the 
physiologic changes of pregnancy (Urrutia & Thorp, 2012).  There is mounting evidence 
indicating the consequences of having severely deficient levels of vitamin D during pregnancy 
and the impact on the fetus which include: rickets, preeclampsia, preterm birth, increased risk of 
cesarean section, low birth weight infants, maternal infections, and gestational diabetes mellitus 
(GDM) (Dawodu et al., 2017; Hamilton, et al., 2010; Wagner, McNeil, Johnson, Hulsey, 
Ebeling…et al., 2013).  
Vitamin D deficiency disproportionately affects minority groups adversely and poorer 
health outcomes have been reported in African American and Hispanic women (Weishaar & 
Vergili, 2013; Bodnar & Simhan, 2010; Hossein-Nezhad, 2012).  Because African American and 
Hispanic women are at high risk for having vitamin D deficiency, it is important to investigate if 
vitamin D deficiency could contribute to the frequency and type of pregnancy symptoms 
experienced by these women.  Based on a recent study using electronic medical record data of a 
predominantly African American and Hispanic, Medicaid, patient population, 88% of the 302 
women studied had vitamin D levels <30 ng/ml (Woo & Penckofer, 2015, April).  In addition, 
4 
 
 
 
81% of the African American women studied (n=138) were deficient with a level < 20 ng/ml 
while 50% of the Hispanic women (n= 164) were deficient with a level < 20 ng/ml (Woo & 
Penckofer, 2015, July). 
Purpose 
The purpose of this study was to determine if women who are vitamin D deficient have a 
greater frequency of pregnancy symptoms including depression and sleep disruption, which may 
alter their participation in health-promoting behaviors (e.g., eating a healthy diet, exercise) and 
consequently impact their quality of life.  Although vitamin D deficiency has been associated 
with some of the common pregnancy symptoms such as fatigue, depressed mood, 
musculoskeletal pain, urinary incontinence in women who are not pregnant, these associations 
have not been reported in pregnant women.  Understanding the relationships between vitamin D 
status and pregnancy symptoms in a population at risk for vitamin D deficiency could provide 
more clinical information and in turn improve the care delivered to these women.  Due to the 
cross-sectional nature of this study, causative linkages cannot be established but important 
relationships between vitamin D status, pregnancy symptoms, depression, sleep quality, health-
promoting behaviors and quality of life were studied. 
Theoretical Framework  
The theoretical framework chosen for this study was based on Wilson & Cleary’s (1995) 
model on health-related quality of life.  This theory examined multiple relationships affecting a 
person’s quality of life which start at an individual level but also include the environment of the 
individual that can have an overarching impact on a person’s biologic factors, symptom status, 
functional status, general health perceptions, and overall quality of life (Wilson & Cleary, 1995).  
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Wilson & Cleary developed this framework to study clinically relevant variables that impact 
quality of life.  Their model attempted to combine the established biological and physiological 
factors that are known to impact quality of life and integrated the psychosocial factors that play a 
significant role as well.  Wilson-Cleary’s model is composed of five levels of patient outcomes 
which include: biological and physiological variables, symptoms status, functional status, 
general health perceptions, and overall quality of life.  As shown in Figure 1, the model provided 
an excellent framework for the proposed study because it incorporates multiple facets of health 
that impact on overall quality of life.  
Figure 1. Adaptation of Wilson & Cleary’s (1995) conceptual model for health-related quality of 
life 
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The characteristics of the individual included in the proposed study are as follows: the 
ethnicity and race of the individual, age, education, and employment status.  The main biological 
variable in the proposed study is the serum vitamin D status as well as factors that can impact 
vitamin D level such as diet (Block’s Vitamin D and Calcium screener), season of the year for 
data collection, and level of obesity (measured as body mass index) (Holick, 2007; Hossein-
Nezhad & Holick, 2013).  Other biologic factors to be assessed include maternal health 
characteristics, anemia status (hemoglobin from complete blood count) (e.g., parity, obstetric 
history), as well as comorbid disorders (e.g., depression) and medications including vitamins.  
Symptom status will assess type and frequency of pregnancy symptoms (Pregnancy Symptom 
Inventory), sleep quality (Pittsburgh Sleep Quality Index), and depressive symptoms (Edinburgh 
Postnatal Depression Scale).  Functional status will assess health promotion activities (Health 
Promotion Lifestyles Profile scale, HPLP v.2).  General health perceptions will be assessed by 
asking women their perception on overall health in pregnancy and health of the unborn baby 
(Standard Form-12 version 2). Lastly, overall quality of life will include measures of functional 
mental and physical health and well-being (SF12, v2). 
 Characteristics of the environment that impact symptom status, functional status, general 
health perceptions, and quality of life included in this study are the following: spirituality, social 
support, and socioeconomic status (SES) as variables that impact a patient’s quality of life.  The 
inclusion of the spirituality variable is important to assess in African American and Hispanic 
women since evidence shows that spirituality is an important component that influences health in 
these ethnic groups (Koenig, 2012).  The conceptual model is depicted in Figure 1.  
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Specific Aims 
 The primary aims of this study were: (1) to determine if there was a relationship between 
vitamin D status, pregnancy symptoms including depression and sleep disruption, health-
promoting behaviors, and quality of life and birth outcomes and (2) to determine if differences 
existed in vitamin D level, pregnancy symptoms, sleep quality, depressive symptoms, health-
promoting behaviors, and quality of life between African American and Hispanic women.  The 
primary hypothesis was: Women who were vitamin D deficient would have more pregnancy 
symptoms including poor sleep quality and more depressive symptoms, fewer health-promoting 
behaviors, and poorer quality of life.  The secondary hypothesis was: There would be differences 
in pregnancy symptoms including depressive symptoms and sleep quality, health-promoting 
behaviors, and quality of life between African American and Hispanic women.  As an 
exploratory aim, if there was a significant relationship between vitamin D status and pregnancy 
symptoms, whether depressive symptoms mediated this relationship would be studied.  
 In conclusion, vitamin D deficiency is common in pregnancy and there are also multiple 
physiological discomforts of pregnancy including poor sleep, fatigue, urinary issues, and 
musculoskeletal pain which are common in pregnancy.  Since there is evidence to show that 
many of the symptoms of pregnancy such as musculoskeletal pain and poor sleep are associated 
with vitamin D deficiency in the non-pregnant population, it was important to see if this 
relationship existed in pregnant women.  The theoretical framework that guided the study was 
Wilson & Cleary’s Model of health-related quality of life which provided an understanding of 
the impact of the biological/physiological variables, its impact on symptom status, and how it 
impacted functional status and ultimately quality of life.  
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CHAPTER TWO 
LITERATURE REVIEW 
Introduction 
 As described in Chapter One, the theoretical framework that guided this study was based 
on Wilson & Cleary’s quality of life model which describes the key components affecting health-
related quality of life.  The key components reflected in their model include the following: 
biological and physiological variables, symptom status, functional status, general health 
perception and quality of life.  Individual and environment characteristics which impact quality 
of life were also integrated components. The main variable of interest in this study was the role 
vitamin D status had on symptom and functional status in pregnant women and the impact it had 
on quality of life.  Each theoretical component of the model is described below based on the 
published literature and was synthesized to provide the rationale for the proposed study. 
Characteristics of the Individual 
 Age is an important variable that can influence pregnancy symptoms, maternal health, 
vitamin D status, and quality of life (Dotlic et al., 2012; Nazik & Eryilmaz, 2014; Zib, Lim, & 
Walters, 1999).  As women get older, they may experience an increase in pregnancy symptoms 
which may or may not be related to other chronic illnesses due to aging (Bahadoran & 
Mohamadirizi, 2015; Nazik & Eryilmaz, 2014).  On the other hand, adolescent pregnant women 
may be at greater risk for pregnancy symptoms and vitamin D deficiency due to their developing 
bones, pubescence, and ever changing bodies (Williams, 2014; King et al., 2015).  
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Evidence in the literature indicates that ethnicity is an important individual characteristic 
in regards to vitamin D status.  African American and Hispanic women are more likely to be 
vitamin D deficient when compared to their Caucasian counterparts (Ginde et al., 2010; Castro & 
Penckofer, 2014; Taksler, Cutler, Giovannucci, & Keating, 2014; Holick, 2007; Hossein-Nezhad 
& Holick, 2013).  Hispanic women also have lower vitamin D levels than Caucasians, but higher 
levels than African Americans  (Ginde et al., 2010; Daly et al., 2012; Giovannucci et al., 2006).  
The NHANES data (n=14,319) which included both men and women, compared vitamin D 
status based on ultraviolet (UV) radiation and ethnicity, and showed that non-Hispanic Blacks 
were likely to be deficient despite being in the highest UV index quartile (Taksler et al., 2014).  
 Employment and education status is another individual characteristic that can  impact 
both pregnancy symptoms and vitamin D status.  Logically speaking a pregnant woman who 
works outside (e.g., mail delivery person) may have a different symptom profile than one who 
works inside (e.g., secretary) due to different vitamin D exposures from the sun. However, there 
are no studies to date that examine whether types of occupation (indoor or outdoor) impact 
pregnancy symptoms.  One study reported that employment was a significant predictor of more 
pregnancy symptoms in healthy pregnant women (n=909) who resided in Turkey (Nazik & 
Eryilmaz, 2014) . They also reported that employment was associated with a greater incidence of 
management strategies for pregnancy symptoms.   
Employment and education are often related.  Less education has been associated with 
lower vitamin D levels in epidemiologic studies (Daly et al., 2012; Forrest & Stuhldrere, 2011).  
Lower educational levels have also been associated with a decreased likelihood of informing 
healthcare providers of symptoms such as urinary incontinence and low back pain (Colapinto, 
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Rossiter, Khan, Kirk, & Veugelers, 2014; Giovannucci et al., 2006; Kahyaoglu Sut & Balkanli 
Kaplan, 2015; Telleen, 1993; Zib et al., 1999).  Thus, it is possible that women who are 
employed and/or more educated are likely to report symptoms to their healthcare providers 
because they can seek attention for treatment of these symptoms.   
Biological Factors 
 
 The main biological variable of interest for the proposed study was vitamin D status and 
its impact on pregnant women in relation to their symptoms and functional status.  There was 
significant evidence addressing the biological implications of vitamin D during pregnancy.  
Thus, a review of this information is provided.  
Vitamin D in Pregnancy 
Vitamin D status is essential not only to the mother’s health but also to the health of the 
fetus.  The need for increased vitamin D intake during pregnancy is due to the increased needs of 
the fetus (Hollis & Wagner 2012; Urrutia & Thorp, 2012; Pludowski et al., 2013).  The 
Endocrine Society defines the standard range of vitamin D as follows: adequate vitamin D level 
is > 30 ng/ml, insufficient defined as 20-30 ng/ml, deficient defined as <20 ng/ml and severely 
deficient described as <10 ng/ml (Holick, 2007).  During pregnancy with development of the 
placenta, a megalin transport system is developed that can transport the large vitamin D complex 
metabolite across the maternal-fetal surface by expressing genes CYP27B1 which can then 
synthesize the vitamin D metabolite to its active biological product of 25(OH)D (Hossein-
Nezhad & Holick, 2013; Wagner, Taylor, Dawodu, Johnson, & Hollis, 2012).  Of concern is that 
currently the American College of Obstetrics (ACOG), World Health Organization (WHO), and 
American College of Nurse Midwives (ACNM) recommend against routine vitamin D screening 
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in all pregnant women, but do recommend screening for those at high risk for vitamin D 
deficiency (Dawodu & Wagner, 2012).  Thus, pregnant women are not being routinely screened 
for vitamin D deficiency and even those at risk for vitamin D deficiency are not being tested by 
obstetric providers (Thatcher & Clarke, 2011; Kaludjerovic & Vieth, 2010; Dawodu & Wagner, 
2012).  Women at risk for vitamin D deficiency include those individuals with darker skin 
complexion (different ethnic groups), those living in northern latitudes, and those with obesity, 
malabsorptive disorders, hepatic or renal failure, and poor dietary intake (Hossein-Nezhad, 
2012).  Dawodu & Wagner (2012) described the epidemic of vitamin D deficiency as a global 
epidemic that is not being addressed to reduce the burden of disease that vitamin D 
supplementation could provide.  Therefore, there is a clinical gap in identifying and screening 
women at risk for vitamin D deficiency in pregnancy. 
 The NHANES data showed that almost three quarters of the nation’s African American 
childbearing women are vitamin D insufficient/deficient and more than half of childbearing 
Hispanic women are deficient (Yetley et al., 2010; Ginde et al., 2010).  Other studies have also 
shown that vitamin D deficiency is very common in pregnant women (Holick, 2010; 
Kaludjerovic & Vieth, 2010; McAree et al., 2013; Johnson et al., 2012).    
 There are vitamin D receptors (VDR) on all reproductive tissues including the placenta 
which supports the hypothesis that vitamin D could play an important role in the physiologic 
changes of pregnancy (Urrutia & Thorp, 2012).  There are consequences of having severely 
deficient levels of vitamin D during pregnancy which may contribute to adverse pregnancy 
outcomes such as increased incidence of GDM and preeclampsia.  The following section will 
summarize research in regards to vitamin D status and adverse pregnancy outcomes. 
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Associations of Vitamin D and Pregnancy Outcomes 
 Preeclampsia.  This is a significant adverse outcome in pregnancy because it has high 
maternal as well as neonatal morbidity and mortality (Achkar et al., 2014; Tabesh, Salehi-
Abargouei, Tabesh, & Esmaillzadeh, 2013).  Preeclampsia is an important risk factor for having 
a preterm birth since the only treatment for preeclampsia is delivery for the safety of the mother 
and fetus.  There is evidence to indicate that inflammatory cytokines are implicated in the 
development of preeclampsia and that vitamin D which has anti-inflammatory effects, may play 
a role (Achkar et al., 2014).  One mechanism of its anti-inflammatory effect is the 
downregulation of uncommitted helper T cells and promotion of the “proliferation of 
immunosuppressive regulatory T cells” (Wagner et al., 2012, p. 212).  There is also in vivo 
evidence to show that vitamin D plays a role in promoting IL-10 production which is anti-
inflammatory and suppresses the production of inflammatory cytokines like IL-6, TNFα, and 
IL1β (Korf, Decallonne, & Mathieu, 2012; Hollis & Wagner, 2013).  Therefore, in the presence 
of high levels of maternal serum vitamin D, there may be important anti-inflammatory effects 
which can potentially protect against the development of preeclampsia.   
Tabesh et al. (2013) conducted a meta-analysis of all the studies investigating the 
association of vitamin D deficiency and preeclampsia. That meta-analysis found a significant 
relationship between vitamin D deficiency and preeclampsia.  However, the authors concluded 
that more robust and well-powered studies are needed to strengthen this relationship.   
A nested case control study published findings after the meta-analysis by Tabesh et al. 
(2013) and showed promising results (Achkar et al., 2014).  That study used a robust research 
design and had a larger sample size of women with preeclampsia (n=169) and without (n=1975).  
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Strengths of this study included its method of measuring vitamin D which was 
chemiluminescence immunoassay as well as controlling for significant covariates (i.e., BMI, 
maternal age, smoking, parity, season, cohort site, and year of collection).  Their findings 
revealed an odds ratio of 2.48 (95% CI 1.29 -2.83) of preeclampsia in the low vitamin D (<30 
nmol/l which is equivalent to 12 ng/ml) group when compared to those with normal vitamin D 
levels.  Finally, it is also important to note that two randomized control trials evaluating birth 
outcomes and vitamin D supplementation corroborated the epidemiological evidence showing 
the association between preeclampsia and vitamin D (Wagner et al., 2013; Wagner et al., 2015).    
 Preterm birth.  A consequence of maternal vitamin D deficiency is the increased risk of 
preterm birth.  The main mechanism associated with vitamin D’s role in preventing preterm birth 
is its effect on the innate immune system. Vitamin D is known to activate Toll-like receptors 
(TLR) on macrophages, leading to an antimicrobial pathway evidenced in both maternal and 
neonatal blood (Walker et al., 2011; Kaludjerovic & Vieth, 2010; Wagner et al., 2012; Korf, 
Decallonne, & Mathieu, 2014).  The antimicrobial pathway has been instrumental in preventing 
perinatal infections associated with preterm delivery especially those in preventing bacterial 
vaginosis which is most common in African American women who have a higher incidence of 
vitamin D deficiency (Christesen et al., 2012; Thorne-Lyman & Fawzi, 2012; Weinert & 
Silveiro, 2014).   
A more recently published study reported a significant decrease in preterm birth in 
vitamin D deficient pregnant women who were supplemented with vitamin D.  Sablok et al. 
(2015) conducted a clinical trial where women were randomized to vitamin D supplementation 
(n=120) or placebo (n=60).  The dosages of vitamin D provided for supplementation were based 
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on their vitamin D level (the more deficient they were, the higher the dosage of vitamin D they 
received).  Doses were as follows: placebo dose vs. one dose of 60,000 IU at 20 weeks gestation, 
or two doses of 120,000 IUs at 20 and 24 weeks gestation, or 4 doses of 120,000IUs at 20, 24, 28 
and 32 weeks gestation.  One hundred percent compliance was reported since administration of 
the treatment or placebo was provided at their clinic visits.  It should be noted that the study was 
conducted in India where vitamin D deficiency is very common due to cultural and religious 
practices of wearing head to toe covering; hence, limiting sunlight exposure as well as darker 
skin complexion (Sablok et al., 2015).  Their study showed that those in the treatment group 
(8.3%) had significantly lower rates of preterm labor and birth compared to those in the placebo 
(21.1%) group (p = .02), but there were no differences in GDM or hypertensive disorders of 
pregnancy (Sablok et al., 2015). 
Four randomized controlled trials which were sufficiently powered have demonstrated 
that vitamin D supplementation reduces the risk of preterm delivery (Wagner et al., 2015; Sablok 
et al., 2015; Dawodu et al., 2013; Wagner et al., 2013).  It should be noted that for the patient 
populations studied all were pregnant women at greatest risk for vitamin D deficiency (i.e., 
African American women) (Bodnar & Simhan, 2010; Weishaar & Marcley, 2013). Evidence 
demonstrates a relationship between vitamin D supplementation and reduced rates of preterm 
delivery.  Given this information, clinicians should identify women at risk for vitamin D 
deficiency to prevent preterm delivery and consider vitamin D supplementation as an adjunct 
therapy. 
Finally, two recently published meta-analyses analyzed the impact of vitamin D 
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deficiency and preterm birth.  Both reported positive associations between vitamin D deficiency 
as defined as < 20 ng/ml and increased risk of preterm birth (Qin, Lu, Yang, Xu, & Luo, 2017; 
Zhou, Two, Huang, Zhu, & Tao, 2017).  One meta-analysis included ten studies (n=10,098) 
which showed an increased risk of preterm birth with vitamin D deficiency (defined as <20 
ng/ml) (OR = 1.29, 95% CI: 1.16–1.45) but included only observational studies.  The other meta-
analysis included randomized controlled trials and observational studies.  An association was 
found between increased preterm birth risk and vitamin D deficiency (defined as < 20 ng/ml) 
(pooled OR, 1.25; 95% CI: 1.13–1.38) (Zhou et al., 2017).  Lastly, an analysis of the randomized 
control trials using various doses of vitamin D supplementation (2000 IU to 120,000 IU) but 
excluding studies using both vitamin D and calcium supplementation also reported more than a 
50% reduction in the risk of preterm births (RR 0.57; 95%CI: 0.36-0.91).  However, this meta-
analysis did not include the clinical trials conducted by Hollis and colleagues (2013). 
Gestational diabetes mellitus.  Maternal vitamin D deficiency has been implicated in 
increased risk of GDM (Poel et al., 2012; Lu, Xu, Lu, & Zhang, 2016).  Vitamin D has been 
shown in many epidemiologic studies to influence glucose homeostasis and insulin resistance 
(Weinert & Silveiro, 2014; Burris et al., 2012; Thorne-Lyman & Fawzi, 2012).  The lower the 
vitamin D level, the increased risk of GDM diagnosis based on a meta-analysis of seven 
observational studies evaluating the risk of GDM and vitamin D deficiency and was verified in 
another meta-analysis that included twenty observational studies (Poel et al., 2012; Lu et al., 
2016).  GDM is linked to maternal and neonatal morbidities which include the following: 
increased risk of preeclampsia, macrosomia, increased risk of stillbirth, increased risk of preterm 
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birth, increased incidence of birth defects with poor control, and type 2 diabetes later in life 
(Burris & Camargo, 2014).   
Despite the plethora of correlational studies showing that vitamin D has an impact on 
glucose tolerance, there is a dearth of randomized controlled trials evaluating vitamin D 
supplementation in pregnant women with GDM.  A recent study examined vitamin D 
supplementation of 5,000 IU daily versus a placebo group receiving 400 IU of vitamin D daily, 
which is equivalent to the prenatal vitamin prescribed for women who are <20 weeks gestation 
(Yap et al., 2014).  Pregnant women were enrolled into the study after confirming their vitamin 
D levels were < 32 ng/ml, and randomly assigned to the control or treatment group, while also 
allowing pregnant women who had ≥ 32 ng/ml to be in a nonrandomized control group.  The 
control group (n=80) had twelve pregnant women who tested positive for GDM while the 
treatment group (n=78) had only seven test positive for GDM but there was not a statistical 
difference (OR 0.56; 95% CI: 0.21-1.50; p = 0.25) (Yap et al., 2014).  Although there was not a 
statistically significant difference in incidence of GDM in the two groups, the lower the baseline 
vitamin D level, the higher the fasting blood glucose on the two hour glucose tolerance test.  A 
serious limitation of this study was that women who had sufficient vitamin D levels (≥32 ng/ml) 
were included in the analysis which could have decreased the effect that vitamin D 
supplementation could have had on those who were deficient.   
  Asemi et al. (2014) evaluated women already diagnosed with GDM who were 
randomized into a treatment of one capsule of 50,000 IUs of vitamin D (n=23) or a matching 
placebo (n=22).  Participants were provided pills at 28 weeks gestation and again at 34 weeks 
gestation.  Decreased maternal polyhydramnios and infant hyperbilirubinemia, was reported but 
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no differences in cesarean section rates, insulin therapy after intervention, newborn birth size and 
Apgar score were found. However, the study was only powered for the outcomes of newborn 
weight. This study is unique because the effects of high dose supplementation of vitamin D on 
women already diagnosed with GDM was examined.  However, the small sample size was not 
sufficient to detect changes in other outcomes.   
There have been many studies with larger sample sizes that have shown an inverse 
relationship with vitamin D status and risk of GDM (Burris et al., 2012; Maghbooli, Hossein-
Nezhad, Karimi, Shafaei, & Larijani, 2008; Zuhur, Erol, Kuzu, & Altuntas, 2013; Soheilykhah, 
Mojibian, Rashidid, Rahimi-Saghand, & Jafari, 2010).  However, there are no randomized 
control trials showing a decreased incidence of GDM with adequate vitamin D supplementation 
in vitamin D deficient women.     
In contrast, another study examined a cohort of pregnant women who were enrolled at 24 
to 30 weeks gestation and followed again at 6 to 12 weeks postpartum and screened for vitamin 
D levels both in pregnancy and postpartum (Pleskacova et al., 2015). Their study showed no 
significant difference in vitamin D status between those who were diagnosed with GDM (n=47) 
vs. healthy pregnant women (n=29), as vitamin D status was low in both groups (95.7% < 20 
ng/ml in GDM group; 93.1% <20 ng/ml in control group), but the study was limited due to the 
small sample size.    
Small for gestational age (SGA) babies.  Findings of studies conducted to evaluate the 
association between SGA and maternal vitamin D deficiency are conflicting simply due to the 
variation of when vitamin D status was measured (early or late in the pregnancy) (Weinert & 
Silveiro, 2014; Bodnar & Simhan, 2010).  Many observational and cross-sectional studies have 
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shown correlations with maternal vitamin D deficiency, SGA and low birth weight (Weinert & 
Silveiro, 2014; Kaludjerovic & Vieth, 2010).  One clinical trial (Sablok et al., 2015) found that 
women who received the higher dose of vitamin D supplementation had higher birthweight 
babies.  However, Wagner et al. (2013) did not see a significant difference in birthweight in their 
randomized controlled trial where the control group received 400 IUs daily (n=110) and the 
treatment groups received either 2000 IUs (N=201) or 4000 IUs (n=193) of vitamin D daily.  
Therefore, there is a need for better quality—more sufficiently powered and well-designed 
randomized controlled clinical trials—to establish the association between vitamin D deficiency 
and SGA babies.   
Maternal health history and characteristics. There are many characteristics of maternal 
health that can impact pregnancy symptoms, quality of life and vitamin D status.  There has been 
some evidence to show that multiparous women who have a history of a forceps or vacuum 
delivery, increasing age, or obesity are prone to more pregnancy symptoms (Rodriguez, Bohlin, 
& Lindmark, 2001; Wallace, Boyer, Dan, & Holm, 1986).  However, one study of 117 pregnant 
women (34% primaparas and 64% multiparas) reported no difference in the frequency of 
pregnancy symptoms between parity (Zib, Lim, & Walters, 1999).  The top five symptoms 
reported by these women included micturition, fatigue, pelvic pressure, insomnia, and lower 
backache which were greatest during the third trimester.  Differences in types of symptoms by 
parity were noted with multigravidas having more stress incontinence and skin dryness and 
primigravidas having more striae gravidarum (Zib, Lim, & Walters, 1999).  Pregnant women 
often do not report their discomforts of pregnancy to their healthcare providers (Wang et al., 
2004; Nazik & Eryilmaz, 2014).  One study of pregnant women (n=950) reported that only 32% 
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of them told their prenatal provider about their low back pain and only 25% of providers 
recommended any treatment (Wang et al., 2004).  In addition to having low back pain, 58% of 
women reported that the low back pain caused sleep disturbances and impaired activities of daily 
living (Wang et al., 2004). 
 A history of depression and/or anxiety prior to pregnancy has been reported to impact 
coping with the symptoms of pregnancy.  In a cross-sectional study of pregnant women (n=215), 
those with severe depressive symptoms and a history of depression had higher frequency and 
intensity of pregnancy symptoms/discomforts and poorer sleep quality (Kamysheva et al., 2008).  
Another prospective study of pregnant women (n=257) showed that the intensity and frequency 
of pregnancy symptoms early in the second trimester were the strongest predictors of depressive 
symptoms experienced late in the third trimester (Kamysheva et al., 2009).  
There is a vast amount of evidence to support that women with higher body mass index 
(BMI), have lower vitamin D levels (Hollis, 2007; Grace, Vincent & Aylwin, 2014; Brock et al., 
2010).  Although the exact mechanism as to why obese individuals have lower vitamin D levels 
is not completely understood, the proposed rationale is that increased adipose tissue causes 
reuptake of the fat-soluble vitamin D which results in less bioavailable vitamin D (Grace, 
Vincent, & Aylwin, 2014).  Since African American and Hispanic women are at a higher risk for 
obesity and poorer maternal health outcomes, the role that vitamin D plays may be confounded 
by the obesity (Bryant, Warjoloh, Caughey, & Washington, 2010). However, there is evidence 
that pregnant women who are obese are more likely to be depressed, have higher levels of 
anxiety, more pregnancy symptoms and have lower quality of life (Li et al., 2012; Amador, 
Juarez, Guizar, & Linares, 2008; Doltic et al., 2014).  A study of Serbian pregnant women 
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(n=604) examining BMI, quality of life, fatigue, depression, social support, and pregnancy 
symptoms reported that obese women were more likely to have higher depression scores (using 
the Beck Depression Inventory), higher pregnancy symptoms (using Pregnancy Symptom Scale), 
and lower mental and physical health as well as decreased health-related quality of life (using the 
SF-36) (Doltic et al., 2014).    
 A meta-analysis of 62 studies examined the association between obesity and mood (i.e., 
perinatal depression and anxiety) in the antepartum and postpartum periods (Molyneaux, Poston, 
Ashurst-Williams, & Howard, 2014).  The report concluded that obese women had significantly 
higher rates of depressive symptoms in pregnancy (OR 1.43, 95% CI 1.27-1.6) and the 
postpartum (OR 1.30; 95% CI 1.20-1.42).  In addition, higher levels of antenatal anxiety were 
also reported (OR 1.41; 95% CI 1.10-1.80) (Molyneaux et al., 2014). 
Symptom Status 
Physiological and anatomical changes associated with pregnancy symptoms.  There 
are many physiological changes that occur in normal pregnancy that can cause the 
discomforts/symptoms experienced during pregnancy.  Changes in hormones (estrogen and 
progesterone) that occur during pregnancy often precipitate symptoms such as breast tenderness.  
One cross-sectional study compared the symptoms of healthy pregnant (n=117) and age-matched 
controls of non-pregnant women (n=119), and reported that symptom frequency was doubled in 
pregnant women (Zib et al., 1999).   
 The major anatomical change during a normal pregnancy includes weight gain from the 
fetus, placenta, and amniotic fluid.  Other changes due to higher hormone levels of progesterone 
and estrogen include a softening of cartilage in joints and relaxation of ligaments (King et al. , 
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2015).  Lordosis of pregnancy helps the body accommodate to the increased weight by causing 
the pelvis to tilt anteriorly and the sacroiliac joint to widen (King et al., 2015).  This can cause 
low back pain as well as pelvic pain depending upon the anatomy of the pregnant woman, fetal 
weight gain, body mechanics, type of occupation, prior history of low back pain or injury, and 
increasing age (Vermani, Mittal, & Weeks, 2011; Wang, et al., 2014).   
 Evidence suggests that 70% of pregnant women will complain of low back pain in 
pregnancy (Chang, Jensen, & Lai, 2014; Facco, Kramer, Ho, & Zee, 2010; Wang et al., 2014).  
Some studies have shown that women with low back or pelvic pain have lower quality of life in 
pregnancy and that it affects African American pregnant women disproportionately (Chang, 
Jensen, & Lai, 2015; Waterfield et al., 2015; Wang et al., 2014; Olsson & Nilssen-Wikmar, 
2004).   
 As the uterus grows, the stomach gets displaced superiorly with intestines moving 
laterally resulting in slower gastrointestinal motility (King et al., 2015).  As a result, constipation 
can be common as the uterus places pressure on the descending colon (King et al., 2015).  In 
addition, due to pressure the uterus puts on the stomach, indigestion can occur and reflux is 
common causing heartburn.  Nausea and vomiting also occur in pregnancy which may be due to 
the anatomic changes previously addressed.  However, these symptoms are not reported by all 
women during pregnancy.  Because the levels of  human chorionic gonadotropin hormone 
exponentially increases early in the first trimester, nausea and vomiting may be more frequent at 
that time and lessens as this hormone levels off as with progression of the pregnancy 
(Cunningham et al., 2010). 
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Psychological and emotional changes. Pregnancy is assumed to be a joyous mental state 
but the reality is that for many women, it can be a very tumultuous and unnerving mental state.  
There are many factors that contribute to the psychological changes that happen in pregnancy 
such as whether the pregnancy was planned or not, wanted or not, what the state of the 
relationship with the father of the baby is, socioeconomic state, medical history, history of 
mental illness prior to pregnancy, age, and social support; all of which can contribute to the 
development of depressive symptoms (Lancaster, Gold, Flynn, Yoo, Marcus, & Davis, 2010; 
Buneviscius et al., 2009).  The adjustment period to finding out about the pregnancy is 
compounded with the hormonal changes that occur with increasing estrogen and progesterone 
which can have an impact on lability of mood (Lancaster et al., 2010).   
Vitamin D and Symptom Complaints  
Vitamin D deficiency has been documented in the literature to be associated with many 
different symptoms including depressive symptoms, fatigue, sleep disorders, musculoskeletal 
pain, and pelvic floor disorders.  Many of these symptoms are common in pregnancy and 
therefore it is important to review the literature to see what the current evidence is in 
understanding the links between these symptoms and vitamin D status.   
Vitamin D and depression.  Much of the evidence related to vitamin D deficiency and 
depression has been published in the general population and many epidemiological and 
observational studies have shown the correlation between vitamin D and depression 
(Jaaskelainen et al., 2015; Kerr et al., 2015; Hogberg, Bech, Hallstrom, & Petersson, 2014; 
Parker, Brotchie & Graham, 2017).  In addition, three major meta-analyses evaluating the 
randomized controlled trials with vitamin D supplementation for treating depression have shown 
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conflicting results (Anglin, Samaan, Walter, McDonald, 2013; Spedding, 2014; Gowda, 
Mutowo, Smith, Wluka, & Renzaho, 2015).  Anglin et al. (2013) and Spedding (2014) both 
showed a significant effect of vitamin D supplementation in reducing depressive symptoms.  
However, Gowda et al. (2015) showed no significant reduction in depressive symptoms with 
vitamin D supplementation but included individuals with sufficient levels of vitamin D in their 
study.  This is a significant limitation as vitamin D supplementation may not improve depressive 
symptoms in persons who are vitamin D sufficient.  A strength of another meta-analysis was that 
the studies with biological flaws and those without were examined separately, and the effect size 
for the ones without biological flaws showed an effect size of vitamin D supplementation 
comparable to that of an anti-depressant medication (Spedding, 2014).  Results of the studies are 
summarized in Appendix E (Table 1). 
The mechanism behind vitamin D and depression has been widely debated.  However, 
evidence indicates that vitamin D receptors located in the brain could play a role in mental illness 
(Patrick & Ames, 2015; Hogberg et al., 2014).  Specifically, it has been suggested that serotonin, 
the hormone responsible for mood regulation, is potentially modulated by vitamin D.  Therefore, 
when vitamin D is deficient, serotonin synthesis can be impacted which can lead to depression, 
anxiety, and other psychiatric disorders (Hogberg et al., 2014; Patrick & Ames, 2015).  In 
addition, vitamin D receptors (VDRs) are involved in the regulation of the hypothalamic-
pituitary axis (HPA) and sympathetic nervous system which is important because dysregulation 
of the HPA and sympathetic nervous system is implicated in depression (Hogberg et al., 2014).   
Despite most of the evidence showing a correlation with vitamin D deficiency and 
depression in adults, one study examined a cohort of 3,251 men and women in the Netherlands 
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aged 55 and older (Jovanova et al., 2017).  This was a population cohort study that demonstrated 
a cross-sectional association with vitamin D status and depression but not a longitudinal 
association.  Serum vitamin D levels were only drawn at baseline along with a baseline Center 
for Epidemiologic Scale–Depression (CES-D) score and follow up CES-D assessments after year 
one and year two.  Participants were followed up to an average of ten years and assessed for 
major depressive disorder diagnosis on their medical record, but serum vitamin D was not taken 
again.  Therefore the analysis was based on whether baseline vitamin D deficiency (defined as 
37.5 nmol/l or 15.2/bg.ml) which was predictive of depressive symptoms and/or major 
depressive disorder over time (Jovanova et al., 2017).  Their study was limited because it is 
unknown if those who were vitamin D deficient at baseline took vitamin D supplements which in 
turn could have improved their vitamin D levels, thus reducing depressive symptoms. 
In addition to the evidence presented about vitamin D and depression which has focused 
on the non-pregnant population, recent literature has been reported on vitamin D and depression 
during pregnancy and the postpartum.  In the past five years, the evidence has significantly 
increased in studies examining vitamin D status and perinatal depression . Appendix E, Table 2, 
delineates studies examining vitamin D status and perinatal depression.  To date, all the studies 
have been observational in nature except for one. Therefore more interventional studies 
evaluating whether vitamin D supplementation in pregnant women improves depressive 
symptoms are warranted. 
The cross-sectional studies have been conducted measuring vitamin D in early pregnancy 
with assessment of depressive symptoms in late pregnancy and/or in postpartum period. Because 
a variety of tools were used for assessing depressive symptoms comparison across studies is 
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difficult. Of the ten studies published, two studies showed no significant association between 
vitamin D status and depressive symptoms, but the participants were predominantly Caucasian 
(Nielsen et al., 2013; Gould et al., 2015).  For example, the study by Gould et al. (2015) had a 
sample of Australian women who were mostly Caucasian (n=919) (non-Caucasian, n=121) and 
only 8% had vitamin D levels < 25nmol (10 ng/ml).  The study conducted by Nielsen et al. 
(2013) used evidence of filling anti-depressant medications as its only measure of depression 
using a retrospective chart review in a case control study.  This study showed no difference risk 
of postpartum depression in those women who had a vitamin D level < 15 nmol/L (6 ng/ml) 
(Nielsen et al., 2013).  A limitation of this methodology is that only individuals prescribed 
medication for depression treatment were studied.  In addition, women who may have had 
counseling as a treatment and those who were not screened at all for postpartum depression were 
not captured.  Evidence shows that many postpartum women go undiagnosed and untreated 
therefore; therefore, using a depressive symptom tool would be beneficial to capture a greater 
incidence of these symptoms (Banti et al., 2011; Bernstein et al., 2008; Bonari et al., 2004). 
The studies that did show a strong association between vitamin D status and depressive 
symptoms in pregnant women or postpartum women were in predominantly African American 
and Latino patient populations.  Thus, race and/or ethnicity may be an important variable for 
consideration in effectiveness.  Cassidy-Bushrow, Peters, Johnson, Li, & Sudhaker (2012) 
demonstrated a significant association of vitamin D deficiency and depressive symptoms (using 
the CES-D) (OR 0.54, 95% CI, 0.29-0.99).  That study included only African American pregnant 
women in a low socioeconomic community and showed that the odds of higher depressive 
symptoms (CESD≥16) decreased by 46% for every one unit increase of log transformed vitamin 
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D level (~2.72 ng/ml).  Another study with an ethnically diverse sample (43 Caucasians, 30 
African Americans, 23 Hispanic, and 1 Asian) showed that postpartum EPDS scores were higher 
for those who had lower vitamin D levels using vitamin <32 ng/ml as the cutoff  when compared 
to those who were sufficient (vitamin D deficiency and > 32 ng/ml) (Murphy, Mueller, Hulsey, 
Ebeling, & Wagner, 2010).  Another study by Robinson et al. (2014) reported that women who 
had the lowest level of vitamin D < 47 nmol (18 ng/ml) were most likely to report postpartum 
depressive symptoms (OR 2.19, 95% CI, 1.26-3.78).  A unique component of this study was that 
depressive symptom screening was done at three days postpartum while participants were still in 
the hospital status post-delivery (Robinson et al., 2014).  However, one of the limitations of 
screening so close to birth is that the volatility of emotions may occur right after childbirth 
especially if there were neonatal complications post-delivery (Gjerdingen & Yawn, 2007; Gavin 
et al., 2005). 
Finally, there was one randomized controlled trial which assessed for an improvement of 
depressive symptoms in Iranian pregnant women (n=169) (Vaziri et al., 2016) following vitamin 
D supplementation.  The sample had a mean vitamin D level of 12.35 ng/ml and pregnant 
women received either a placebo or 2000 IU of vitamin D and both groups were permitted to 
take their prenatal vitamin which has 200-400 IUs of vitamin D. Their study excluded anyone 
who had pregnancy complications, multiple gestation, history of mental illness, or any medical 
complications such as thyroid disease, diabetes, heart disease, etc.  Despite using such a low 
vitamin D supplementation dose for a population so severely deficient, a significant 
improvement of depressive symptoms was noted at 38-40 weeks gestation (p = .01) and 
postpartum at 4 weeks and 8 weeks (p <.0001) (Vaziri et al., 2016).  Of concern, however, is that 
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by the end of the study, only 8% of the sample had a vitamin D level > 30 ng/ml.  Therefore the 
supplementation dose used in the study was not adequate, suggesting that if a higher dose had 
been used, perhaps a greater impact on depressive symptoms would have been seen.  Therefore, 
more robust and well-designed studies need to be done to assess the impact that vitamin D 
supplementation could have on depressive symptoms in pregnancy. 
Vitamin D and sleep.  The link between vitamin D deficiency and sleep disorders has 
been shown in some observational studies with non-pregnant individuals (Appendix E, Table 3).  
Since vitamin D target sites have been found on the areas of the brain that have to do with sleep, 
it is possible that vitamin D may play a role in sleep regulation (Gominiak & Stumpf, 2012).  
The brainstem and periventricular areas of the brain are responsible for the retinal projections of 
light cues involved in the sleep/wake cycle of the circadian clock.  Therefore, if vitamin D plays 
a role in the maintenance of this sleep-wake regulation, then deficient levels of vitamin D could 
potentially cause sleep disturbance (Gominiak & Stumpf, 2012).  In animal studies, vitamin D 
target sites have been documented in the neurons in the midbrain and in the basal forebrain and 
hypothalamic periventricular region which can influence different parts of the sleep cycle 
(Gominiak & Strumpf, 2012).   
There is quite a spectrum of sleep disorders but many of the studies have focused on 
Restless Leg Syndrome (RLS) which is a sensorimotor neurological disorder which causes 
uncontrollable limb movements primarily in the ankles and calves at night leading to sleep 
disturbance (Balaban et al., 2012). In one study, individuals with Vitamin D deficiency as 
measured by < 20 ng/ml (50 nmol/L) had more severe RLS scores when compared to those with 
vitamin D ≥ 20 ng/ml (Cakir et al., 2015).  Interestingly enough, most of the participants in the 
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study were women, as RLS is more common in women than in men, and women are also more 
likely to be vitamin D deficient when compared with men (Cakir et al., 2015; Brock et al., 2010).  
 Vitamin D deficiency is often associated with concurrent musculoskeletal pain and 
muscular myopathy as will be described below, potentially interfering with normal sleep patterns 
(McCarty, Chesson, Jain, & Marino, 2014).  In a pilot study including patients being evaluated at 
a sleep disorder clinic with complaint of nonspecific musculoskeletal pain, 153 patients were 
included in the sample and assessed for vitamin D status (McCarty, Reddy, Keigley, Kim, 
Cohen, & Marino, 2013).  The mean vitamin D for the patient cohort was 19.8 ng/ml with 77 
women who had obstructive sleep apnea and RLS as the most common sleep diagnoses. The 
study also reported that Black ethnicity, age < 60 years, and obesity predicted vitamin D 
deficiency with a 0.73 sensitivity and 0.74 specificity.  In contrast, in another study examining 
elderly (60-80 years) Korean adults (n=1614), vitamin D deficiency was also associated with 
shorter sleep (Kim, Chang, Kim, & Kang, 2014).  Study limitations included self-reported sleep 
duration.  However, another study using actigraphy measurements with elderly U.S. men showed 
that vitamin D deficiency was associated with shorter sleep duration and poorer sleep efficiency 
function (Massa, et al., 2015). 
 Ethnicity is an important factor that can have a significant impact on not only vitamin D 
deficiency but also the presence of sleep disorders (Andersen & Tufik, 2012).  A study of 
patients (n=81) who were largely female (95%) being seen at a sleep disorder clinic who had 
complaints of musculoskeletal pain reported no association between excessive daytime 
sleepiness and vitamin D status when the analysis was run on the total sample.  However when 
evaluating just the African American patients (35%), there was a significant correlation between 
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lower vitamin D status and excessive daytime sleepiness (McCarty Reddy, Keigley, Kom, & 
Marino, 2012).  Another study (n=1721) found similar results in that those who were vitamin D 
deficient (<20 ng/ml) and were more likely to be African American had shorter sleep duration 
and poorer sleep efficiency based on actigraphic measurements (Bertisch, Sillau, de Boer, Szklo, 
& Redline, 2014).  Their study included an older population with a mean age of 68.2 years and 
an ethnically diverse sample with 37.2% being White, 27.7% being African American, 11.9% 
being Chinese American, and 23.2% being Hispanic.  
 One of the few intervention studies that evaluated sleep quality and vitamin D deficiency 
was a one-armed intervention done on veteran men who had complaints of chronic pain that 
showed improvement of pain, sleep latency, sleep duration, and various aspects of quality of life 
(Huang, Shah, Long, Crankshaw, & Tangpricha, 2012).  The study design incorporated two 
groups, a vitamin D deficient group (< 20 ng/ml) and vitamin D insufficient (20 to 29 ng/ml). 
Findings indicated that 84% of the deficient group was made up of African American males and 
60% of the insufficient group was made up of African American males.  Pain was measured on a 
0 to 10 analog scale, but also using the bodily pain subscale of the SF-36.  In addition, the SF-36 
subscales for physical functioning and physical role functioning, and sleep quality using the 
PSQI were assessed, and all demonstrated statistical improvements following vitamin D 
supplementation.   
 One study examining vitamin D and sleep quality was conducted with women who were 
at 36 weeks gestation of their pregnancy (n=91), which showed no associations between vitamin 
D status and sleep quality (using the Pittsburg Sleep Quality Index) (Gunduz et al., 2015).  The 
mean vitamin D level was 22.9 ng/ml, and no difference in sleep quality was found between 
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women classified into deficient (< 20 ng/ml) or non-deficient (>20 ng/ml) groups.  However, 
sleep quality was reported to be poor for both groups.  The study had some limitations in that it 
only included women who had delivered babies at term and without complications. 
 Poor sleep quality is common in pregnancy and can be related to other pregnancy 
symptoms.  A large study of pregnant women (n=2427) assessing sleep quality using the 
Pittsburgh Sleep Quality Index (PSQI), the Epworth Sleepiness Scale (ESS), the vitality scale of 
the SF-36, the Insomnia Severity Index (ISI), the International Restless Legs Syndrome 
questionnaires, and a short version of the Pregnancy Symptom Inventory (PSI), reported that the 
majority reported experiencing poor sleep quality (76%) (Mindell, Cook & Nikolovski, 2015).  
An important finding also reported was that a high frequency of pregnancy-related symptoms 
was correlated with poorer sleep quality (Mindell et al., 2015).  In conclusion, poor sleep quality 
and sleep disturbances are common in pregnancy.  Since there is evidence to show that vitamin 
D deficiency could exacerbate poor sleep, it is important to address these issues since they can 
affect the health of both the mother and baby (Mindell, Cook & Nikolovski, 2015). 
Vitamin D and musculoskeletal pain.  There is a plethora of data published about the 
association of vitamin D deficiency and musculoskeletal pain as evidenced below by (Appendix 
E, Table 4).  The mechanism by which vitamin D plays a role in musculoskeletal pain is in 
calcium/ phosphorus homeostasis; however, there are other ways vitamin D affects skeletal 
muscle (Girgis, Cliften-Bligh, Hamrick, Holick, & Gunton, 2013).  Vitamin D receptors are 
found in skeletal muscle and are involved in not only calcium homeostasis but muscle 
contraction by calcium influx affecting muscle contractility (Girgis et al., 2013).  In addition, in 
animal models and some human models vitamin D receptors have been found in skeletal muscle 
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providing evidence that vitamin D status is essential in establishing muscle strength and muscle 
mass (Girgis et al., 2013).  This would explain why those who are vitamin D deficient are more 
prone to myalgias, myopathy, and falls or fracture risks (Wacker & Holick, 2013).   
In evaluating the evidence of vitamin D deficiency and musculoskeletal pain, most of the 
studies include an overwhelming majority of women in their sample sizes (Lodh et al., 2015; 
Bergstrom, Palmer, Persson, & Blanck, 2014; Le Goaziou et al., 2014; Al-Jarallah, Shehab, 
Abraham, Mojiminiyi & Abdella, 2013; Schreuder, Bernsen, & van der Wouden, 2012; Knutsen 
et al., 2010; Lofti, Abdel-Nasser, Hamdy, Omran, & El-Rehany, 2007; Gerdhem, Rinsgberg, 
Obrant, & Akesson, 2005; Plotnikoff & Quigley, 2003).  There has been evidence to suggest that 
there is a differing impact of vitamin D deficiency on musculoskeletal pain based on ethnicities.  
Studies that have included immigrant women from Middle Eastern, South Asian, and African 
countries and also those that have a significant African American population are noted to have 
more severe vitamin D deficiency as well greater musculoskeletal pain (Plotnikoff & Quigley, 
2003; Lodh et al., 2015; Bergstrom et al., 2014; Schreuder et al., 2012; Knutsen et al., 2010; 
Lofti et al., 2007).   
A recent meta-analysis which included nineteen randomized controlled trials (n=3,436) 
provided limited confirmation that vitamin D supplementation improved pain scores when 
compared to the placebo (mean difference -0.57, 95% CI:-1.00 – -0.15, p = .007) (Wu, Malihi, 
Steward, Lawes & Scragg, 2016).  However, there was significant heterogeneity of studies 
included in the analysis with some studies that recruited patients with chronic pain and some 
with localized pain.  In addition, the vitamin D supplementation provided in the studies varied 
from high dose (100,000) to low dose (as low as 400 IU) (Wu et al., 2016).  
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One of the only studies that actually included pregnant women showed that vitamin D 
levels were significantly lower in immigrant women (n=68) when compared with a control group 
of native Swedish women (n=51) at 12 weeks gestation who also had significantly higher pain 
scores for complaints of musculoskeletal pain (Bergstrom et al., 2014).  The study was a 
prospective study that evaluated a cohort of immigrant women and control group of native 
Swedish women who were pregnant and had musculoskeletal pain complaints.  Vitamin D levels 
were drawn at 12 weeks gestation and again at 6-12 months postpartum.  The pain scores in the 
immigrant women group had improved by 6 months postpartum which correlated with increased 
levels of vitamin D without mention of vitamin D supplementation in either groups (Bergstrom 
et al., 2014).  When comparing the vitamin D levels to those of native Swedish pregnant women 
(N=50), 77.9% of the immigrant women had vitamin D levels of <25 nmol/L (10/ng/ml) whereas 
only 3.9% of the controls.   
There is evidence that women are at risk for both musculoskeletal pain and vitamin D 
deficiency, however there is not sufficient evidence for causality (Straube, Straube, & Moore, 
2015).  Using the Cochrane Database, only ten studies after rigorous review for quality and 
design were included in a meta-analysis demonstrating no statistically significant difference 
between placebo and vitamin D supplementation in treating chronic painful conditions (Straube 
et al., 2015).  The meta-analysis included a vast array of chronic painful conditions such as 
fibromyalgia, rheumatoid arthritis, osteoarthritis, and non-specific musculoskeletal pain, and 
used a variety of administration methods of vitamin D supplementation from oral to parenteral 
administration.  Therefore, the eclectic nature of studies could explain the nonsignificant results.  
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Vitamin D and pelvic floor disorders.  Pelvic floor muscles are challenged and strained 
during a normal pregnancy.  There is some evidence that vitamin D deficiency could be 
associated with greater incidence of pelvic floor disorders.  The rationale behind vitamin D and 
pelvic floor disorders follows the same rationale as with other musculoskeletal systems. Vitamin 
D receptors in the pelvic floor muscles may provide support and strength to the bladder and 
urethra.  Only one study to date has examined this phenomenon in pregnant women.  A cross-
sectional study of pregnant women (n=148) in their third trimester who were in a university 
hospital setting had blood drawn for vitamin D levels at about 36 weeks gestation (Aydogmus et 
al., 2015).  Women were grouped based on mode of delivery and by vitamin D status (deficiency 
defined as <15 ng/ml and sufficiency as>30 ng/ml).  Pelvic floor muscle strength was measured 
at 8 to 10 weeks postpartum using a perineometer, pelvic floor disorder symptoms were 
measured using Urinary Distress Inventory short form (UDI-6), and the Incontinence Impact 
Questionnaire short form (IIQ-7) was also administered.  Results indicated that women who were 
vitamin D deficient had significantly worse pelvic floor muscle strength, both in women who had 
vaginal deliveries and cesarean section.  
 Many epidemiological surveys have been done to test the association of vitamin D 
deficiency and pelvic floor disorders for both men and women (Appendix E, Table 5), with a 
significant increased odds of vitamin D deficiency in those with pelvic floor disorders.  To date, 
there have been no randomized control trials evaluating if vitamin D supplementation improves 
pelvic floor disorders. 
 Vitamin D and fatigue. The hallmark symptom of vitamin D deficiency reported in the 
general population is that of fatigue (Roy, Sherman, Monari-Sparks, Schweiker, & Hunter, 
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2014).  In the EViDiF (Effect of correction of Vitamin D in Fatigue) study, patients (n=132) who 
had complaints of fatigue, stable chronic medical conditions, and had vitamin D (<30 ng/ml) 
were given 3 doses of 50,000 IUs of ergocalciferol (D2) weekly for five weeks.  This was a one-
armed study with no control group.  The sample (n=174) was 71% women and was 21% African 
American.  Patients completed the Multidimensional Fatigue Symptom Inventory–short form 
(MFSI–SF) prior to and following supplementation.  Overall, there was a significant 
improvement in fatigue symptoms after treatment (Roy et al., 2014).  In addition, there has been 
another clinical trial evaluating primary care patients (n=138) with mild (20-25 ng/ml), moderate 
(10-19ng/ml), and severely deficient (<10 ng/ml) levels of vitamin D (Arvold et al., 2009).  
Those who had mild or moderate symptoms (n=50 per group) were randomized to 50,000 IUs 
cholcaleciferol or placebo.  For those who were severely deficient all (n=38) were given 50,000 
IUs of cholecalciferol.  Patients took their medications for eight weeks.  To measure symptoms, 
the Fibromyalgia Impact Questionnaire (FIQ) was used which assessed fatigue, generalized 
aching, aching muscles, and muscle weakness (Arvold et al., 2009).  Following treatment, there 
was a significant improvement in FIQ scores in the treatment groups versus the placebo 
(p=0.03).   
 Another recent double blind placebo-controlled clinical trial to assess impact of vitamin 
D supplementation for treatment of fatigue indicated a significant improvement of fatigue 
symptoms with vitamin D treatment (Nowak et al., 2016).  Their study provided a one-time oral 
dose of 100,000 IU of vitamin D (n=58) compared to placebo (n=62) to participants who 
complained of fatigue but were otherwise healthy and also vitamin D deficient (<20 ng/ml).   
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 Fatigue is one of the most common pregnancy symptoms and one of the most debilitating 
(Nazik & Eryilmaz, 2013; Zib, Lim, & Walters, 1999).  There is a gap in the literature however 
as to whether or not fatigue in pregnant women is associated with vitamin D deficiency.  Since 
fatigue is common during pregnancy, understanding the role of vitamin D is important since 
fatigue can cause limitations of activities of daily living which could easily be corrected.  
Functional Status 
 
 Health behaviors such as increased physical activity and nutrition in pregnant women 
have been correlated to better birth outcomes and less depressive symptoms in pregnancy 
(Beckham et al., 2015; Ko, Chen, & Lin, 2015; Kowalska, Olszowa, Markowska, Teplik, & 
Rymaszewska, 2014; McCullough et al., 2015; Misra, Strobino, Stashinko, Nagey, & Nanda, 
1998; Mourtakos et al., 2015).  Physical activity has been shown to be associated with higher 
vitamin D levels in many epidemiologic studies and found to be a modifiable predictor of higher 
vitamin D status (Colapinto et al., 2014; Daly et al., 2012; Gerdhem, Ringsberg, Obrant, & 
Akesson, 2005; Moreno, Valtueña, Pérez-López, & González-Gross, 2011).  The rationale for 
this is that those who engage in physical activity are more likely to be outside in the sun, and 
more likely to have healthier diets (Daly et al., 2012; Colapinto et al., 2014). 
 Another important component of functional status is nutritional intake during pregnancy. 
Healthy nutritional intake is very important for maintaining healthy gestational weight gain in 
pregnancy.  A study done in Spain in Hispanic pregnant women (n=2585), showed that 
predictors for increased fruit and vegetable intake based on the Food Frequency Questionnaire 
(FFQ) were increasing age, higher educational attainment and increased physical activity (Villar-
Vidal et al., 2015).  Compliance with a healthier diet in pregnancy is even more important due to 
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the consequences not only to the mother but the fetus as well.  One study examined vitamin D 
intake and dietary intake in obese and normal weight pregnant women (Karlsson et al., 2014).  
They evaluated the vitamin D status in the first trimester of obese (n= 25) and normal weighted 
(n=80) pregnant women and found that obese women had 33 % higher dietary intake of vitamin 
D in both food and supplement use and yet had significantly lower vitamin D levels when 
compared with normal weighted pregnant women.  Obtaining sufficient vitamin D from dietary 
intake is difficult to achieve, and increased body mass index makes it even more difficult so 
supplementation is even more important in these situations (Hollis & Wagner, 2004; Hollis, 
2012; Ng et al., 2014).  
Quality of Life in Pregnancy 
 
 There is a gap in the literature, as there is no evidence evaluating the association of 
vitamin D status and quality of life in pregnant women.  However there have been some studies 
that have evaluated vitamin D status and quality of life in other patient populations.  A 
systematic review of the literature evaluated vitamin D supplementation and quality of life.  This 
review included 15 articles and found that most of the studies had methodologic flaws such as no 
randomization and blinding (Hoffmann, Senior, & Mager, 2015).  In addition, the studies 
included a variety of patient populations ranging from healthy to those with chronic diseases, and 
ages from adolescence to the elderly (Hoffmann et al., 2015).  Many of the studies did not report 
mean vitamin D levels prior to and following supplementation.  In some of the studies, the 
treatment dose included only 400 IUs of vitamin D.  This is concerning since a dose of 400 IUs 
is often seen as a placebo and will have minimal to no impact on the level.  (Baggerly et al., 
2015; Holick, 2007; Hollis & Wagner, 2004; Wagner et al., 2012). 
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 However, one cross-sectional study that evaluated ninety-seven rheumatoid arthritis (RA) 
patients included measures for vitamin D, quality of life (SF-36), depression (Beck Depression 
Inventory), pain, fatigue, and physical activity (Health Assessment Questionnaire) (Raczkiewicz, 
Kisiel, Kulig, & Tlustochoqicz, 2015).  Their study indicated that those RA participants who had 
lower vitamin D levels (<20 ng/ml) had higher pain scores and higher depression scores and 
lower SF-36 scores for physical quality of life (Raczkiewicz et al., 2015).  Although results from 
this study cannot be applied to pregnant women, it is interesting to note their study focused on an 
at-risk population for pain and their sample also included 86 women and only 11 men. 
Characteristics of the Environment 
 
Spirituality.  Spirituality is an individual characteristic that may impact a women’s 
health during pregnancy.  Spirituality has often been cited as a positive resource, as it relates to 
health, particularly in the African American and Hispanic communitird (Mann, McKeown, 
Bacon, Vesselinov, & Bush, 2012; Jesse, Graham, & Swanson, 2004; Bonelli, & Koenig, 2013).  
Spirituality in pregnancy has been shown to be protective against depressive symptoms, prenatal 
stress, and anxiety (Mann et al., 2012; Jesse, Graham, & Swanson, 2004; Cheadle et al,. 2015).  
One study comprised of largely low-income African American pregnant women (n=130), 
reported that psychosocial risk factors and lower spirituality predicted smoking and substance 
abuse (Jesse, Graham, & Swanson, 2006).  Another study of low socioeconomic African 
American women (n=702) reported that those who had lower spirituality and religiosity scores at 
baseline ( 6-12 weeks postpartum) had increased depressive symptoms at 6 -10 months as well as 
12-15 months postpartum after controlling for significant confounders (e.g., family support, 
perceived emotional support, SES) (Cheadle et al,. 2015). 
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Social support.  Another essential characteristic of the environment is social support.  
Social support is a vital psychosocial variable that has a profound impact on the mental and 
emotional health of pregnant women.  It is not only in pregnancy that social support has been 
shown to have protective effect on health outcomes, but in the general population as well 
(Salinero-Fort et al., 2011; White et al., 2009).  Strong social support in pregnancy has been 
linked with decreased adverse birth outcomes, prenatal stress, and depressive symptoms (Collins 
et al., 1993; Dominguez et al., 2005; Sumner et al., 2011).  One study examined psychosocial 
factors like social support, intimate partner violence, trauma exposure, and post-traumatic 
distress symptoms in low income pregnant Latina pregnant women (n=203) and followed them 
at three months postpartum (Sumner et al., 2011).  They reported that positive emotional well-
being was correlated with increased levels of social support, being foreign-born, and residing in 
the United States for less than ten years (Sumner et al., 2011).  For low income, pregnant African 
American pregnant women (n=1383), it has been reported that positive social support serves as a 
mediator between the adverse effects of poor neighborhood quality and perceived stress 
(Giurgescu et al., 2015).  For high risk pregnant women (n=105), it has been reported that social 
support has a direct effect on preparation for motherhood (Giurgescu, Penckofer, Maurer, & 
Bryant, 2006).  Therefore, social support is a protective resource that can impact maternal well-
being in vulnerable populations. 
Socioeconomic status.  Another environmental characteristic affecting quality of life 
during pregnancy is socioeconomic status.  Lower socioeconomic status has been associated with 
poorer health outcomes in pregnancy due to a lack of resources, increased stress, and depressive 
symptoms (Giugescu et al., 2013; Berkman, 2009; Curry, Latkin, & Davey-Rothwell, 2008).  
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Lower socioeconomic status is associated with living in poorer neighborhoods that have a higher 
incidence of violence and crime.  The detrimental impact of these poorer neighborhoods on 
pregnant women in terms of health outcomes is recently emerging (Giurgescu et al., 2015; 
Acevedo-Garcia et al., 2004; Culhane & Elo, 2005; Kim, 2010; Sealy-Jefferson, Giurgescu, 
Helmkamp, Misra, & Osypuk, 2015).   
Poorer neighborhoods and violence ridden areas may also have an impact on vitamin D 
status. It is logical to assume that persons, who live in neighborhoods with violence, will spend 
less time outdoors due to fear or the perception of unsafe conditions, thus not reaping the 
benefits of the natural absorption of vitamin D.   Thus, socioeconomic status should be 
considered when examining the quality of life of pregnant women. 
In conclusion, there is mounting evidence in regards to the role that vitamin D status has 
on symptom status which provided the theoretical basis for the proposed study.  Since there is a 
gap in the literature in regards to the role that vitamin D status has in pregnancy and its 
relationship with symptoms, health-promoting behaviors, and quality of life, the proposed study 
was undertaken.   
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CHAPTER THREE 
METHODOLOGY 
This chapter will address the study design, the clinical setting including the sample 
population and recruitment strategies, and methods of data collection, and all of the measurement 
tools used for the study will be described.  Vitamin D deficiency is very prevalent in African 
American and Hispanic women especially for those living in a northern latitude.  The primary 
aim of the study was to determine if women who were vitamin D deficient had more symptoms 
of pregnancy.  In addition, whether women who were vitamin D deficient reported fewer health-
promoting behaviors and poorer quality of life was studied.  An exploratory aim of the study was 
to test if depressive symptoms mediated the relationship between vitamin D status and pregnancy 
symptoms, and also to test any ethnic differences in pregnancy symptoms between African 
American and Hispanic women. 
Design 
A cross-sectional design was used to explore the relationships between variables of 
interest (Hulley, 2008).  This study examined the relationships between vitamin D and individual 
characteristics, biological factors, symptom status, functional status, and their impact on health-
related quality of life.  All of the variables were collected at one time point.  Therefore, causal 
inferences cannot be made because temporal precedence will not be established.  Due to the 
nature of the design, it cannot be assumed that the independent variables caused the dependent 
variables, but associations will be established.  Therefore, the study explored the associations
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between vitamin D (independent variable) and symptoms, functional status, and quality of life 
(all dependent variables of interest). 
Setting 
 The study was conducted in a federally qualified health center (FQHC) in an urban, 
predominantly Medicaid patient population located in a northern latitude.  As shown in pilot 
data, vitamin D deficiency is highly prevalent in the population to be studied.  Woo and 
Penckofer (2015, April) showed that 88% of childbearing women had vitamin D levels less than 
30 ng/ml at this FQHC.  The study site has a medically and economically at-risk patient 
population serving predominantly African American and Hispanic women.  The FQHC has six 
different clinic locations where obstetric patients were being seen.  Data collection occurred at 
all of these sites in the winter and spring time to capture women when they are most at risk for 
vitamin D deficiency. 
Sample 
An essential step in research design is establishing an adequate sample size to see a 
statistically significant effect, which is done through a power analysis.  Since there have been 
limited studies that have looked at pregnancy symptoms, an estimated fifteen participants per 
predictor variable will be used to achieve power (Stevens, 1999).  Since there are seven main 
variables being studied which include vitamin D status, pregnancy symptom status, depressive 
symptom status, health behaviors, quality of life, and social support and spirituality, the 
estimated sample size for the study was 105 participants (15 x 7= 105).  However, in order to 
account for missing data (maximum of 20%), 125 participants were recruited.   
The sampling procedure used was convenience.  A prior data-mining research study done 
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by the researcher showed that among childbearing women, 88% of a sample size of 302 women 
had vitamin D levels <30ng/mL; therefore it would be a patient population that was accessible 
and was largely vitamin D deficient (Woo & Penckofer, 2015, April).  Inclusion criteria were the 
following: 1) > 18 years of age; 2) speak and read English or Spanish; 3) confirmed pregnancy at 
24 to 32 weeks gestation; and 4) willing to have an extra blood draw for vitamin D level if 
necessary (if recruited before or after their GDM screen).  Exclusion criteria were the following: 
1) significant mental health issues (e.g., treatment for substance abuse, psychosis, bipolar 
disorder, or schizophrenic episode; 2) pre-gestational diabetes, HIV infection, and any 
autoimmune disorder such as multiple sclerosis or systemic lupus erythematosus.  
The rationale for excluding  patients with diabetes was that evidence suggests that 
depressive symptoms are more prevalent in women with type 1 or type 2 diabetes (Doyle, 
Halaris, & Rao, 2014; Penckofer, Doyle, Byrn, & Lustman, 2014; Park, Park, Quinn, & Fritschi, 
2015; Fritschi et al., 2012).  Since pregnant women with HIV infection and autoimmune 
disorders may be more symptomatic and are referred to a collaborating maternal fetal medicine 
provider, they were also excluded.        
Recruitment of Study Participants 
 Recruitment of study participants was from all six of the outpatient clinics at the FQHC 
that cared for a large obstetric patient population.  A letter was sent to all current and future 
pregnant patients describing the study along with study contact information (Appendix B).  
Addresses of all pregnant patients in their first trimester and early second trimester were 
extracted from the electronic medical record and an informational study letter was sent 
(Appendix B).  
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 A meeting was arranged with all obstetric providers to enlist provider support for study 
recruitment.  Once approval was given, medical assistants were informed about the study and 
given flyers to distribute to patients of providers who agreed. Flyers were also posted at all six 
clinic locations. The sample flyer (in Appendix C) was approved by the Clinic Quality 
Assurance team at the FQHC and the Institutional Review Board (IRB) of Loyola University.   
The investigator recruited in the main obstetric clinic at the FQHC where 40% of the 
obstetric patients were seen and enrolled as they came for their appointments.  Potential 
participants were also approached while waiting for their appointment and consented in a private 
area.  Patients completed the questionnaires while waiting to be seen, and finished after their 
provider appointment if needed.  Blood was drawn after their appointment in conjunction with 
their two-hour glucose tolerance test, when possible.  This is the diagnostic screening tool used 
at this facility to assess for GDM.   
The investigator also viewed the list of scheduled obstetric patients each week to be 
strategic about which clinic to recruit at on a daily basis.  The investigator also received phone 
calls from interested patients that heard about the study through the study flyer, and discussed the 
details about the study to these patients.  If the patient was interested, the investigator met them 
at their next scheduled obstetric appointment.  
Some of the clinical sites provided prenatal care in a group setting known as “Centering 
Pregnancy”.  The investigator also attended group sessions at each of the sites that conducted 
“centering groups” to describe the study, determine eligibility to participate, and if agreeable, 
enroll participants.  The investigator then collected the data at that time if participants were 
willing to participate or scheduled another time convenient for them.  
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Collection of Data  
Informed consent was reviewed and signed (see Appendix D) for each participant. 
Patients completed the self-report questionnaires while in the waiting room or in the centering 
room.  As stated previously, after their clinic visit with the provider, they had their vitamin D 
level drawn, along with their two-hour glucose tolerance test for GDM screening when 
applicable.  One red top tube (3 ml) was drawn, and the blood centrifuged after 30 minutes to 
obtain the serum via pipetting.  According to Quest laboratory standards, at least 0.5 ml of serum 
was placed in a plastic screw top tube, labeled with their study identification number, and placed 
in the refrigerator for Quest pickup.  
Once all questionnaires were completed and reviewed for missing data and blood was 
collected, participants were given a $20 stipend.  The results of the serum vitamin D level was 
given to the primary care provider by the principal investigator, who then reviewed the test 
results with their patient at their future prenatal visit. 
Measurements 
 The study measurements were organized using the Wilson & Cleary Health-Related 
Quality of Life Model.  The variables were grouped according to the major components of that 
model: individual characteristics and environment, biological and physiological variables, 
symptom status, functional status, and quality of life.  The tools are listed in Table 1 and the 
instruments are included in Appendix A in both English and Spanish.  The description of each 
instrument and its reliability and validity is addressed below.  
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Table 1. Variables and Measurements of Study  
 Variable Measurement Data collection 
method 
Characteristics of the 
Individual 
Race/Ethnicity  Demographic form 
(created by researcher) 
 
Self-report 
Age Demographic form 
(created by researcher) 
 
Self-report 
Employment status Demographic form 
(created by researcher) 
 
Self-report 
Education status 
 
Demographic form 
(created by researcher) 
 
Self-report 
Type of prenatal care 
(centering vs. 
traditional) 
Demographic form  Self-report 
Intent to breastfeed 
 
Demographic form Self-report 
WIC status 
 
Demographic form Self-report 
Biological  and 
Physiological Factors 
Vitamin D status 
 
Dietary screener for 
vitamin D and 
Calcium 
Season of collection 
Quest LC-MS 
 
Block’s Vitamin D/Ca 
short screener 
 
Demographic form 
Serum via 
venipuncture 
Self-report 
 
 
Self-report 
 
 Body Mass Index 
Current weight 
 
 
Pre-pregnancy weight 
Height and weight 
conducted at visit;  
 
 
 
Demographic form 
Scale and 
stadiometer 
measures 
 
 
Self-report 
 Hemoglobin  EMR collection of 
complete blood count per 
clinic protocol 
EMR 
 Results of 2 GTT EMR collection  
 
EMR 
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Table 1 (cont.)    
    
 Maternal Health 
Factors 
(medical and obstetric 
history, mental health 
history, medications) 
Demographic form  Self-report 
 Gestational age at 
delivery 
Birthweight 
Complications 
Type of delivery  
EMR collection from 
mother’s record 
EMR 
Symptom status Pregnancy symptoms Pregnancy Symptom 
Inventory (frequency and 
limitations on activities 
of daily living) 
 
Self-report 
 Depressive symptoms Edinburgh Postnatal 
Depression Scale 
(EPDS) 
 
Self-report 
 Sleep symptoms Pittsburgh Sleep Quality 
Index (PSQI) 
 
Self-report 
Functional status Health behaviors  Health-promoting 
Lifestyles Profile 
(HPLPv2) 
 
Self-report 
 Limitations of 
pregnancy symptoms 
on activities of daily 
living 
PSI subscale Self-report 
Overall Quality of life Quality of life  SF-12 
 
Self-report 
Characteristics of the 
environment 
Socioeconomic Status Demographics form 
 
Self-report 
 Spirituality Spiritual Perspectives 
Scale 
 
Self-report 
 Social Support Multidimensional Scale 
of Perceived Social 
Support (MSPSS) 
 
Self-report 
 Marital status 
 
Demographics form Self-report 
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Characteristics of the Individual 
Demographics.  Important demographic information about participants such as their age, 
race/ethnicity, employment status, and education status were collected on a form created by the 
investigator (Appendix A-Instruments). Relevance of each of these demographic variables is 
discussed in Chapter Two. 
Biological and Physiologic Factors 
Vitamin D serum.  There has been much controversy over the years as to the best 
method for measurement of serum vitamin D.  The methods (radioimmunoassay and high liquid 
performance chromatography) to measure vitamin D levels in the clinical population have 
generated different results in the literature relative to the association of vitamin D and various 
health outcomes (Wallace et al., 2010; Hollis, 2010).  
 The gold standard in vitamin D research has been the liquid chromatography and mass 
spectrometry method which is costly, but separates out vitamin D2 and D3 metabolites (Holick, 
2007; Phinney et al., 2012; National Institute of Standards and Technology, SRM 972a).  
Phinney et al. (2012) provided the basis for the Standards Resource Manual (SRM) that certifies 
the adequacy of the measurement of vitamin D metabolites and recommended liquid 
chromatography and mass spectrometry as the gold standard for measuring the three different 
metabolites of vitamin D: total serum, vitamin D2, and vitamin D3.  However since measurement 
of the different vitamin D metabolites was not needed, radioimmunoassay was selected for the 
study. 
 Quest diagnostics has been the leading provider for vitamin D measurement using the 
radioimmunoassay which is consistent with the NHANES data, Centers for Disease Control 
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certified, and meets all internal quality standards for measuring serum vitamin D.  For this 
reason, the proposed study used Quest Diagnostics to run the serum vitamin D levels.  The 
clinical site is certified by Occupational Safety and Health Administration (OSHA) and the Joint 
Commission on Accreditation of Healthcare Organizations (JCAHO) for use at the FQHC and 
follows strict standards for laboratory procedures.   
Vitamin D dietary intake.  Torin Block’s vitamin D and calcium screener was 
developed from their more widely known Food Frequency Questionnaire that is an extensive 
self-report evaluation of diet assessment using a law of averages approach (Cummings, Block, 
McHenry, & Baron, 1987).  It has 19 food items and three questions on supplement use and 
questions that adjust for food fortification practices (Cummings et al., 1987).  The Block vitamin 
D/calcium screener was tested for validity against a seven-day food record on 37 senior citizen 
women with a strong correlation (r = 0.76) (Cummings et al., 1987).  The Vitamin D/Calcium 
screener was also validated against a four-day food record over one year to a sample of 260 
women in the age range of 45-70 years of age with a moderate correlation (r = 0.64) (Block, 
Woods, Potosky, & Clifford, 1992). 
 The vitamin D/calcium screener was only available in English and had not been 
translated into Spanish.  Therefore, in order to include dietary vitamin D intake in the proposed 
study that included Spanish language participants, a professional language translation service 
was employed to translate the Block’s vitamin D/calcium screener into Spanish.  Nutriquest 
which is the company that owns the copyright on the vitamin D/calcium screener has given 
permission to the investigator for translation of the tool into Spanish (T. Block & K. Kline, 
personal communication, May 14, 2015).  The translation was performed by VIA Translation 
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Incorporated and the instrument is enclosed in Appendix A along with its attestation for 
translation.   
 VIA Translation Incorporated has provided a certified and licensed Spanish translation of 
Block’s vitamin D/calcium screener.  An outside linguist was employed to review the final 
translation and to confirm that translation was adequate.  A clear limitation of using this 
translated instrument is that it has no psychometric data available for this version, but was being 
assessed in this study.  
Symptom Status 
Pregnancy symptom inventory.  The Pregnancy Symptom Inventory (PSI) is a 41-item 
questionnaire to assess common symptoms that pregnant women report and their corresponding 
limitations on activities of daily living.  The instrument was created to be used as a clinical tool 
for healthcare providers to refer pregnant women for appropriate consultations if needed in 
regards to their symptoms.  An initial list of 40 symptoms was generated by asking seven 
physicians and midwives working in the Maternity Outpatient Department of their health system 
(Foxcroft, Callaway, Byrne, & Webster, 2013).  This list of 40 symptoms was then given to a 
series of focus groups with women in different trimesters of pregnancy.  Many of the symptoms 
on the first list were elicited from the focus groups and one item was added to allow participants 
to report a symptom not already listed (Foxcroft et al., 2013).  The 41-item inventory rates each 
of the 41 symptoms on a likert scale: 0 = never experiencing the symptom, 1 = a little of the time 
experiencing the symptom, 2 = sometimes experiencing the symptom to 3 = often experiencing 
the symptom, with an option of writing in a 42nd symptom if it was not listed.  If the participant 
marks “1” or greater for a pregnancy symptom, the participant then answers how limiting this 
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pregnancy symptom is on their activities of daily living (1 = “not limited at all”, 2 = “limited a 
little”, and 3 = “limited a lot”).   
Test-retest reliability with several days in between administration has been reported in 
pregnant women (n=211).  Correlations ranged from 0.51 to 1.0 when examining each item, for 
test-retest, and most of the items had correlations ≥ 0.70.  For this study, the symptoms most 
frequently reported as “often” included urinary frequency, tiredness, poor sleep, and back pain 
(Foxcroft et al., 2013).   
For the proposed study, a total symptom score was calculated using all items.  In 
addition, a descriptive analysis of which of these symptoms was most bothersome was done.  
Because this tool has only been used for clinical utility and not for research purposes, reliability 
and validity is described in Chapter Four.  
The PSI was not available in Spanish, so a professional translation service, VIA 
Translation Incorporated, was also used to officially translate the document.  Two professionals 
who spoke Spanish and worked with the intended population translated the document separately 
and then compared translations.  The verbiage for symptoms and wording was adjusted based on 
two independent reviewers.  This copy of the tool in Spanish was then given to the VIA 
translation services to certify the translation as another means of ensuring validity of the 
translation.  The certificate for translation is in Appendix A.   
Depressive symptoms.  The measure chosen for depressive symptoms in pregnancy was 
the Edinburgh Postnatal Depression Scale developed by Cox, Holden and Sagovsky (1987).  The 
EPDS is a 10-item instrument using a likert scale asking the respondent to rate how often they 
had a certain thought or feeling ranging from 0 = no, never, 1 = not very often, 2 = yes, 
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sometimes, 3 = yes, most of the time.  The responses vary based on the question but have a range 
score of 0 to 3, with a minimum score of zero and a maximum score of 30.  Respondents rate 
their symptoms based on how they have felt in the past seven days.  Murray and Cox (1990) 
tested the validity of the EPDS for screening of depression in pregnant women (n=100) who 
were between 28 and 32 weeks gestation.  The EPDS had a sensitivity of 75% and specificity of 
90%.  Validity of the EPDS was established by its ability to distinguish between minor and 
major depression.  The positive predictive value was 50% (Murray & Cox, 1990).  Reliability of 
the EPDS has been established with Cronbach alphas ranging from 0.73 to 0.91 in a systematic 
review (Kozinksy & Dudas, 2014).  
More recent studies have provided validity and reliability evidence for the EPDS for 
depression screening in pregnancy.  Bunevicius, Kusminskas, Pop, Pedersen, & Bunevicius 
(2008) reported a test-retest reliability for the EPDS of 0.81 and a sensitivity of 92% and 
specificity of 95% for women in the first trimester.  A sensitivity of 92% and specificity of 92% 
was reported for women in the second and third trimesters.  The Spanish translation of the EPDS 
has reported a sensitivity of 79% and specificity of 95.5% with a positive predictive value of 
63.2% (Garcia-Esteve, Ascaso, Ojuel, & Navarro, 2003).   
Sleep quality.  The Pittsburgh Sleep Quality Index (PSQI) was used to measure sleep 
quality symptoms.  The PSQI is a 19-item instrument that generates seven component scores 
which include: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, 
use of sleeping medication, and daytime function.  The majority of items ask the respondent to 
rate their sleep symptoms on a Likert scale with responses ranging from 0 = not during the past 
month to 3 = three or more times per week, which is calculated into a global score.  A global 
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PSQI score of >5 indicates a “poor sleeper” and in their original study, a diagnostic sensitivity of 
89.6% and a specificity 86.5% was reported (Buysse, Reynolds, Monk, Berman, & Kupfer, 
1988). 
 PSQI was used in prospective study of pregnant women (n=252) who completed the 
Beck Depression Inventory (BDI) and the PSQI in their second and third trimesters of pregnancy 
(Skouteris, Wertheim, Germano, Paxton, & Milgrom, 2009).  The PSQI had a Cronbach alpha of 
0.71 at first time-point (15 to 23 weeks gestation) and then Cronbach alpha of 0.76 at the second 
time-point (29-39 weeks gestation).  However, when removing the sleeping medication 
component (since many of the sleeping aids cannot be used in pregnancy), the Cronbach alpha 
improved to 0.72 and 0.78 respectively.   
The Spanish PSQI has been validated in Peruvian pregnant women (n=652) who were ≤ 
16 weeks gestation and had low incomes (Zhong, Gelaye, Sanchez, & Williams, 2015).  The 
Cronbach alpha was 0.57 and although internal consistency was low, it had good construct 
validity as evidenced by strong correlations with depressive symptoms (measured by Patient 
Health Questionnaire–9) (r = 0.49) and anxiety (Generalized Anxiety Disorder–7) (r = 0.46).  
(Zhong et al., 2015).  Another study looking at a population of Spanish speaking Hispanics of 
Mexican descent (n=792) who completed the PSQI over the phone, reported a Cronbach alpha of 
0.77.  However, the women in this study were not pregnant (Tomfohr, Schweizer, Dimsdale, & 
Loredo, 2013).  The Spanish version of the PSQI has been well validated and shown to have a 
Cronbach alpha of 0.77 to 0.89 in a variety of populations (Cuellar, Baldwin, Benavente, & 
Crowe, 2010).  
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Functional Status 
Health-promoting behaviors.  The instrument selected to measure health-promoting 
behaviors was the Health Promotion Lifestyles Profile v. 2 (HPLPv.2).  The psychometric 
properties of the HPLP were established using literate adult volunteers (n=952) (Walker, 
Sechrist, & Pender, 1987).  It showed a Cronbach alpha of 0.919 and a test-retest (3-week time 
period) reliability of 0.854 (Walker, Sechrist, & Pender, 1987).  The HPLP was updated in 1996 
to the HPLP version 2 (Walker & Hill-Polerecky, 1996)   
The HPLPv.2 is a 52 item self-report questionnaire that assesses six domains which 
include the following: health responsibility, physical activity, nutrition, spiritual growth, 
interpersonal relations, and stress management.  Respondents are asked to rate the frequency of 
the reported behavior reflecting each of these domains using a Likert scale ranging from 1 = 
never 2 = sometimes, 3 = often, or 4 = routinely. The Cronbach alpha for internal consistency 
has been reported as 0.943 for the total score with the range for each of the six domains from 
0.793 to 0.873 (Walker & Hill-Polerecky, 1996).    
The HPLPv2 was tested in 100 pregnant women and 90 non pregnant women to establish 
psychometrics of this population (Telleen, 2003).  The Cronbach alpha was reported as 0.93, and 
the subscale scores ranged from 0.72 to 0.89.  
 The HPLPv.2 has been validated in Spanish.  Walker, Kerr, Pender and Sechrist (1990) 
reported a Cronbach alpha for the total score as 0.93, a two-week test-retest reliability of 0.86, 
and the alpha coefficients for the subscales from 0.70 to 0.87.  To establish these psychometrics, 
Hispanic adult students (n=499) in an adult basic education class for English as a second 
language class in a local community college were surveyed (Walker, Kerr, Pender, & Sechrist, 
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1990).   It should be noted that the HPLPv.2 Spanish version has not been used with Spanish-
speaking Hispanic pregnant women, so the current study assessed reliability and validity of this 
measure for the proposed study.   
Quality of Life 
Standard form–12 (SF-12).  Quality of life was measured using the SF-12.  It is a 12-
item questionnaire that is an abbreviated version of the parent instrument of the Medical 
Outcomes Survey known as the SF-36 (Ware & Sherbourne, 1992).  The SF-36 is an instrument 
that measures generic self-report quality of life and has been used in a vast array of populations 
including elderly, pregnancy, multiple sclerosis patients, cancer patients, healthy adult, etc. 
(Kossakowski et al., 2015).  The SF-12 was created as an abbreviated version to decrease 
participant burden and increase convenience.   
 SF-12 measures two different components, physical health and mental health.  Each 
component is assessed by six items.  The scores are standardized using norm-based references 
and a score of 50 (out of 100) equates an average quality of life and function whereas scores less 
than 30 represents functioning at a level lower than 98% of the population (Ware, Turner-
Bowker, & Gande, 2005).  The SF-12 was used to study health-related quality of life in a 
population of predominantly Caucasian pregnant women (n=363) at three time points (36 weeks 
gestation, 6 weeks postpartum and 12 weeks postpartum) (Emmanuel & Sun, 2013).  The 
Cronbach alpha for the total score of the SF-12 at 36 weeks gestation was 0.81, at 6 weeks 
postpartum was 0.83, and at 12 weeks postpartum was 0.86.  The Cronbach alpha based on the 
U.S. population in 2009 for MCS was 0.88 and for PCS was 0.92 (Ware et al., 2010).  The 
Spanish version of the SF-12 has also shown sound psychometric properties with a Cronbach 
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alpha of 0.87 and was used on pregnant primarily foreign born low income Latina women 
(n=203) living in the Los Angeles area (Sumner et al., 2011).   
Characteristics of the Environment 
Characteristics of the environment are included on the demographic and health form 
created by the investigator (Appendix A).  These variables included the participant’s spirituality, 
social support, socioeconomic status (demographic form), and marital status (demographic 
form).   
Spirituality.  Spirituality is an individual characteristic often reported by the African 
American and Hispanic communities which may positively impact the well-being of pregnant 
women (Mann, 2008).  To measure spirituality in a reliable method, the Spiritual Perspectives 
Scale was used. This scale is a 10-item instrument created by Pamela Reed, a nurse researcher.  
This instrument “measures person’s perspectives on the extent to which spirituality permeates 
their lives” and the degree to which “they engage in spiritually-related interactions” (Reed, 1987, 
p.337).  The instrument uses a 6-point likert scale with the first four questions asking about the 
frequency of spiritual activities (e.g., “In talking with your family or friends, how often do you 
mention spiritual matters?”), with responses ranging from 1 = not at all to 6 = about once a day).  
The next six questions ask about the significance of their spiritual activities or beliefs with likert 
responses ranging from 1 = strongly disagree to 6 = strongly agree. 
 The Spiritual Perspectives Scale has been reported as a valid and reliable instrument for 
African American pregnant women (Dailey & Stewart, 2007).  The Cronbach alpha was reported 
as 0.91, which is comparable to other studies looking at predominantly White pregnant women 
which was 0.91 (Jesse & Reed, 2004).  The construct validity of the instrument has been 
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established, as there are high correlations with other spirituality and religiosity scales and low 
correlations with measures of depression using the Center for Epidemiologic Studies–Depression 
(CES-D) and the Profile of Mood States (POMS) as well as the measure of stress using the 
Perceived Stress Scale (PSS).   
 The SPS has also been shown to be reliable in a Spanish speaking population.  The 
Cronbach alpha for one study on HIV-infected women in Columbia showed an internal 
consistency of 0.92 (Perez-Giraldo, Veloza-Gomez, & Ortiz-Pinilla, 2012).  Another study that 
examined cardiovascular risk factors in older Hispanic women in the U.S. showed a Cronbach 
alpha of 0.77 (Etnyre et al., 2006).  It should be noted that the tool has not been used in Spanish-
speaking pregnant women, but due to the acceptable psychometric evidence of its use in 
Spanish-speaking Hispanic women, it has been selected to be used for the proposed study. 
Social support.  The instrument selected to measure social support was the 
Multidimensional Scale of Perceived Social Support (MSPSS).  This is a 12-item instrument that 
measures subjective social support using a Likert scale where 1 = very strongly disagree to 7 = 
very strongly agree) (Zimet, Dahlem, Zimet, & Farley, 1988).  There are three subscales of 
significant other support, family support, and friend support.  The psychometrics of the 
instrument were tested on pregnant women.  Data reported a Cronbach alpha of 0.92 for the total 
score, 0.90 for the family subscale, 0.94 for the friend subscale, and 0.90 for the significant other 
subscale.   
 The Spanish version of the MSPSS has demonstrated acceptable psychometric properties 
with a Cronbach alpha of 0.85 in elderly men and women (Mantuliz & Castillo, 2002).  
Measurement equivalence has been demonstrated between the English version of the MSPSS and 
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the Spanish version (Landeta & Calvete, 2002).  The instrument has been shown to have a fourth 
grade reading level and has been used in low-income and culturally diverse samples (Canty-
Mitchell & Zimet, 2002; Sigler & Rank, 2007; Stephens, Stein, & Landrine, 2010). 
Human Subjects Protection 
 The proposed study was submitted to the Institutional Review Board at Loyola University 
and received approval from the proposed recruitment site from the board of directors and IRB at 
Loyola (see Appendix D).  An informed consent form (Appendix D), was signed by each 
participant and was available in English and was translated professionally by VIA translators 
into Spanish upon IRB approval of the English version.  Attestation of the Spanish translation of 
the informed consent is found in Appendix D.  The consent form informed the participant that 
their healthcare provider at the proposed clinic site would be notified if a positive response was 
noted on question number 10 of the EPDS (“The thought of harming myself has occurred to 
me”).  The participant would then be assessed by the clinician for safety before returning home. 
 The patient questionnaire booklet was assigned the same identification number as their 
blood sample.  All data was aggregated and no identifiers were used for the analyses. All the 
participants’ information was be coded with an identification number so responses remained 
anonymous.  The tools completed on paper were kept by the investigator in a locked file cabinet.  
The electronic information was also password-protected on the investigator’s computer.  
 Since participants could potentially experience some discomfort due to the venipuncture, 
the proposed study minimized this harm by timing enrollment to the time of GDM screening so 
there was only one blood draw.  The amount of blood drawn for the vitamin D was one 3 ml red 
top tube per Quest protocol.  The amount of blood removed for this study is minimal and will not 
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put the pregnant woman or the growing fetus at risk for any harm since blood volume in 
pregnancy increases by 35-50% (King et al., 2015).  Because it was possible that participants 
could experience some distress while filling out the EPDS, they were instructed to inform the 
principal investigator or healthcare provider if distress was experienced.  The EPDS was a tool 
used in the clinical practice where recruitment occurred so participants had previous exposure to 
these questions.     
 There were no direct benefits to women for participating in the study.  However, since 
participants could inquire about the importance of vitamin D status in pregnancy, they were told 
to discuss this with their healthcare provider.  The results of the vitamin D were given to the 
participant’s obstetric provider.  The informed consent stated that the participants would be paid 
a stipend for their participation in the study, although this was not a benefit of study 
participation.  
Statistical Analysis 
 Description of the statistical analyses proposed to answer each research aim will be 
described below. 
Aim 1  
To determine if there was a relationship between vitamin D status (sufficient vs. 
deficient), pregnancy symptoms including depression and sleep disruption, health-promoting 
behaviors, and quality of life and birth outcomes. 
Hypothesis 1.  Individuals who have deficient levels of vitamin D are hypothesized to be 
more likely to have more pregnancy symptoms, poor sleep quality, more depressive symptoms 
and engaged in less health-promoting behaviors and/or have decreased quality of life.  
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Conversely, it is hypothesized that individuals engaging in health-promoting behaviors are less 
likely to have deficient levels of vitamin D.  With vitamin D measured on a binary scale as 
sufficient (vitamin D level >30 ng/ml) versus deficient (vitamin D level <30 ng/ml), both 
univariable and multivariable binary logistic regression models were used to assess the 
association between these outcomes and vitamin D status.  As a measure of effect size, 
univariable odds ratios along with their 95% confidence intervals were reported, and based on 
univariate analysis, multivariable models were reported with adjusted odds ratios for each factor 
after controlling for significant factors impacting the outcome.  In order to assess what predictors 
were significantly different between vitamin D groups, a series of Chi-square tests and 
independent sample t-tests and ANOVA tests were used and reported. 
Aim 2  
To determine if differences existed in vitamin D level, pregnancy symptoms, sleep 
quality, depressive symptoms, health-promoting behaviors, and quality of life between African 
American and Hispanic women. 
Hypothesis 2.  There would be differences in vitamin D levels, pregnancy symptoms, 
sleep quality, depressive symptoms, health-promoting behaviors, and quality of life between 
African American and Hispanic women.  For Aim 2, vitamin D levels as well as all study 
outcomes were compared between the African American and Hispanic women samples.  For 
those measures that are of interval level data, t-tests were used to assess for differences between 
these two groups. 
Exploratory aim.  If a significant relationship between vitamin D levels and total 
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pregnancy symptom scores was found, it would allow for a mediational analysis to be conducted 
to assess if depressive symptoms mediated the relationship between vitamin D levels and 
pregnancy symptom scores. 
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CHAPTER FOUR 
 
RESULTS 
 
This chapter will describe the results of the study.  Basic descriptive statistics on the 
study sample will be delineated along with each of the key study variables.  In addition, each of 
the study aims will be addressed. The primary aim evaluated the relationship between vitamin D 
status and pregnancy symptoms including depression and sleep disruption, health behaviors, 
quality of life, and birth outcomes.  The secondary aims evaluated ethnic differences in vitamin 
D status and pregnancy symptoms, sleep quality, depressive symptoms, health behaviors, and 
quality of life between African American and Hispanic women.  The exploratory aim assessed 
whether or not depressive symptoms was a mediator between vitamin D status and pregnancy 
symptom profiles.    
Enrollment 
 Three main recruitment strategies were used.  First, a letter explaining the study was sent 
to all eligible women (babies were 24-32 weeks gestational age) who received prenatal care at 
the sites of data collection.  The clinic generated the mailing list (approved by the IRB at the site) 
for the sole purpose of sending the recruitment letters.  The letters (Appendix B) were mailed in 
the middle of February, 2016.  The second strategy for recruitment was from attendance at 
Centering Pregnancy groups which are standard group prenatal visits based on the month of the 
patient’s due date.  Each Centering Pregnancy group was given a brief presentation of the study, 
and women were asked to participate if they met the inclusion criteria.  Many
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women were amenable to participating and due to the nature of the groups, were all in the 
targeted gestational age range.  The last strategy was at the time of their obstetric appointment, 
where the PI determined women’s interest in the study.  Since one of the clinic sites (A) was the 
main obstetric clinic, the PI was predominantly at this location where 70.4% (n=88) patients 
were recruited.  However, there were a total of five other clinic sites where the rest of the 
patients were recruited: 13.6% (n=17) at site B, 6.4% (n=8) at site C, 4% (n=5) at site D, 4% 
(n=5) at site E, and 1.6% (n=2) at site F.  Many clients were open to participating in the study 
because they had heard about the study via letter and/or flyers in the clinic.  Also, many 
providers at the site talked to their patients and referred them for participation.    
 Figure 2 illustrates the flow of patient enrollment.  The Centering groups proved to be the 
best recruitment method as 67 women were enrolled by this strategy. Since many women were 
waiting at the clinic for their glucose tolerance test for two hours either before or after their 
Centering group, they were quite open to participation.  
Figure 2. Enrollment flow diagram  
 
  
63 
 
 
 Overall, the combination of mailed letters, seeing flyers about the study in the clinic, and 
referral to the study by their prenatal providers was the most successful recruitment strategy. 
There were about fifteen patients (12%) who received the letter and called the PI to make 
arrangements for study participation at their prenatal appointment.   
 The final sample of 125 pregnant women was achieved in a little over three months 
(March to early June, 2016).  Most of the sample was recruited in the spring season aside from 
six participants, therefore minimizing seasonal differences on vitamin D levels.  The recruitment 
site was also in a northern latitude state, therefore exposure to sunlight during winter months was 
less.  
Data Entry  
 
All self-reported questionnaires were entered manually by the PI and were de-identified 
so that participants were only identified by an assigned ID number.  Raw data were entered 
directly into SPSS software (SPSS Windows version 22.0, Chicago, IL).  Data double data entry 
was done on the entire sample.  Percent error based on double data entry was 5.2%, and 
discrepancies were addressed by referencing the patient questionnaire.  Therefore, data quality 
was ensured with zero percent discrepancy noted upon completion.  In addition, scores for all of 
the instruments were manually calculated for five random participants in order to compare the 
SPSS syntax created to tabulate the scores for each of the instruments.  By doing this, it provided 
evidence of accuracy of the syntax created for the instruments. 
Missing Data  
 Once data entry was completed, a table was created that listed any missing data from the 
self-report questionnaires and EMR data.  There were very limited missing data as the researcher 
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would examine the booklets upon submission for any missing data.  One participant was only 
able to complete the main outcome questionnaires (demographic tool, PSI, SF-12, and the EPDS 
instruments) as she was sent to the hospital by her provider following her visit to rule out 
preterm labor contractions.  
 There were five symptoms (study ID #004–symptom dizziness; study ID #016–symptom 
thrush; study ID # 081–symptom taste changes; study ID #092–symptoms breast pain, and sore 
nipples) which were reported by participants (n=4), but they did not complete the limitation of 
the symptom to their activities of daily living.  Thus, this aspect of the measurement was not 
obtainable on these individuals. 
Discussion of Key Study Variables  
 
 Each of the key study variables were analyzed for normality and outliers.  Using SPSS 
version 22.0, each variable was tested for normal distribution based on visualization of their 
histograms and evaluating skewness and kurtosis using the Shapiro-Wilks test of significance.  
The Shapiro-Wilks test was selected because the sample size is relatively small (n=125) (Field, 
2009).  In the present sample, the only variables normally distributed were the physical 
component score (PCS) and mental component score (MCS) of the SF-12 quality of life 
instrument.  All others were not normally distributed and will be described in the following 
sections.  The analysis of the variables will be described based on the theoretical model outlined 
in chapter one.  Characteristics of the individual (demographics, medical/obstetric history, 
spirituality), characteristics of the environment (SES and social support), and 
biological/physiologic factors (vitamin D status, hemoglobin, hemoglobin A1C), symptom status 
(PSI, PSQI, EPDS), functional status (HPLPv.2, PSI subscale), general health perceptions, and 
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quality of life (SF-12).  
Characteristics of the Individual  
 In order to assess the characteristics of the individual that could impact quality of life, 
demographic, medical history, and obstetric history were collected.  
Description of the Sample 
 As shown in Table 1, almost half the sample was Hispanic (42%) and the rest were non-
Hispanic (58%).  Race was distributed as African American (49%), White (5.6%), mixed (1.6%) 
and Asian (0.8%). Women were predominantly either single, living with or not living with their 
partner (71.2%), had an income < $40,000 (87.2%), had at least a high school education (86.4%), 
were predominantly on Medicaid insurance (77.6%), had an unplanned pregnancy (65.6%), had 
no history of depression (88%) or anxiety (93.6%), did not have GDM (86.4%), and planned to 
breastfeed (80%).  The sample was predominantly multiparous (78.4%). The average self-
reported pre-pregnancy BMI was 28.35 (SD=7.8), however BMI was not available on six 
participants since they failed to report a pre-pregnancy weight.  According to CDC guidelines, 
BMI greater than 25 and up to 29.99 is considered overweight, thus many women were 
overweight.   
 Table 2 includes a description of the total sample and a breakdown by vitamin D 
deficient (< 20 ng/ml) and sufficient (> 20 ng/ml) groups using Institute of Medicine (IOM) 
guidelines (Ross et a., 2012).   To see if there were any differences in demographics between 
vitamin D groups, statistical testing was done.  Findings indicated that there were differences 
between groups for income (χ2(4) = 11.2, p = .025), planned pregnancy (χ2(1) = 5.45, p = .020) 
and plan to breastfeed (χ2(1) = 3.98, p = .046).  There were also significant differences when 
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comparing African American and Hispanics ( χ2(1) = 10.02, p = .002).  Overall, the deficient 
group was more likely to be African American, lower income, had a higher unplanned pregnancy 
rate, and had a higher rate of not planning on breastfeeding.  
Table 2. Description of Sample 
Variable 
 
Total Sample 
n= 125 (%) 
Vitamin D 
<20 ng/ml (n=73) 
Vitamin D 
≥ 20 ng/ml (n=52) 
Age         Mean (SD) 
                Range 
26.77 (5.7) 
18-43 
26.10 (5.4) 
18-39 
27.73(5.7) 
18-43 
Gestational age 
Mean (SD) 
Range 
 
27.7 
24-32.6 
 
27.9(2.5) 
24.1-32.6 
 
27.5(2.5) 
24-32.4 
Primipara 
 
27(21.6) 
 
15(20.5) 
 
12 (23.1) 
 
Multipara 
 
98(78.4) 
 
58 (79.5) 
 
40 (76.9%) 
 
*Race/Ethnicity 
Black 
Hispanic 
White 
Asian 
Mixed 
 
62 (49.6) 
53 (42.4) 
7 (5.6) 
1 (0.8) 
2 (1.6) 
 
46 (63) 
24(33) 
1(1.3) 
0 
2(2.7) 
 
16(30.7) 
29(55.8) 
6(11.5) 
1(2) 
0 
Pre-pregnancy BMI 
Mean (SD) 
Range 
 
28.35(7.8) 
16.8-53.0 
 
29.0(8.0) 
16.8-53.0 
 
27.5(7.7) 
18.6-50.40 
 Marital Status 
Married 
Divorced 
Separated 
Single, living with 
partner 
Single, not living 
with partner 
 
35 (28) 
0 (0) 
1 (0.8) 
48 (38.4) 
 
41 (32.8) 
 
15(20.5) 
0(0) 
1(1.3) 
29(39.7) 
 
28(39.5) 
 
20(38.4) 
0 
0 
19(36.5) 
 
12(23.1) 
*Income 
<$5,000 
$5,000 to $14,999 
$15,000 to $24,999 
$25,000 to $39,999 
>$40,000  
 
 
39 (31.2) 
20 (16.0) 
29 (23.2) 
21 (16.8) 
16(12.8) 
 
 
27(37) 
11(15) 
21(29) 
7(9.6) 
7(9.5) 
 
 
12(23) 
9(17.3) 
8(15.4) 
14(27) 
9(17.3) 
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Table 2 (cont.)    
    
Employment 
Full time 
Part time 
Unemployed 
Other________ 
 
 
38 (30.4) 
32 (25.6) 
50 (40) 
5 (4) 
 
22 (30.1) 
17(23.3) 
31(42.5) 
3(4.1) 
 
16(30.7) 
15(28.8) 
19(36.5) 
2(4) 
Education Status 
 
< High School 
High school 
Associate’s degree/ 
Technical college 
Some college 
College degree 
Graduate degree 
 
 
 
17 (13.6) 
50 (40) 
8 (6.4) 
 
35 (28.0) 
6 (4.8) 
9 (7.2) 
 
 
9(12.4) 
32(43.9) 
5(6.8) 
 
23(31.5) 
2(2.7) 
2(2.7) 
 
 
8(15.4) 
18(34.6) 
3(5.7) 
 
12(23.1) 
4(7.7) 
7(13.5) 
 
Type of insurance 
Medicaid 
Medicaid HMO  
Private insurance  
Obamacare plan 
No insurance 
 
 
47 (37.6) 
50 (40) 
23 (18.4) 
2 (1.6) 
3 (2.4) 
 
 
27(37) 
31(42.5) 
11(15.1) 
2(2.7) 
2(2.7) 
 
20(38.5) 
19(36.5) 
12(23.1) 
0 
1(1.9) 
 
*Planned Pregnancy 
No 
Yes 
 
 
82 (65.6) 
43 (34.4) 
 
 
54(74) 
19(26) 
 
 
28(53.8) 
24(46.2) 
History of 
Depression 
No 
Yes 
 
 
110 (88) 
15 (12) 
 
 
65(89) 
8(11) 
 
 
42(80.7) 
10(19.3) 
 
History of Anxiety 
No 
Yes 
 
117 (93.6) 
8 (6.4) 
 
70(95.9) 
3(4.1) 
 
47(90.4) 
5(9.6) 
Enrolled in 
Centering 
Yes 
No 
 
 
58 (46.4) 
67 (53.6) 
 
 
43(58.9) 
30(41.1) 
 
 
24(46.2) 
28(53.8) 
WIC enrolled 
No 
Yes 
 
53 (42.4) 
72 (57.6) 
 
30(41.1) 
43(58.9) 
 
23(44.2) 
29(55.8) 
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Table 2 (cont.)    
    
GDM 
No 
Yes 
 
108 (86.4) 
17 (13.6) 
 
65(89) 
8(11) 
 
43(82.7) 
9(17.3) 
*Plan to Breastfeed 
No 
Yes 
 
25 (20) 
100 (80) 
 
19(26) 
54(74) 
 
6(11.5) 
46(88.5) 
History of type of 
delivery 
NSVD 
Yes 
No 
Cesarean section 
Yes 
No 
 
 
56 
69 
 
13 
112 
 
 
41(56.2) 
32(43.8) 
 
7(9.6) 
66(90.4) 
 
 
28(53.8) 
24(46.2) 
 
6(11.5) 
46(88.5) 
Gestational age at 
start of PNC 
mean(SD) 
(n=120)  
8.6(4.4) 9.1(4.4) 8.0(4.3) 
Gestational age at 
delivery  
mean(SD) 
(n=115) 
38.9(1.8) 38.8(1.8) 39.1(1.8) 
Type of delivery 
(n=115) 
NSVD 
Cesarean section 
 
 
 
89 
26 
 
 
51 
16 
 
 
38 
10 
Birthweight (gms) 
mean(SD) 
(n=115) 
3239.6(526.7) 3206.2(529.8) 3283.1(525.1) 
Complications 
 
No complications 
Preeclampsia 
Preterm-birth 
Chorioamnionitis 
Other  
(n=115) 
 
 
73 
12 
6 
10 
5 
 
 
41/67(61.1) 
10/67(15) 
4/67(5.9) 
8/67(11.9) 
1/67(1.4) 
 
 
32/46(69.5) 
2/46(4.3)  
2/46(4.3) 
2/46(4.3) 
4/46(8.6) 
*p<.05 significant group χ2 group differences 
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Biological Factors 
 
Vitamin D Status 
 
 This study measured vitamin D levels using radioimmunoassay (RIA) at 24-32 weeks 
gestation using Quest Diagnostics. Based on current clinical practice, vitamin D levels are not 
routinely obtained in the third trimester in routine prenatal care.  However, the professional 
organizations for obstetricians and nurse midwifes—American College of Obstetrics and 
Gynecology (ACOG) and American College of Nurse Midwife (ACNM)—both recommend 
prenatal screening of vitamin D status on those with risk factors for vitamin D deficiency. No 
guidelines about rescreening patients to assess if their vitamin D levels are adequate after initial 
prenatal screening exist.  In the current study, the serum vitamin D levels were not normally 
distributed using the Shapiro-Wilks test.  There was a positive skew (p<0.05) due to the large 
numbers of women who were vitamin D deficient.  The level of vitamin D ranged from 5-54 
ng/ml, and the mean level for the sample was 19.46ng/ml which is deficient by IOM standards.  
The percent in each IOM group as well as the mean per group are provided in Table 3.       
Table 3. Vitamin D Status based on Institute of Medicine Guidelines 
 
Vitamin D 
<20 ng/ml 
n(%) 
Mean vitamin D 
level deficient 
group mean (SD) 
Vitamin D 
≥ 20 ng/ml 
n(%) 
Mean vitamin D 
level sufficient 
group 
mean (SD) 
73(58.4) 
 
13.56(3.6) 52(41.6) 27.75(5.9) 
 
 Table 4 shows the breakdown of vitamin D levels based on the Endocrine Society 
guidelines where vitamin D levels were grouped into three categories: sufficiency (>30 ng/ml), 
insufficient (20-29 ng/ml), and deficient (<20 ng/ml) (Holick et al., 2011).  Using these 
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guidelines, 87.2% of women had a vitamin D level < 30 ng/ml while only 12.8% had normal 
vitamin D levels.   
Table 4. Vitamin D Status based on Endocrine Society Guidelines 
Deficient 
<20 ng/ml 
n (%) 
Insufficient 
20-29 ng/ml 
n (%) 
Sufficient 
≥ 30 ng/ml 
n (%) 
73 (58) 
 
36 (29) 16 (13) 
  
Table 5 reveals that African Americans were more likely to be deficient while Hispanics 
and other races (Caucasian =7, Mixed= 2, Asian=1) were likely to be sufficient.  Using an 
analysis of variance (ANOVA), the mean vitamin D level for Hispanic women (21.13 ±7.4) was 
significantly higher than African American women (17.02± 8.3).  There were significant 
differences among the values of race/ethnicity, [F(2, 122) = 7.07, p = .001].  To further examine 
the differences among the variables, t-tests were calculated between each pair of measurements.  
Tukey pairwise comparisons were conducted with the following noted:  (1) the mean of vitamin 
D serum levels for African American pregnant women (M = 17.02, SD = 8.33) was significantly 
smaller than for Hispanic (M = 21.13, SD = 7.43) [t (113) = 2.774, p = .006];  (2) the mean of 
vitamin D serum levels for AA (M = 17.02, SD = 8.33) was significantly smaller than for other 
race (M = 25.80, SD = 9.60) [t (70) = -3.030, p = .003]; (3) the mean of vitamin D serum levels 
for Hispanic (M = 21.13, SD = 7.43) was not significantly smaller than for other race (M = 25.80, 
SD = 9.60) [t (61) = -1.738, p = .087].  
Table 5. Vitamin D Status based on Race/Ethnicity 
 M SD n 
AA 17.02 8.33 62 
Hispanic 21.13 7.43 53 
Other 25.80 9.60 10 
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Dietary Vitamin D and Calcium Intake 
Dietary vitamin D and calcium intakes were measured using Block’s vitamin D and 
calcium screener.  The results showed the mean level of dietary vitamin D intake for the sample 
was 144.6 IU/day (SD= ±132.8) and average vitamin D supplement use was 482.7 IU/day (SD= 
±390.8).  Important to note, prenatal vitamins usually have about 400 IUs of vitamin D although 
some brands have as high of 800 IUs/prenatal vitamin.  In Table 6, only the participants who 
reported taking vitamin D supplements were more likely to have sufficient levels of vitamin D [ 
t(123) = -3.51, p = .001], confirming differences in vitamin D supplement intake between 
vitamin D groups.  There was no significant difference in dietary vitamin D or calcium intake, or 
calcium supplement intake, reported between vitamin D groups.   
Table 6. Dietary and Supplement Use of Calcium and Vitamin D  
 Dietary vitamin 
D intake 
(IU/day) 
mean(SD) 
Supplement use 
vitamin D 
(IU/day) 
mean(SD) 
Dietary calcium 
intake 
(mg/day) 
mean(SD) 
Supplement 
calcium intake 
(mg/day) 
mean(SD) 
Total sample 
(n=125) 
144.6(132.8) 482.7(390.8) 873.9 (617.8) 171.9(133.6) 
Vitamin D 
<20 ng/ml 
n=73 
141.3(146.0) 387.66(239.1) 830.9(635.7) 153.5(82.9) 
Vitamin D 
≥ 20 ng/ml 
n=52 
149.2(112.7) 616.1(509.5) 934.4(592.5) 
 
197.8(180.4) 
 
Hemoglobin Status 
 
 Another biological factor that was measured in this study was hemoglobin and hematocrit 
status.  Abnormally low hemoglobin, defined as a hemoglobin < 10.5 g/dL (King et al., 2015) is 
also known as anemia.  Iron-deficiency anemia is one of the most common causes of 
fatigue/tiredness and therefore is usually measured in the third trimester since most pregnant 
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women will need some supplementation.  In the present sample, two people were missing their 
hemoglobin and hematocrit values.  The mean value of hemoglobin was 11.2(1.02) and for 
hematocrit was 34.6(2.9).  Table 7 shows the breakdown of hemoglobin values based on vitamin 
D group.   
Table 7. Hemoglobin and Hematocrit Values of Vitamin D Groups 
 
 Hemoglobin 
mean(SD) 
Hematocrit 
mean(SD) 
Total sample 
(n=123) 
 
11.2(1.02) 
 
34.6(2.9) 
Vitamin D 
<20 ng/ml 
n=71 
 
10.9(1.01) 
 
34.0(2.9) 
Vitamin D 
≥ 20 ng/ml 
n=52 
11.5(1.0) 35.2(2.7) 
 
A difference in mean value hemoglobin between vitamin D groups existed [ t(121) = -
2.52, p = .013], indicating that the mean hemoglobin in the deficient group was significantly 
lower than the mean hemoglobin in the vitamin D sufficient group. 
Hemoglobin A1C Status 
 
Another biological marker collected from the electronic medical record was the prenatal 
hemoglobin A1C.  Hemoglobin A1C is a biological marker of average glucose control over the 
past three months (Cunningham et al., 2010).  A level 6.0% or greater at the beginning of 
pregnancy can indicate undiagnosed type 2 diabetes or pre-gestational diabetes.  Due to the 
increased risk of GDM in the study population, the clinic has a standard protocol to include 
hemoglobin A1C on their initial prenatal panel of labs.  Seven participants were missing a 
hemoglobin A1C level.  Table 8 shows the mean values of hemoglobin A1C based on vitamin D 
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groups and there was almost a significant difference between vitamin D groups [ t(116) = 1.953, 
p = 0.053] .  
Table 8. Hemoglobin A1C based on Vitamin D Groups 
 Hemoglobin A1C 
mean(SD) 
Total sample 
(n=118) 
5.2(0.4) 
Vitamin D 
<20 ng/ml 
n=70 
5.3(0.36) 
Vitamin D 
≥ 20 ng/ml 
n=48 
5.1(0.34) 
 
Symptom Status 
 
Pregnancy Symptom Inventory 
 
 The Pregnancy Symptom Inventory (PSI) is a 42-item questionnaire that measures 
different pregnancy symptoms/discomforts found in pregnancy and has an option for writing in 
any additional symptom experience.  None of the study participants reported additional 
symptoms. There was no missing data on the frequency of the symptoms reported.  Four 
participants were missing the symptom limitations.  Since this tool has only been used once, 
comprehensive examination of this tool was done to provide evidence for future use.  Therefore, 
the PSI was examined for frequency of symptoms, limitations of symptoms on activities of daily 
living, and functional impact of symptoms as well as whether there were differences in these 
aspects between women who were deficient and those who were not.   
Pregnancy symptom frequency.  As noted in Table 9, the most frequently reported 
symptoms showed that tiredness, urinary frequency, food cravings, back pain, headache, and 
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poor sleep were the symptoms most often reported.   
Table 9. Frequency of Reported PSI Items (n=125) 
Symptom No (%)* 
 
Yes (%)* 
 
Tiredness 20(16) 105(84) 
Urinary 
frequency 
24(19.2) 101(80.8) 
Food 
cravings 
26(20.8) 99(79.2) 
Back pain 26(20.8) 99(79.2) 
Headache 27(21.6) 98(78.4) 
Poor sleep 35(28) 90(72) 
Breast pain 40(32) 85(68) 
Sore nipples 40(32) 85(68) 
Hip/pelvic 
pain 
43(34.4) 82(65.6) 
Nausea 52(41.6) 73(58.4) 
Changes in 
nipples 
52(41.6) 73(58.4) 
Shortness of 
breath 
53(42.4) 72(57.6) 
Leg cramps 55(44) 70(56) 
Stretch 
marks 
55(44) 70(56) 
  
75 
 
 
Table 9 (cont.)   
Increased 
vaginal 
discharge 
57(45.6) 68(54.4) 
Constipation 60(48) 65(52) 
Forgetfulness 62(49.6) 63(50.4) 
Vomiting 63(50.4) 62(49.6) 
Itchy skin 63(50.4) 62(49.6) 
Dizziness 66(52.8) 59(47.2) 
Dry mouth 68(54.4) 57(45.6) 
Snoring 69(55.2) 56(44.8) 
Restless leg 74(59.2) 51(40.8) 
Reflux 76(60.8) 49(39.2) 
Vivid dreams 76(60.8) 49(39.2) 
Swollen 
hands/feet 
77(61.6) 48(38.4) 
Incontinence 79(63.2) 46(36.8) 
Feeling 
depressed 
80(64) 45(36) 
Acne 80(64) 45(36%) 
Changes in 
libido 
82(65.6) 43(34.4) 
Taste/smell 
changes 
57(45.6) 43(54.4) 
Sciatic 89(71.2) 36(28.8) 
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Table 9 (cont.)   
Anxiety 91(72.8) 34(27.2) 
Altered body 
image 
98(78.4) 27(21.6) 
Carpel tunnel 99(79.2) 26(20.8) 
Painful veins 104(83.2) 21(16.8) 
Hemorrhoids 108(86.4) 17(13.6) 
Heart 
palpitations 
108(86.4) 17(13.6) 
Varicose 
veins 
109(87.2) 16(12.8) 
Brownish 
marks on 
face 
110(88) 15(12) 
Thrush 117(93.6) 8(6.4) 
Fainting 117(93.6) 8(6.4) 
*No = never; yes = rarely, sometimes, often 
 The symptoms that were reported by more than 60% of the sample were compared by 
vitamin D groups (Table 10). The symptoms most commonly reported in the vitamin D deficient 
group were tiredness, urinary frequency, and back pain.  In contrast, the symptoms most 
commonly reported in the vitamin D sufficient group were tiredness, urinary frequency, and 
headache.  There were no symptoms that were significantly different between vitamin D groups.  
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Table 10. Most Frequently Reported PSI Items by Vitamin D Groups 
Symptom 
 
Vitamin D < 20 ng/ml 
(n=73) 
n(%) 
Vitamin D ≥ 20 ng/ml 
(n=52) 
n(%) 
Tiredness 60(82) 45(86) 
Urinary frequency 59(81) 42(80) 
Food cravings 58(79) 40(77) 
Back pain 62(85) 37(71) 
Headache 57(78) 41(79) 
Poor sleep 54(74) 38(73) 
Breast pain 50(68) 35(67) 
Sore nipples 53(73) 33(63) 
Hip/pelvic pain 44(60) 38(73) 
 
A sum total PSI score was calculated for each individual by adding all of the symptoms 
according to the rating reported for each item (1=never,  2=rarely, 3= sometimes, 4=often). The 
possible range for the total PSI scores is 0-126, and for this study the range was 0-78. Table 11 
shows the mean PSI total score based on vitamin D categories and no significant difference was 
observed.  The Cronbach alpha for the PSI total score was 0.895, indicating adequate reliability 
(Nunnally & Bernstein, 1994; Devillis, 2012).   
Table 11. Total PSI Scores by Vitamin D Groups  
Total sample 
n=125 
mean(SD) 
range 
Vitamin D 
< 20 ng/ml 
n = 73 
mean(SD) 
 
Vitamin D 
≥ 20 ng/ml 
n = 52 
mean(SD) 
36.23(18.0) 
 
36.2(17.4) 36.3(18.8) 
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Pregnancy symptom limitation.  Of the symptoms that were commonly reported, Table 
12 shows the frequency of the limitation that each symptom had on participants (1 = not limited 
at all, 2 = limited a little, 3 = limited a lot).  Therefore, only participants who selected either 
rarely, sometimes, or often for having the symptom would answer the limitation question for that 
symptom.  For example, if a participant selected “never” for the symptom, then the limitation 
section did not apply.  The frequency of the limitation for each symptom is presented as well as 
the total limitations (sum of a little + a lot) in Table 12.  The symptoms most frequently causing 
limitations were the following: tiredness (83.8%), poor sleep (77.8%), back pain (76.7%), and 
hip/pelvic pain (71.9%).  The table only includes symptoms that were reported more than 20% of 
the time.  Therefore, symptoms such as hemorrhoids, thrush, painful veins, carpel tunnel, 
fainting, heart palpitations, varicose veins, and brownish marks on face were not reported.  
Table 12. Frequency of PSI Item Limitations 
Symptoms N = valid 
responses 
No 
limitations 
n(%) 
Limit a 
little 
n(%) 
Limit a lot 
n(%) 
Total 
Limitation 
Tiredness 105 17(16.2) 54(51.4) 34(32.4) 83.8 
Nausea 73 29(39.7) 37(50.7) 7(9.6) 51.6 
Vomiting 62 24(38.7) 31(50.0) 7(11.3) 61.3 
Reflux 48 21(42.9) 22(44.9) 5(10.2) 55.1 
Constipation 65 36(55.4) 24(36.9) 5(7.7) 44.6 
Dry mouth 57 48(84.2) 8(14.0) 1(1.8) 15.8 
Food cravings 99 64(64.6) 29(29.3) 6(6.1) 35.4 
Poor sleep 90 20(22.2) 37(41.1) 33(36.7) 77.8 
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Table 12 (cont.)      
Restless leg 51 26(51.0) 16(31.4) 9(17.6) 49 
Leg cramps 70 29(41.4) 32(45.7) 9(12.9) 58.6 
Snoring 56 37(66.1) 13(23.2) 6(10.7) 33.9 
Urinary frequency 101 44(43.6) 47(46.5) 10(9.9) 56.4 
Incontinence 46 24(52.2) 20(43.5) 2(4.3) 47.8 
Increased vaginal 
discharge 
68 56(82.4) 10(14.7) 2(2.9) 17.6 
Changes in libido 43 31(72.1) 7(16.3) 5(11.6) 27.9 
Sciatica 36 15(41.7) 12(33.3) 9(25.0) 58.3 
Back pain 99 23(23.2) 33(33.3) 43(43.4) 76.7 
Hip/pelvic pain 82 23(28.0) 36(43.9) 23(28.0) 71.9 
Breast pain 85 65(76.5) 15(17.6) 5(5.9) 23.5 
Headache 98 35(35.7) 44(44.9) 19(19.4) 64.3 
Sore nipples 85 68(80.0) 11(12.9) 6(7.1) 20 
Dizziness 59 26(44.1) 30(50.8) 3(5.1) 55.9 
Shortness of breath 72 27(37.5) 36(50.0) 9(12.5) 62.5 
Taste/smell 
changes 
68 45(66.2) 20(29.4) 3(4.4) 33.8 
Forgetfulness 63 30(47.6) 27(42.9) 6(9.5) 52.4 
Feeling depressed 45 18(40.0) 23(51.1) 4(8.9) 60.0 
Anxiety 34 15(44.1) 15(44.1) 4(11.8) 55.9 
Vivid dreams 49 43(87.8) 6(12.2) 0 12.2 
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Table 12 (cont.)      
Altered body 
image 
27 22(81.5) 5(18.5) 0 18.5 
Acne 45 38(84.4) 5(11.1) 2(4.4) 15.5 
Itchy skin 62 50(80.6) 10(16.1) 2(3.2) 19.3 
Changes in nipples 73 63(86.3) 9(12.3) 1(1.4) 13.7 
Stretch marks 70 59(84.3) 10(14.3) 1(1.4) 15.7 
Swollen hands/feet 48 27(56.3) 16(33.3) 5(10.4) 43.7 
 
It is interesting to note that when comparing the symptoms most frequently reported, 
some did not have significant limitations.  For example, the symptoms of food cravings and sore 
nipples had limitations of 35.4% and 20% respectively, yet their frequency was 79.2% and 68% 
respectively.  In contrast, only 36% of women reported feeling depressed, but was reported as 
having limitations by 60% who reported the symptom.  Table 13 compares the symptoms 
reported with the most limitation based on vitamin D groups and the number of women who 
rated that symptom as limiting a little and/or limiting a lot.  Table 14 shows the mean values for 
the symptoms causing highest level of limitation.  Those who were deficient were compared to 
those who were sufficient, using independent samples t-test. The symptoms having greater 
limitations in those with vitamin D deficiency were: tiredness [ t(101.54) = 2.20, p = .030], poor 
sleep [ t(90) = 2.27, p = .026], back pain [t(97) = 3.13, p = .002], and hip/pelvic pain [t(80) = 
2.10, p = .039].  Each of these symptoms were significantly different between vitamin D groups.   
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Table 13. Most Limiting PSI Items by Vitamin D Groups 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 14. Means of Limitation Scores by Vitamin D Groups 
 
 
 
 
 
 
 
 
 
 
 
*p < 0.05 ** p < .01 
Symptoms 
 
Vitamin D < 20 ng/ml 
n/total who had symptom(%) 
Vitamin D ≥ 20 ng/mln/total who 
had symptom(%) 
Tiredness 
(n=105) 
51/60 
(85) 
37/45  
(82) 
Poor sleep 
(n=92) 
45/54 
(83) 
26/38 
(68) 
Back pain 
(n=99) 
54/62 
(87) 
22/37 
(59) 
Hip/pelvic pain 
(n=82) 
35/44 
(80) 
24/38 
(63) 
Headache 
(n=98) 
36/57 
(63) 
28/41 
(68) 
Shortness of 
breath (n=71) 
28/41 
(67) 
17/30 
(57) 
Vomiting (n=62) 
24/38 
(63) 
14/24 
(67) 
Feeling depressed 
(n=55) 
16/24 
(67) 
11/21 
(52) 
Symptoms 
Vitamin D < 20 ng/ml 
mean(SD) 
Vitamin d ≥ 20 ng/ml 
mean(SD) 
*Tiredness 2.28(0.7) 2.00(0.6) 
*Poor sleep 2.28(0.7) 1.92(0.7) 
**Back pain 2.39(0.7) 1.89(0.8) 
*Hip/pelvic pain 2.16(0.7) 1.82(0.7) 
Headache 1.86(0.7) 1.85(0.7) 
Shortness of breath 1.83(0.8) 1.60(0.6) 
Vomiting 1.74(0.6) 1.71(0.7) 
Feeling depressed 1.79(0.7) 1.57(0.6) 
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Participants were also asked to list the symptom that in their experience was the worst to 
manage.  This was not part of the original instrument but added by the PI.  Table 15 shows the 
top nine symptoms listed as the worst symptom to manage (although 28 were reported) with 
back pain as the most frequently reported.   
Table 15. PSI Items Reported as Worst to Manage (Top 9) 
Symptom Frequency 
n(%) 
Back pain 17 (13.8) 
Hip/Pelvic Pain 15 (12.2) 
Tiredness 15 (12.2) 
None 12 (9.8) 
Poor sleep 9 (7.3) 
Headache 9 (7.3) 
Swollen hands/feet 5 (4.1) 
Urinary frequency 4 (3.3) 
Nausea 4 (3.3) 
 
 Table 16 shows the top six symptoms rated as the worst to manage broken down by 
vitamin D groups.  The frequency of back pain and poor sleep were noted to be much higher in 
the vitamin D deficient group than in the vitamin D sufficient group. 
Table 16. PSI Items Reported as Worst by Vitamin D Groups  
Symptom Vitamin D < 20 ng/ml 
n (%) 
Vitamin D ≥ 20 ng/ml 
n (%) 
Back pain 
 
13 (17.8) 4 (7.7) 
Hip/Pelvic Pain 
 
9 (12.3) 6 (11.5) 
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Table 16 (cont.)   
   
Tiredness 
 
8 (11.0) 7 (13.5) 
Poor sleep 
 
7 (9.6) 2 (3.8) 
None 
 
3 (4.1) 9 (17.3) 
Headache 
 
5 (6.8) 4 (7.7) 
 
Depressive Symptoms 
 The EPDS was used to measure depressive symptoms since this measure is used at the 
clinical site where data collection took place.  The EPDS scores were not normally distributed.  
There is a potential range of 0-30 for scores. For this study, the range was 0-19.  There was a 
significant positive skew since 34.4% of women reported no symptoms of depression reflecting a 
score of zero on the EPDS.  The mean scores between vitamin D groups was not statistically 
significant [ t(123) = 0.530, p = 0.597].  
Table 17. Mean EPDS Scores (n=125) 
 Total 
sample 
mean(SD) 
Vitamin D 
< 20 ng/ml 
mean(SD) 
Vitamin D 
≥ 20 ng/ml 
mean(SD) 
 
EPDS 
score 
3.9(4.5) 
0-19 
4.05(4.8) 
0-19 
3.62(4.1) 
0-17 
 
Evidence indicates that a prior history of depression will increase the risk of depression in 
pregnancy. There were eighteen women with a history of depression.  Of these, ten were in the 
vitamin D sufficient group and eight in the deficient group.  The mean EPDS score of those 
without a history of depression was M = 3.05, SD = 3.673 and the mean EPDS of those with a 
history of depression was M = 8.94, SD = 5.955—significantly different [t(123)=-5.722, p = 
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.000].  However, when rerunning the analysis excluding persons with history of depression from 
analysis,  the EPDS means are still not significantly different between vitamin D groups [ t(105) 
= 1.451, p = .150].    
Sleep Quality 
 Sleep quality was measured with the Pittsburgh Sleep Quality Index (PSQI) in order to 
have a valid measure for sleep.  The PSQI instrument is a validated measure for evaluating sleep 
in pregnancy.  PSQI is calculated into seven components: subjective sleep quality, sleep latency, 
sleep duration, habitual sleep efficiency, step disturbances, use of sleeping medication, and 
daytime dysfunction.  The items are then summed for a global PSQI score with higher the scores 
indicating poorer the sleep quality.  The maximum PSQI score is 21 and the minimum score is 
zero.  A score of five and below is considered to be indicative of good sleep quality (Buysse, 
1989).  The range of scores for the current study ranged from 0-14.  Mean scores for each 
component are summarized in Table 18.  
 It is important to understand the calculation of each of the PSQI sleep components.  The 
first component of subjective sleep quality used question #6 which asked “During the past 
month, how would you rate your sleep quality overall?” with answers ranging from: 0 = very 
good, 1 = fairly good, 2 = fairly bad, 3 = very bad.  The second component that labeled sleep 
latency was computed from question #2 which asked “how long has it usually takes you to fall 
asleep each night?” with responses being categorized as 0 = ≤ 15 minutes, 1 = 16-30 minutes, 2 
= 31-60 minutes, 3 = > 60 minutes and question #5A which asked “how often have you had 
trouble sleeping because you cannot get to sleep within 30 minutes?” with responses categorized 
as 0 = not during the past month, 1 = less than once a week, 2 = once or twice a week, 3 = three 
or more times a week.  The scores for this component are calculated and summed up so that 0 = 
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sum of #2 and #5A is 0, 1 = sum of #2 and #5A is 1-2, 2 = sum of #2 and #5A is 3-4, 3 = sum of 
#2 and #5A is equal to 5-6, which can be interpreted as that, for people with higher sleep latency 
scores, it takes them longer to get to sleep and usually cannot get to sleep within 30 minutes.    
 Sleep duration is the third component of the PSQI and uses question #4 which asks “how 
many hours of actual sleep did you get at night?” with responses categorized as 0 = > 7 hours, 1 
= 6-7 hours, 2 = 5-6 hours, 3 = < 5 hours.  Therefore, the higher the number on this component, 
the less actual sleep they got at night.  The fourth component of habitual sleep efficiency is a 
calculation using the responses to question #4 (above), question #3 (“when have you usually 
gotten up in the morning?”), and question #1 (“when have you usually gone to bed at night?”) 
which calculates a habitual sleep efficiency percentage.  Therefore the answers are categorized as 
0 = > 85%, 1 = 75-84%, 2 = 65-74%, 3 = < 65%.  Higher responses to this component show 
poorer habitual sleep efficiency. 
 The fifth component of the PSQI is sleep disturbances and calculates the sum of 
questions #5A through J, which list a variety of sleep disturbances such as “have to get up to use 
the bathroom” or “feel too cold” which are categorized as 0 = not during the past month, 1 = less 
than once a week, 2 = once or twice a week, 3 = three or more times a week for each statement.  
The sum of the sleep disturbances are used to determine the sleep disturbance score which is 
categorized as 0 = 0 sleep disturbances, 1 = 1-9 sleep disturbances, 2 = 10-18 sleep disturbances, 
3 = 19-27.  Higher component 5 sleep disturbance score means poorer sleep quality.  The sixth 
component of the PSQI is use of sleeping medication and uses the responses to question #7 
(“how often have you taken medicine (prescribed or “over the counter”) to help you sleep?”) 
with responses 0 = not during the past month, 1 = less than once a week, 2 = once or twice a 
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week, 3 = three or more times a week. 
 The seventh component of the PSQI called daytime dysfunction uses the responses to 
question #8 (“how often have you had trouble staying awake while driving, eating meals, or 
engaging in social activity?”) with responses of 0 = not during the past month, 1 = less than once 
a week, 2 = once or twice a week, 3 = three or more times a week) and question #9 (“how much 
of a problem has it been for you to keep up enough enthusiasm to get things done?”) with 
responses of 0 = no problem at all, 1 = only a very slight problem, 2 = somewhat of a problem, 3 
= a very big problem.  The sum of the responses to these questions is calculated as their 
component 7 score with categories of 0 = sum of #2 and #5A is 0, 1 = sum of #2 and #5A is 1-2, 
2 = sum of #2 and #5A is 3-4, 3 = sum of #2 and #5A is equal to 5-6.  
Despite non-normal distribution of the vitamin D values, independent sample t-tests were 
used to assess any difference in means of PSQI global scores and component scores between 
vitamin D groups.  Findings indicated that those who were vitamin D deficient had worse sleep 
than those who were vitamin D sufficient [ t(122) = 3.68, p < .001] based on the PSQI global 
score.  Findings also indicated that for those who were vitamin D deficient, they had less sleep 
duration [t(121.227) = 3.468, p = .001], more use of sleeping medication [t(93.76) = 2.81, p = 
.006], more daytime dysfunction [t(122) = 2.85, p = .005], and worse habitual sleep efficiency 
[t(120.80) = 2.68, p = .008], which were statistically significant.  
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Table 18. Mean PSQI Total and Subscale Scores (n=124) 
PSQI 
component 
Total 
sample 
mean(SD) 
Vitamin D 
< 20 ng/ml 
mean(SD) 
Vitamin D 
≥ 20 ng/ml 
mean(SD) 
1  Subjective 
sleep quality  
1.06(0.8) 1.14(0.8) 0.94(0.8) 
2  Sleep latency 
 
1.16(1.0) 1.22(1.1) 1.1(1.0) 
**3  Sleep 
duration 
0.73(0.9) 0.94(1.0) 0.42(0.7) 
*4  Habitual 
sleep efficiency 
0.87(1.1) 1.07(1.2) 0.60(0.7) 
5  Sleep 
disturbances 
1.52(0.6) 1.58(0.6) 1.44(0.6) 
*6  Use of 
sleeping 
medication 
0.27(0.8) 0.42(0.9) 0.08(0.3) 
**7   Daytime 
dysfunction 
0.73(0.8) 0.90(0.8) 0.50(0.6) 
**Total PSQI 
Global score 
6.3(3.5) 7.28(3.6) 5.1(2.9) 
*p < 0.05 ** p < .01 *one participant left without completing the PSQI 
Functional Status 
Health-Promoting Lifestyle Profile 
 The Health-Promoting Lifestyles Profile (HPLP)v.2  instrument was created to assess 52 
health behaviors and are rated as: never=1, sometimes=2, often=3, and routinely=4.  Therefore, a 
mean score between 3 and 4, would indicate that an individual was practicing health-promoting 
behaviors more often.  The HPLP has six subscales including physical activity, nutrition, health 
responsibility, interpersonal relations, spiritual growth, and stress management.  The Cronbach 
alpha for the HPLP for this study was 0.938.  The Cronbach alpha for each of the subscales was: 
physical activity (0.819), nutrition (0.727), health responsibility (0.62), interpersonal relations 
(0.842), spiritual growth (0.820), and stress management (0.745).  
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Table 19. Subscale Scores and Average Item Subscale Scores for HPLPv2 (n=124)* 
 Range of scores 
Possible Actual Mean total 
score (SD) 
Mean item 
response 
Physical activity 
(n=8 items) 
8-32 8-28 15.9(4.7) 1.99(0.6) 
Nutrition 
(n=9 items) 
9-36 13-35 23.1(4.4) 2.56(0.5) 
Health 
responsibility  
(n=9 items) 
9-36 14-36 22.6(4.6) 2.51(0.5) 
Interpersonal 
relations  
(n= 9 items) 
9-36 15-36 26.0(5.3) 2.89(0.6) 
Spiritual growth 
(n=9 items) 
9-36 17-36 27.5(4.8) 3.06(0.5) 
Stress 
management 
(n=8 items) 
8-32 12-32 18.8(4.3) 2.48(0.5) 
Total scores 
(n=52 items) 
52-208 91-195 134.9(22.3) 2.59(0.4) 
*one participant left without completing the HPLPII  
 As reflected in Table 19, physical activity and stress management subscales were low 
when compared to the interpersonal and spiritual growth subscales suggesting that persons were 
less likely to be physically active or practicing stress management.  The mean HPLP score was 
2.6, which would be that the individuals reported healthy behaviors in the “sometimes” to 
“often” range.  Unfortunately, however, most women did not report their behaviors as being 
practiced routinely.  
  When analyzed based on vitamin D group, there were no significant differences in either 
total HPLP scores or any of the subscale scores (Table 20).  Although the dietary scores were 
higher in the sufficient vitamin D group (suggesting practicing better nutrition more often), they 
were not statistically different from those who were deficient.  
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Table 20. Mean Subscale Scores of HPLPII between Vitamin D Groups (n = 124) 
HPLP subscale Vitamin D 
< 20 ng/ml 
mean(SD) 
Vitamin D 
≥ 20 ng/ml 
mean(SD) 
Physical activity 
 
1.96(0.53) 2.02(0.65) 
Nutrition 
 
2.5(0.44) 2.67(0.54) 
Health responsibility 
 
2.49(0.52) 2.52(0.48) 
Interpersonal 
relations 
2.83(0.6) 2.96(0.6) 
Spiritual growth 3.04(0.55) 3.07(0.5) 
Stress management 
 
2.46(0.49) 2.5(0.59) 
Total HPLP score 
 
2.56(0.42) 2.64(0.44) 
 
General Health Perceptions 
 General health perceptions were measured in this study by asking women to rate the 
health of their pregnancy and the health of their unborn baby using the same likert scale items as 
the first question of the SF-12 (1 = excellent, 2 = very good, 3 = good, 4 = fair, 5 = poor).   
 Table 21 shows the responses of the participants to these questions. Overall, the sample 
had positive general health perceptions as 86.2% reported their perception of their pregnancy as 
“good” or better, and 97.6% of the sample replied “good” or better for their unborn baby.  For 
the general health perception of the pregnancy, the means were not different between vitamin D 
groups [t(104) = .289, p = .773] or the general health perception of the fetus [t(104) = .004, p = 
.997].  
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Table 21. General Health Perception between Vitamin D Groups* 
GHP - 
pregnancy 
Total 
(%) 
n=124 
Vitamin D 
< 20 ng/ml 
(%) 
n=72 
Vitamin D 
≥ 20 ng/ml 
(%) 
n=52 
Excellent 
 
20(16) 15(21) 5(9.6) 
Very good 
 
41(33.1) 20(28) 21(40.4) 
Good 
 
46(37.1) 23(32) 23(44.2) 
Fair 
 
16(13) 13(18.9) 3(5.8) 
Poor 
 
1(0.8) 1(0.1) 0 
 M = 2.48 
SD = 1.069 
M = 2.43 
SD = 0.801 
GHP–unborn 
baby 
 
Total Vitamin D 
< 20 ng/ml 
n=72 
Vitamin D 
≥ 20 ng/ml 
n=52 
Excellent 
 
42(33.9) 27(37.5) 15(28.8) 
Very good 
 
47(37.9) 24(33.3) 23(44.2) 
Good 
 
32(25.8) 18(25) 14(27) 
Fair 
 
3(2.4) 3(4.2) 0 
Poor 
 
0 0 0 
 M = 1.95 
SD = .898 
M = 1.95 
SD = .795 
*one participant left without completing the General Health Perception questions  
Quality of Life 
Standard Form–12 (SF-12) 
 The SF-12v2 was used to measure the health-related quality of life of the study sample.  
Quality Metric which is the company that has copyrighted the SF-12, created a software to 
calculate norm-based scores for each subscale of the SF-12.  The data was collected and 
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uploaded into the software per their written protocol.  Based on their own data quality check, the 
SF-12 scores in the given sample had no missing data, 100% had responses within the tool range, 
and had excellent concurrent and discriminant validity.  The evidence for concurrent and 
discriminant validity on the dataset is provided in Appendix F and was provided by the SF-12 
software scoring management system (Maruish, 2012). 
 Interpretation of the SF-12v2 is based on norm-based scoring which means that the scale 
is 1-100, with 50 being the average quality of life for the US population.  Scores above 50 reflect 
better quality of life and scores below 50 reflect lower quality of life.  The scoring software 
creates norm-based scores for each of the eight domains and a total score for the physical and 
mental component score.  The physical component score is composed of four domains: physical 
functioning, role functioning (physical), bodily pain, and general health.  In addition, the mental 
component score is composed of four domains: vitality, social functioning, role functional 
(emotional), and mental health.  As you can see in Figure 3, the domains of physical functioning, 
role functioning, bodily pain, social functioning, and role functional (emotional) were below 50, 
and the domains that were above 50 were general health (physical component score domain), 
vitality (mental component score), and mental health (mental component score).   
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Figure 3: SF-12 scores for the total sample 
 
 Table 22 displays the SF-12 subscale scores for both physical component score and the 
mental component score based on vitamin D group.  The only components significantly different 
between vitamin D groups were bodily pain [t(123) = -2.82, p = .006] and physical component 
score [t(123) = -3.30, p = .001]. 
Table 22. SF-12 Scores based on Vitamin D Groups (n=125) 
SF-12 domain 
Norm-based 
scores 
Total sample 
mean(SD) 
Vitamin D 
< 20 ng/ml 
mean(SD) 
 
Vitamin D 
≥ 20 ng/ml 
mean(SD) 
Physical  
functioning 
44.78(9.3) 43.5(9.5) 46.3(8.7) 
Role 
functioning 
(physical) 
45.21(9.0) 43.9(9.0) 46.3(9.3) 
*Bodily pain 
 
47.27(10.3) 45.1(10.6) 50.3(9.2) 
General health 
 
51.49(9.09) 50.4(10.0) 53..02(7.4) 
Vitality 
 
50.88(9.7) 49.71(9.4) 52.4(9.9) 
93 
 
 
Table 22 (cont.)    
    
Social  
functioning 
48.36(9.7) 47.4(10.4) 49.4(9.0) 
Role functional 
(emotional) 
45.93(11.2) 45.4(11.6) 46.1(10.9) 
Mental health 
 
54.44(8.6) 55.2(8.5) 53.6(8.9) 
Mental 
component  
Score (MCS) 
52.19(8.6) 52.4(8.6) 51.5(8.6) 
*Physical 
component 
score (PCS) 
45.45(7.6) 43.43(7.2) 47.74(7.2) 
*p value ≤ 0.001 
Characteristics of the Environment 
To assess for any environmental factors that could impact on quality of life, spirituality  
and social support were assessed in all women.  
Spirituality 
 The Spiritual Perspective Scale (SPS) was used to measure spirituality in the sample to 
see if increased spirituality has any impact on health behaviors or quality of life.  The range of 
possible scores for the SPS tool include 10-60.  The instrument is split into four questions 
addressing spiritual behaviors (question numbers: 1-4) and six questions addressing spiritual 
beliefs (question numbers: 5-10).  The mean spirituality score was 47 in the total sample.  The 
data was negatively skewed with most participants having higher levels of spirituality scores 
which is similar to those found in a comparable study with a mean spirituality score of 43.6 
(Dailey &Steward, 2007).  Table 23 shows that the SPS scores did not differ based on vitamin D 
groups.   
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Table 23. Mean Total SPS Scores by Vitamin D Groups 
Total sample 
(n=124) 
mean(SD) 
range 
Vitamin D 
< 20 ng/ml 
mean(SD) 
range 
Vitamin D 
≥ 20 ng/ml 
mean(SD) 
range 
47 (9.1) 
12-60 
 
45.9(8.4) 
12-60 
48.4(9.7) 
12-60 
 
Social Support 
 Another important variable is social support especially since the study population is a 
predominantly low-income patient population and evidence shows poor social support can 
adversely impact pregnancy with increased rates of prenatal anxiety and depression, preterm 
birth, and low birth weight babies (Rini, Dunkel Schetter, Hobel, Glynn, & Sandman, 2006; 
Dunkel Schetter, 2009; Giurgescu et al., 2015; Sealy-Jefferson et al., 2015).  Surprisingly, social 
support was relatively high as the mean score for the MSPSS was 5.8, with a range of 1-7, with 7 
being the highest score of social support.  There are three subscales for the MSPSS which 
include: significant other, family, and friends.  As shown in Table 24, the mean score for 
significant other was 6.1 which was the highest subscale score. Family and friends subscale 
scores were similar, which shows that the patient population had a significant amount of social 
support, which can potentially have positive impacts on health outcomes and healthy behaviors.  
In addition, the social support subscale scores based on vitamin D groups showed no significant 
differences (Table 25). 
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Table 24. Overall Mean Score for MSPSS and Subscales (n=124) 
 Range of scores 
Possible Actual Mean (SD) 
Significant other 1-7 1-7 6.1(1.4) 
Family 1-7 1-7 5.8(1.6) 
Friends 1-7 1-7 5.5(1.5) 
Total MSPSS score 1-7 1-7 5.8(1.4) 
 
Table 25. Mean MPSS Total and Subscale Scores by Vitamin D Groups (n=124) 
 Vitamin D 
< 20 ng/ml 
mean(SD) 
Vitamin D 
≥ 20 ng/ml 
mean(SD) 
Significant other 
subscale 
6.1(1.4) 6.0(1.5) 
Family 
 
5.7(1.7) 5.8(1.5) 
Friends 
 
5.4(1.6) 5.9(3.0) 
Total MSPSS 
 
5.8(1.3) 5.9(1.7) 
 
Data Analysis for Study Aims 
 
 The primary aim of the study was to determine if pregnancy symptoms could be 
predicted by vitamin D status, health behaviors, quality of life, and outcomes.  The secondary 
aim was to determine if there were any ethnic differences between African American and 
Hispanic women on their pregnancy symptom profile, vitamin D status, health behaviors, quality 
of life, and health outcomes.  The exploratory aim was contingent on the primary aim—that if a 
significant relationship exists between vitamin D status and pregnancy symptoms, see if 
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depression scores mediates that relationship.  In the following sections, the analysis aims will be 
discussed.  
Data Analysis for Aim 1 
 The first aim of the study was to determine if pregnancy symptom functional status could 
be predicted by vitamin D status, health behaviors, and quality of life.  The proposed hypothesis 
is that lower vitamin D status could predict higher pregnancy symptom profiles, poorer health-
promoting behaviors, and poorer quality of life.  In order to examine this hypothesis, multiple 
Kendall’s tau correlation tests were performed (due to non-normally distributed variables) on all 
main variables to see potential associations between variables prior to analysis.   
As noted in Table 26, vitamin D status was significantly correlated with PSQI global 
score and depressive symptoms (EPDS).  The total PSI frequency score was significantly 
correlated with PSQI global score, depressive symptoms (EPDS) and both aspects of quality of 
life (PCS and MCS).  The relationships indicated that the more symptoms experienced by 
women, the worse their sleep, depressive symptoms, and their quality of life.  Health-promoting 
behaviors (HPLP) were not highly correlated with any of the variables other than depression 
which indicated that the more the women reported the depressive symptoms, the less likely were 
they to engage in health-promoting behaviors.  Level of vitamin D was correlated with sleep 
score and physical quality of life.  For those with higher levels of vitamin D, they reported better 
sleep and physical functioning.   
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Table 26. Correlation Table of Major Outcomes based on Conceptual Model   
 
Vitamin 
D 
serum 
levels 
PSI 
total 
score 
PSQI 
global 
Score 
EPDS 
total 
HPLP 
total 
General 
health 
perception 
(1) 
PCS 
(SF-
12) 
MCS 
(SF-
12) 
Vitamin D 
serum levels 
1        
PSI 
frequency 
total 
.014 1       
PSQI global 
score 
-.263** .228** 1      
EPDS total .021 .370** .312** 1     
HPLP total .011 -.045 -.089 -.109 1    
General 
health 
perceptions(
1) 
-.034 .254** .083 .156* -.169* 1   
 
Physical 
component 
score 
.200** -.206** -.190** -.176* .028 -.178** 1  
Mental 
component 
score 
-.073 -.215** -.174** -.426** .113 -.153* .001 1 
*  correlation is significant at the 0.05 level (2-tailed) 
** correlation is significant at the .01 level (2-tailed) 
 
A binary logistic regression was conducted to examine whether serum vitamin D level 
was a significant predictor of pregnancy symptoms, sleep quality, health-promoting behaviors 
and physical quality of life and mental quality of life.  Therefore, a series of univariate analyses 
was initially conducted to assess the impact serum vitamin D had on each of these outcomes.  
Vitamin D level was the independent variable and each outcome was dichotomized to examine 
the impact. 
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One of the major assumptions of binary logistic regression is that the logit of the outcome 
variable is linear to the predictor variable when using a continuous variable (Field, 2009).  In 
order to avoid this assumption, serum vitamin D levels were transformed into a binary variable 
based on IOM guidelines with sufficient being  20 ng/ml and deficient being < 20 ng/ml.  To 
assess the impact of vitamin D status on pregnancy symptoms, a binary variable for pregnancy 
symptom total score was created based on the median score of the pregnancy symptom total 
score which was 36.  Since there is no literature currently using the pregnancy symptom total on 
the PSI tool, an approximation based on the sample for more symptoms (>36) and less symptoms 
(≤36) was used.  The univariate analysis showed that vitamin D status was not a significant 
predictor of pregnancy symptom frequency, as noted in Table 27. 
Table 27: Univariate Logistic Regression Results with Vitamin D Status Predicting Pregnancy 
Symptom Frequency, Sleep Quality, Depressive Symptoms, Health-Promoting Behaviors, and 
Quality of Life 
 
Variable B SE p OR 95% CI 
Pregnancy frequency -.003 0.616 .996 .997 [0.298, 3.334] 
Sleep quality 1.066 0.378 .005 2.905 [1.386, 6.091] 
Depressive symptoms .024 0.408 .953 1.024 [0.460, 2.280] 
Health-promoting behavior .031 0.368 .934 1.031 [0.501, 2.121] 
Mental component score -.119 0.388 .758 .887 [0.415, 1.898] 
Physical component score .1.652 0.429 .000 5.219 [2.251, 12.10] 
 
The PSQI global score already has a cutoff score of > 5 indicating poorer sleep quality 
with  5 score indicating good sleep quality (Buysse, 1989).  In Table 27, vitamin D status was a 
significant predictor of good sleep, suggesting that when compared to patients with sufficient 
vitamin D, those deficient of vitamin D were 2.9 times more likely to have poor sleep quality.    
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Depressive symptoms as measured by EPDS score was categorized based on evidence in 
the literature (> 12 for positive depressive symptoms and  12 EPDS score for low depressive 
symptoms) and vitamin D status was not predictive of low depressive symptoms.  The cutoff 
score of EPDS 12 was used to indicate a positive screen as a conservative measure for good 
sensitivity and specificity for major depressive symptoms in pregnancy (Cox & Holden, 1991).   
Health-promoting behavior was measured by the HPLPv.2 and the binary cutoffs for 
health-promoting behaviors was a HPLP mean score of 1 to 2.5 exhibiting poor health-promoting 
behaviors and HPLP mean score of 2.51 to 4.00 exhibiting good health-promoting behaviors.  
There is no established cutoff for the health-promoting behaviors, but “2” represents exhibiting 
the behavior “sometimes”.  As shown by Table 27, health-promoting behaviors, vitamin D status 
was not predictive of this outcome.  
Quality of life is comprised of the physical component score and mental component 
score.  Both of these measures have national norms with ≥ 50 as better than average quality of 
life and a score <50 as lower than average quality of life.  As shown in Table 27, vitamin D 
status did not significantly predict mental quality of life.  However, vitamin D status did predict 
physical quality of life.  Compared to participants with sufficient vitamin D, those deficient of 
vitamin D were almost six times more likely to have poorer physical quality of life.   
Based on these univariate analyses, only those significantly predicted by vitamin D status 
were included into a binary logistic regression model controlling for significant covariates 
related to sleep quality and physical quality of life.  Correlation analysis was done with each of 
the demographic and outcome variables with sleep quality to detect any significantly correlating 
with sleep quality that could be controlled for.  The variables that significantly correlated with 
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sleep quality included the following: marital status, history of depression, physical component 
score, EPDS score, and PSI total frequency score.   
Covariates theoretically that should be included in predicting sleep quality are age, 
gestational age, history of depression, EPDS score, physical component score, and PSI total 
frequency score. Gestational age was not significantly correlated with sleep quality, but was 
included in the model anyways since there is evidence that sleep quality is worse with 
advancement of gestational age. 
Assumptions used for binary logistic regression include ensuring that there is not 
multicollinearity amongst variables in the model based on variance inflation factors (VIFs) 
(Field, 2009).  Variance Inflation Factors (VIFs) were calculated to detect the presence of 
multicollinearity between predictors.  High VIFs indicate increased effects of multicollinearity in 
the model.  Variance Inflation Factors greater than 5 are cause for concern, whereas VIFs of 10 
should be considered the maximum upper limit (Menard, 2009).  All predictors in the regression 
model have VIFs less than 10.  Table 28 presents the VIF for each predictor in the model. 
 Since vitamin D status is the main independent variable of interest, binary vitamin D 
variable using the IOM guidelines for sufficient and deficient were used.  In addition, two items 
on the Pregnancy Symptom Inventory tool were removed: “poor sleep” (item number nine) and 
“feeling depressed”(item thirty-two).  A new total pregnancy symptom total score variable was 
calculated without those two items since sleep quality was being measured by the PSQI and 
depressive symptoms were being measured by the EPDS.  
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Table 28. Variance Inflation Factors for Covariates in Sleep Quality Model 
Variable VIF 
Marital status 1.163 
Gestational age 1.065 
EPDS depression score 1.666 
History of depression 
Age 
1.346 
1.168 Physical component score 1.174 
Pregnancy symptom total score 1.359 
 
After controlling for marital status, gestational age, EPDS depressive symptom score, 
history of depression, age, physical component score, and pregnancy symptom total score, there 
remained a significant association between vitamin D status and sleep quality.  That is, compared 
to patients with sufficient vitamin D, those deficient of vitamin D were 3.1(95% CI: 1.292–7.47) 
times more likely to have poor sleep quality.  Despite controlling for other significant covariates, 
the predictive value of vitamin D status on sleep quality remained constant as seen in Table 29.  
Pregnancy symptom total score was also barely statistically significant with an odds ratio less 
than one and a 95% confidence interval of 0.93-0.99.   
Table 29. Logistic Regression Results Predicting Sleep Quality 
Variable B SE p OR 
(Intercept) 4.002 3.37 .236  
Marital status (2) -.175 0.13 .186     0.84 
Gestational age -.151 0.09 .091     0.86 
EPDS depression score -0.08 0.06 .200     0.92 
History of depression -.184 0.75 .805     0.83 
Age .024 0.04 .538     1.02 
Physical component score -.009 0.03 .776       .99 
Pregnancy symptom total score -.038 0.02 .026       .96[.93-99] 
IOM vitamin D groups 1.054 3.447 .012     3.1[1.29-7.43] 
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Binary logistic regression model to control for potential confounding variables for 
physical quality of life included based on correlation analyses of all demographic and the 
outcome variable physical quality of life included: EPDS depression score, sleep quality score, 
general health perceptions 1 (health of pregnancy), pregnancy symptom total score, and serum 
vitamin D.  Pre-pregnancy BMI was added though not significantly correlated with physical 
quality of life due to the theoretical reason that those who are more obese would have poorer 
quality of life.  Table 30 shows the VIFs of all of the predictors, and none were greater than ten.  
The adjustment of the pregnancy symptom total score made for the prior analysis was also 
applied to this analysis since both sleep quality and EPDS depressive symptoms score correlated 
with physical quality of life.  Therefore, all these predictors were put in a binary logistic 
regression model with physical quality of life as the dependent variable.   
Table 30. Variance Inflation Factors for Covariates in Physical Quality of Life 
 
Variable 
 
VIF 
Pre-pregnancy BMI 
EPDS depression score 
1.486 
1.403 
Sleep quality score 
General health perceptions 1 
1.335 
1.470 
Pregnancy symptom total score 1.596 
 
Using the IOM categories for vitamin D (sufficient or deficient) and controlling for pre-
pregnancy BMI, EPDS depression score, sleep quality score, and pregnancy symptom total 
score, a significant association between vitamin D and physical quality of life remained.  The 
binary logistic regression indicated that compared to those with sufficient vitamin D, those with 
deficient vitamin D were 5.78 (95% CI: 2.13–15.7) times more likely to report poor physical 
quality of life (Table 31)  
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Table 31.: Logistic Regression Results Predicting Physical Quality of Life 
Variable B SE p OR 
(Intercept) -1.19 1.39 .392  
Pre pregnancy BMI -0.24 0.03 .493 0.97 
EPDS score -0.89 0.07 .175 0.92 
Sleep quality -0.01 0.08 .947 0.99 
General health perceptions (1) -0.34 0.28 .235 0.72 
Pregnancy symptom total score -0.01 0.02 .277 0.98 
IOM Vitamin D group 1.754 0.51 .001 5.78 [2.13, 15.7] 
 
Data Analysis for Aim 2 
 
 The secondary aim to assess if there were any ethnic differences between African 
American and Hispanic women in their vitamin D status, pregnancy symptom profile, sleep 
quality, depressive symptoms, health-promoting behaviors, and quality of life.  A series of 
statistical analyses were used based on the assumptions of independent t-tests and the results are 
summarized in Table 32.  
Table 32. Summary of Ethnic Differences of Key Variables 
 African 
American 
Hispanic t-statistic p value 
*Vitamin D  
Mean(SD) 
 
17.02(8.33) 
 
 
21.13(7.43) 
 
 
t(113) = -2.77 
 
p = .006 
PSI frequency total (pregnancy 
symptom total) 
Mean(SD) 
,  
 
 
36.21(17.44) 
 
 
36.3(18.8) 
 
 
t(113) = -1.059 
 
 
p = .292 
*PSQI (sleep quality) 
Mean(SD) 
  
 
7.34(3.49) 
 
5.33(3.22) 
 
 
t(112) = 3.18 
 
p = .002 
*EPDS  (depressive symptoms) 
Mean(SD) 
  
 
 
4.63(5.23) 
 
 
 
2.42(3.25) 
 
 
t(103.83) = 2.77 
 
 
p = .007 
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Table 32 (cont.)     
     
HPLPv.2 (health-promoting 
behaviors) 
Mean(SD) 
 
 
 
2.62(0.47) 
 
 
2.54(0.36) 
 
 
t(110.72) = 0.97 
 
 
p = .336 
Physical component score (quality 
of life) 
Mean(SD) 
 
 
 
44.21(7.82) 
 
 
46.84(6.89) 
 
 
t(113) = 1.905 
 
 
p = .058 
Mental component score 
(quality of life) 
Mean(SD) 
  
 
 
52.12(9.31) 
 
 
52.27(7.89) 
 
 
t(112.14) = -0.15 
 
 
p = .988 
*p values <.01  
 For each analysis comparison, none of the variables were normally distributed based on 
Shapiro-Wilk tests (Razali & Wah, 2011).  However, the mean of any random variable will be 
approximately normally distributed as sample size increases according to the Central Limit 
Theorem (CLT) (Field, 2009).  Therefore, with a sufficiently large sample size (n > 50), 
deviations from normality will have little effect on the results (Stevens, 2009).  Thus, a series of 
independent t-tests were conducted to compare ethnic differences in vitamin D levels, pregnancy 
symptom total scores, sleep quality, health-promoting behaviors, and quality of life.  
Comparison between African American and Hispanic women.  In Table 31, the 
results of the comparisons between these groups are noted.  For African Americans, their vitamin 
D levels were lower than Hispanics [t(113) = -2.77, p = .006].  There were no differences 
between pregnancy symptom total scores between these groups [t(113) = -1.059, p = .292].  For 
sleep quality, the mean PSQI global sleep quality score in African American pregnant women 
was significantly higher than in the Hispanic pregnant women [t(112) = 3.18, p = .002] 
indicating worse sleep quality in African American pregnant women.  For depressive symptoms, 
the scores were worse for those who were African American as compared to those who were 
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Hispanic [t(103.83) = 2.77, p = .007].  However, the mean scores for both groups were still 
within normal range.  There were no differences between health-promoting behaviors between 
these groups [t(110.72) = 0.97, p = .336].  Finally, for both mental and physical quality of life, 
there was no significant difference between groups on these outcomes [t(112.14) = -0.15, p = 
.988; t(113) = 1.905, p = .058]  However, there was a trend for those who were African 
American to have lower physical quality of life. 
Exploratory Aim  
 
 As a result of the null effect of vitamin D status on pregnancy symptoms, the exploratory 
aim could not be evaluated.  However, since sleep quality was significantly associated with 
vitamin D status, a mediational analysis was conducted to evaluate if depressive symptoms 
explains the strength of the relationship between vitamin D and sleep quality.  In addition, due to 
the assumption that in a mediation model, all the variables need to be continuous, the serum 
vitamin D was used as a continuous variable (Field, 2009). 
A Baron and Kenny mediation analysis was conducted to assess if depressive symptoms 
mediated the relationship between serum vitamin D levels and sleep quality.  To determine 
whether a mediating relationship was supported by the data, three regressions were conducted.  
For mediation to be supported, four items must be met: 1) the independent variable must be 
related to the dependent variable, 2) the independent variable must be related to the mediator 
variable, 3) the mediator must be related to the dependent variable while in the presence of the 
independent variable, and 4) the independent variable should no longer be a significant predictor 
of the dependent variable in the presence of the mediator variable (Baron & Kenny, 1986).  In 
106 
 
 
this analysis, the independent variable is serum vitamin D levels, the mediator is depressive 
symptoms, and the dependent variable is sleep quality. 
 First, the regression with serum vitamin D levels predicting sleep quality was conducted.  
The regression of sleep quality on serum vitamin D levels was significant, F(2, 122) = 16.05, p < 
.001.  The results showed that serum vitamin D levels was a significant predictor of sleep 
quality, B = -0.14, indicating that the first criterion for mediation was satisfied.  Second, the 
regression with serum vitamin D levels predicting depressive symptoms was conducted.  The 
regression of depressive symptoms on serum vitamin D levels was not significant, F(2, 122) = 
0.27, p = .605.  The results showed that serum vitamin D levels was not a significant predictor of 
depressive symptoms, B = 0.03, indicating that the second criterion for mediation was not 
satisfied.  Next, the regression with serum vitamin D levels and depressive symptoms predicting 
sleep quality was conducted.  The regression of sleep quality on serum vitamin D levels and 
depressive symptoms was significant, F(3, 121) = 26.56, p < .001 suggesting that serum vitamin 
D levels and depressive symptoms accounted for a significant amount of variance in sleep 
quality.  
The individual predictors were examined further.  The results showed that serum vitamin 
D levels was a significant predictor of sleep quality when depressive symptoms was included in 
the model, B = -0.15, indicating that the third criterion for mediation was satisfied.  The results 
showed that depressive symptoms was a significant predictor of sleep quality when serum 
vitamin D levels was included in the model, B = 0.33, indicating that the fourth criterion for 
mediation was not satisfied due to the assumption that the serum vitamin D should no longer be a 
significant predictor of the sleep quality in the presence of the mediator variable of depressive 
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symptoms.  As a result, since item 2 and item 4 were not met, mediation cannot be supported.  
Therefore, depressive symptoms is not a mediator between serum vitamin D levels and sleep 
quality.  Results of the mediation analysis are summarized in Table 33. 
Table 33. Regression Results with Depressive Symptoms Mediating the Relationship Between 
Sleep Quality and Serum Vitamin D Levels 
 
Dependent Independent B SE t p 
Regression 1:      
Sleep quality Serum vitamin D levels -0.14 0.03 -4.01 < .001 
      
Regression 2:      
Depressive symptoms Serum vitamin D levels 0.03 0.05 0.52 .605 
      
Regression 3:      
Sleep quality Serum vitamin D levels -0.15 0.03 -4.76 < .001 
 Depressive symptoms 0.33 0.06 5.73 < .001 
      
 
In conclusion, the pregnancy symptom total score was not significantly predicted by 
vitamin D status.  However, it was evident that sleep quality and physical quality of life was 
significantly predicted by vitamin D status.  Despite controlling for significant covariates, the 
predictive power of vitamin D status for poorer sleep quality and physical quality of life 
remained significant.  Furthermore, the only ethnic differences found between African American 
and Hispanic pregnant women were vitamin D, sleep quality, and depressive symptoms with a 
trend toward significance in regards to physical quality of life.  Finally, the exploratory aim 
proved to be insignificant in regards to depressive symptoms mediating the relationship between 
vitamin D and sleep quality. The major implications for the results will be discussed in the 
following chapter.  
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CHAPTER FIVE 
DISCUSSION 
Vitamin D deficiency is highly prevalent in pregnant women and there is an exacerbated 
risk in African American and Hispanic pregnant women (Ginde et al., 2010).  Studies have 
reported that symptoms such as poor sleep quality, depressive symptoms, musculoskeletal pain, 
and urinary complaints have been associated with vitamin D deficiency in women who are not 
pregnant as well as men (McCarty et al., 2013; Cassidy-Bushrow et al., 2012; Spedding, 2014; 
Huang et al., 2013; Aydogmus et al., 2015).  Because these same symptoms are commonly 
reported during pregnancy (King et al., 2015; Nazik & Erilmaz, 2014), this study sought to 
determine whether these symptoms were due to low vitamin D levels.  In addition, since these 
symptoms can impact quality of life and health outcomes, this was also examined.  Currently 
there is a gap in the literature investigating the relationship of low vitamin D levels and 
symptoms experienced during pregnancy and its association with health and quality of life. 
The Wilson & Cleary (1995) Health-Related Quality of Life framework which addresses 
multiple factors and their interrelationships with quality of life was used to guide this study 
(Figure 1).  Thus, the findings from this study will be discussed relative to this model based on 
the following areas:  characteristics of the individual, biological factors, symptom status, health 
behaviors, health perceptions, quality of life and characteristics of the environment. 
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Characteristics of the Individual 
Description of the Sample 
The convenience sample of 125 pregnant women who participated in the study was 
comprised of mostly African American (49.6%) and Hispanics (42.4%)  The racial distribution 
for the sample compared to data from the National Health and Nutrition Examination Survey 
(NHANES) from 2001 to 2006.  NHANES had a racial distribution of 16% non-Hispanic Black 
and 20% of Hispanic pregnant women with the majority of pregnant women in the non-Hispanic 
White category of 56% (Ginde et al., 2010).  The discrepancy noted in the current study can be 
explained by the fact that the recruitment site was a federally qualified health center (FQHC) 
serving a predominantly Medicaid patient population.  The average mean age of participants was 
26.7 years with a range from 18 to 43 years of age, with a breakdown of 8% (n=10) 18-19 year 
olds, 81.6% (n=102) 20-34 year olds, and 10.4% (n=13) 35-44 year olds.  The age breakdown of 
the sample was similar to that of the NHANES study examining pregnant women: 9% in the age 
range of 13-19 years (the inclusion criteria for the current study was a minimum age of 18 years 
old), 78% in the age range of 20-34, and 13% in the age range of 35-44.  Therefore, the majority 
of the participants were in the 20-34 years range which is consistent with the literature.  Older 
women are more prone to having more discomforts of pregnancy simply due to age and 
increased likelihood of pregnancy complication, however women 35-44 years of age in the 
current sample actually had lower pregnancy symptom total scores than their younger 
counterparts which was not statistically significant (King et al., 2015; Zib et al., 1999; 
Cunningham et al., 2014).  Women who were aged 35-44 years reported fewer pregnancy 
symptoms than the younger cohort and this was also not statistically significant. 
In terms of education, 40% of participants had some college education.  There was a 
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fairly evenly split between those with lower vs higher levels of education level.  There is 
evidence that the higher the education level of the pregnant woman, the better the management 
of pregnancy symptoms (Nazik & Erilmaz, 2014; Telleen, 1993). 
In addition to education, 70% of the sample reported an income <$30,000 which reflects 
a very low income.  However, this level of income is consistent with that reported by FQHCs 
and in the state of Illinois, 1,229,655 people were cared for by a FQHC (Kaiser Family 
Foundation, 2015).  It was also noted that women who were vitamin D deficient (< 20 ng/ml) 
had significantly lower income when compared with those who were vitamin D sufficient (20 
ng/ml) as reported in Table 1.  Evidence exists that low-income women are faced with 
significantly more adversity and stress related to their economic status which can negatively 
impact health outcomes (Giurgescu et al., 2013; Alhusen, Gross, Hayat, Rose, & Sharps, 2012; 
Hirst et al., 2016; Giscombe & Lobel, 2005). 
Another important characteristic to recognize is marital status as it can be a reflection of 
social support and paternal involvement (Rini et al., 2006; Dunkel-Schetter, Gurung, Lobel, & 
Wadhwa; Abdou et al., 2010).  Only 28% of the sample was married with no significant 
difference between vitamin D groups, but there was a significant difference in marital status 
based on ethnicity.  In the entire sample of the 125 pregnancy women, only four African 
American women were married compared to 26 Hispanic women and five women of other 
ethnicities.  One review article written by Dunkel-Schetter, Sagrestano, Feldman, and 
Killingsworth (1996) noted that impact of spousal involvement or intimate partner involvement 
had a greater predictive value on better maternal child health outcomes than family support.  
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 Another important component that was unique to the current study population was the 
fact that almost half (46.4%) of the sample participated in Centering pregnancy group prenatal 
group care model.  One of the hallmarks of Centering pregnancy model is social interaction and 
bonding that occurs between pregnant women who are of similar gestational age (Rising, 1998).  
Some investigators have conjectured that the social support inherent in the model is one of the 
reasons it has been shown to be effective in improving adverse birth outcomes for at risk 
pregnant women specifically in low-income and low resource patient populations (Conde, 2010; 
Andersson, Christensson, &Hildingsson, 2013; Rotundo, 2011).   However, in the current sample 
those who were in centering prenatal care did not have significantly higher social support scores 
when compared with those who were in routine prenatal care.  The mean MSPSS total score for 
those in Centering was 5.84 (SD=1.6) and those in routine prenatal care was 5.81(SD=1.4).  
Therefore, interestingly enough social support was not higher in patients in the Centering model, 
but social supports were elevated in the sample as a whole. 
Biological Factors 
Vitamin D Status 
Vitamin D deficiency in pregnant women is highly prevalent (Hollis & Wagner, 2013; 
Hossein-Nezhad & Holick, 2012; Dawodu et al., 2013).  An NHANES study of 928 pregnant 
women showed that 80% of Non-Hispanic Black women had a vitamin D level < 20 ng/ml and 
45% of Hispanic women had vitamin D levels < 20 ng/ml.  In the current study, 74% of African 
American women had vitamin D levels < 20 ng and 45% of Hispanic women had vitamin D 
levels < 20 ng/ml.  Therefore, the current data demonstrated comparable findings to the 
NHANES report of vitamin D status in pregnant women.  This finding is concerning as there is 
epidemiologic evidence that insufficient levels of vitamin D have been associated with vitamin D 
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deficiency in newborns which can lead to Rickett’s disease, small for gestational age, increased 
asthma symptoms (Aghajafari et al., 2013; Hossain et al., 2014; Litonjua et al., 2014; Weiss & 
Litonjua, 2016; ).  Thus, the potential policy implications for vitamin D supplementation during 
pregnancy are significant if future clinical trials of pregnant women yield positive outcomes 
(Litonjua et al., 2016; Jelsma et al., 2013; Hollis & Wagner, 2017). 
Dietary Vitamin D and Calcium Intake 
 Dietary intake of vitamin D and calcium is negligible in terms of raising a person’s serum 
vitamin D level to a sufficient level (Hossein-Nezhad & Holick, 2013; Hollis & Wagner, 2013).  
In order to raise serum vitamin D levels, an adequate dietary vitamin D supplement needs to be 
taken in order to adequately raise serum vitamin D levels (Burris, Thomas, Zera, & McElrath, 
2015; Dawodu et al., 2013; Wagner et al., 2013).  A prenatal vitamin only has about 400-600 IU 
of vitamin D which is not high enough to raise serum vitamin D levels if one is deficient as 
evidenced in numerous randomized control trials (Wagner et al., 2013; Hollis et al.,   2013; 
Dawodu et al., 2013; Asemi et al., 2014).  In the current study, 74.4%(n=93) of women were 
taking daily prenatal vitamins and 58.4% of these women remained deficient (<20 ng/ml). 
Hemoglobin Status 
 Iron deficiency anemia is common in pregnancy especially in the late second and early 
third trimester due to some of the physiological changes of pregnancy (Cunningham et al., 2014; 
King et al., 2015).  Women in the current study had a mean hemoglobin of 11.2 g/dl which is 
consistent with that observed during the late second and early third trimester (> 10.5 g/dl) 
(Cunningham et al., 2014; King et al., 2015).  Anemia in pregnancy is predominantly caused by 
iron deficiency and is related to the increased maternal plasma volume and the increased iron 
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needs of the fetus and pregnancy (Cunningham et al., 2014; King et al., 2015; Laflamme, 2011).  
Based on the World Health Organization (WHO), the prevalence of iron deficiency diagnosed 
(<10.5 g/dl) in developed countries is 18% (De Benois, McLean, Egli, & Cogswell, 2008; 
daCosta, Vargas, Clode, & Graca, 2016).  In the current sample, about 22.4 % of participants had 
a hemoglobin level < 10.5 which is comparable to other studies (DeBenois et al., 2008; daCosta 
et al., 2016).   
 It is important to recognize that women who were vitamin D deficient had lower levels of 
hemoglobin (<10.5 g/dl) and hematocrit (< 32%).  One potential mechanism that could explain 
this difference is possible suppression of iron-regulatory hepcidin by vitamin D which has been 
reported (Bacchetta et al., 2014).  Hepcidin is an important biomarker for iron homeostasis 
because it “suppresses membrane expression of ferroportin, which is the only known exporter of 
intracellular iron” (Bacchetta et al., 2014, p.564).  Although these researchers studied persons 
with chronic kidney disease and not pregnant women, in vitro and in vivo models that showed 
that cultured hepatocytes or monocytes when treated with 25-hdyroxyvitamin D (biological 
available form of vitamin D), decreased hepcidin levels which in turn had positive effects on 
hemoglobin status.  Their sample of seven healthy volunteers received a single dose of vitamin 
D2(100,000 IU of ergocalciferol) and hepcidin levels were measured twenty-four hours after 
supplementation.  They reported a 34% decrease in hepcidin levels, but no changes in serum iron 
concentration, iron binding capacity or transferrin saturation (Bacchetta et al., 2014).  However, 
the findings were limited due to the small sample and the fact that they only measured 
immediately post supplementation (24 and 72 hours) yet the half-life of hemoglobin is 50-55 
days.  Thus, since the supplementation results of the study were limited since hemoglobin has a 
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half-life of 50-55 days.  Thus, future trials are needed to assess if vitamin D supplementation 
improves hemoglobin levels over time.  
Hemoglobin A1C 
 Glucose metabolism as measured by hemoglobin A1C is not routinely measured as part 
of the initial obstetric panel of pregnant patients but is often done when a woman has risk factors 
for GDM (Laptook, Homko, & Biastre, 2013).  The mean hemoglobin A1C in the current sample 
was 5.2% and did not differ between vitamin D groups which is consistent with the literature 
related to type 2 diabetes (Krul-Poel, Wee, Lips, & Simsek, 2017).  A meta-analysis and 
systematic review which included nineteen studies on the effect of vitamin D supplementation in 
patients with type 2 diabetes mellitus, found no significant difference in hemoglobin A1C levels 
between those that received vitamin D supplementation and those that did not (Krul-Poel et al., 
2017). 
Symptom Status 
Pregnancy Symptom Inventory 
 The Pregnancy symptom inventory (PSI) instrument is a clinical tool developed to assist 
clinicians in screening their patients for common discomforts of pregnancy that could be 
negatively impacting their activities of daily living (Foxcroft et al., 2013).  The initial study used 
the PSI on 211 pregnant women having routine midwifery appointments in Australia and 
reported that the top four most often symptoms included: urinary frequency (85.2%), tiredness 
(87%), poor sleep (62.5%) and back pain (60%) (Foxcroft et al., 2013).  These findings were also 
found in the current study: tiredness (84%), urinary frequency (81%), back pain (79%), and poor 
sleep (72%), but at a much higher frequency for back pain and poor sleep.  It is not by 
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coincidence that the incidence of poor sleep and back pain was higher in the current study since 
these symptoms are associated with vitamin D deficiency and the original study did not report on 
the demographics of their study population, thus the ethnicity or race of the sample was 
unknown.  In addition, the mean gestational age range the women in their study was 12-42 week 
which was much larger than the current study. 
Therefore, consistent with the literature that vitamin D deficiency is associated with 
musculoskeletal pain and poor sleep in the non-pregnant population, it was also found in the 
current study with pregnant women (Wu et al., 2016; McCarty et al., 2013).  It is plausible that  
vitamin D status be an important predictor for the presence of more severe musculoskeletal pain 
and poor sleep in pregnancy,  however further research and investigations is needed. 
At the time of the collection of data for this study, there was no Spanish version of the 
PSI.   Consequently, as previously reported, this investigator had the tool translated 
professionally.  Most recently, the psychometrics of the Spanish version of the PSI tool were   
reported in a sample of 120 healthy pregnant women in Spain (Oviedo-Caro, Bueno-Antequera, 
& Munguia-Izuierdo, 2016).  In that sample, the following symptoms were reported to be 
problematic: urinary frequency (88.4%), tiredness (73.5%), poor sleep (69%) and increased 
vaginal discharge (64%).  Although the age of women in that study were older than the current 
study population (72.8% were 31 to 44 years of age), the symptoms are comparable to the 
current study with a few exceptions (Oviedo-Caro et al., 2016).  Vaginal discharge was reported 
highly (64.1%) in the Spanish cohort study (Oviedo-Caro et al., 2016), but was not commonly 
reported in the current total sample (35%) or even with the Hispanic population (39.6%).  The 
Hispanic participants in the current study had most commonly reported tiredness (71.6%), 
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urinary frequency (69.8%), back pain (54.7%), and poor sleep (52.8%) and at lower frequencies 
than the Spanish cohort which could be reflective of the older population that was in the study.   
Although no psychometrics were reported for the initial study on the PSI (Foxcraft et al., 
2013), acceptable weighted Kappa coefficients ranged from 0.589 to 0.889 are now reported on 
the Spanish version of the PSI tool (McHugh, 2012).  According to measurement theory a weight 
Kappa coefficient of 0.41 to 0.60 is considered moderate and 0.60 to 0.80 is considered 
substantial interrater reliability.  For clinical and healthcare studies substantial or above should 
be acceptable (McHugh, 2012).  Another measure of interrater reliability, the test-retest 
reliability (82% to 96%), was also reported by these authors and > 80% test-retest reliability is 
generally considered acceptable (Oviedo-Caro et al., 2016; McHugh, 2012).  The principal 
investigator for the current study spoke with Oviedo-Caro, the PI for the Spanish PSI 
psychometric paper and compared translations.  These translations were almost identical aside 
from one or two symptoms which reflected regional differences (Oviedo-Caro, personal 
communication, September 29, 2016).  For this study, the English and Spanish instrument 
demonstrated reliability that was Cronbach alpha of .893 for the English tool and .921 for the 
Spanish tool, both of which are acceptable (DeVillis, 2011).   
 The PSI provided valuable information about the frequency and type of the symptoms 
pregnant women reported.  Total scores on the PSI were not significantly different between 
vitamin D status, however, the limitations imposed by some symptoms were significantly 
different with women who were vitamin D deficient reporting more limitations imposed by the 
following symptoms: tiredness, poor sleep, back pain, and pelvic and hip pain when compared to 
those who were sufficient.  Since there has been no literature to examine the limitations impacted 
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by pregnancy symptoms this study was able to add this unique information to the symptoms 
reported by diverse women who are pregnant. 
Depressive Symptoms  
 Depression is a highly prevalent, both in the antenatal period (9 to 20%) and postpartum 
period (19.2%) which has devastating consequences to the mother as well as to the family 
(Garfield, Matthews, & Janusek, 2015; Byrn & Penckofer, 2015; Melville et al., 2010; Gavin, 
Gaynes, Lohr, Meltzer-Brody, Gartlehner, & Swinson, 2005).   More recently, depression is 
being studied during the antenatal period in order to prevent pregnancy complications such as 
preterm delivery and poor maternal attachment with negative sequelae on infants as well as 
depression development in the postpartum period (Davalos, Yadon, & Tregellas, 2012; 
Giurgescu et al., 2015; Plant et al., 2013).   Although depressive symptoms have been associated 
with lower vitamin D in numerous studies in nonpregnant populations (Spedding, 2014, Anglin 
et al., 2013), its study in women during the antenatal and postnatal period is limited.  The 
evidence of vitamin D deficiency and perinatal depression has been strong with multiple 
observational studies and epidemiologic studies showing an inverse relationship between vitamin 
D and depressive symptoms (Cassidy-Bushrow et al., 2012; Huang et al., 2014, Brandenburg et 
al., 2012; Robinson et al., 2014; Bobbitt et al., 2015).   
For this study, depressive symptoms was measured by the EPDS.  Results showed that 
the scores for this sample were unexpectedly low for an underserved, low socioeconomic status 
patient population.  The mean EPDS score was 3.9 (range of scores = 0 to 19).  The total 
potential range for this tool is 0 to 30.  This finding is somewhat consistent with another study in 
the same region that examined pregnant women.  Byrn and Penckofer (2015) studied depression 
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in pregnant women with 48% of the sample who had GDM and 52% who did not have GDM.  
The mean EPSD for the women in that study was 6.26 with no differences between groups, 
however, a history of depression was associated with higher EPDS scores for women who had 
GDM.  In the current study, the EPDS scores were lower but presence of GDM was less 
(13.6%).   In addition, in the Byrn and Penckofer (2015) study, 15% of the sample had a history 
of depression whereas only 12% had a history of depression in this study sample.   Thus, the 
current study has some comparable findings to previous patients from the same geographic 
region.    
Another study used a convenience sample of African American pregnant women (n=166) 
at 24-28 weeks gestation and assessed for depressive symptoms with EPDS as well as social 
support (Alheusen et al., 2012).  That study reported clinically significant depressive symptoms 
(EPDS> 12) in more than half of their women (59%; n=98).  A significantly higher incidence of 
depressive symptoms accompanied by lower social support scores (Alheusen et al., 2012) were 
reported as compared to the current study.  Potential reasons for differences may have included 
the following:  women in the current study reported good social support and spirituality and only 
12.8% of the sample of the current study had an income > $40,000.  Both of these previous 
studies although important, did not address vitamin D status and its potential role in depression 
during pregnancy.   
 In terms of studies that have examined depression during pregnancy and vitamin D status, 
one such study used the Center for Epidemiologic studies (CES-D) to measure depressive 
symptoms (Cassidy-Bushrow et al., 2012).  In this study, African American pregnant women 
(n=178) of low socioeconomic status and had a mean Center for Epidemiologic Studies 
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Depression (CES-D) score of 15.2 (score of ≥ 16 is considered depression).  This study also 
included pregnant women with comorbidities such as pre-gestational diabetes and hypertension 
which may have contributed to their depressive symptoms.  In addition, the mean vitamin D was 
13.4 ng/ml for this sample which may have been contributory, yet the vitamin D level for the 
current study was comparable at 17.02 ng/ml in African American pregnant women.  Another 
study has shown that vitamin D was not associated with postpartum depressive symptoms in 605 
women with postpartum depression when compared with 875 postpartum women without 
postpartum depression (Nielsen et al., 2013).  
 Another recently published study from Iran, conducted a randomized control trial that 
had 78 pregnant women in the treatment group of 2000 IU daily of vitamin D supplementation 
starting at 26-28 weeks gestation and 75 pregnant women in the placebo group (Vaziri et al., 
2016).  The baseline EPDS scores for both groups was not significantly different nor were their 
vitamin D levels, with a mean vitamin D level of 12.35 ng/ml at baseline for the entire sample.  
The results of the study reflected a significant decrease of depressive symptoms at 38–40 weeks 
gestation (p=.01) and at 4 and 8 weeks after birth (p<.001) in the vitamin D supplementation 
group (Vaziri et al., 2016).  To date, this is the only vitamin D supplementation trial in regards to 
perinatal depression.  
 Overall in the current study, depression did not differ between women who were 
sufficient and those who were insufficient.   However, given that the women in the study were 
primarily not depressed, it would be challenging to find statistical significance.  In addition, in 
the current study, the EPDS is used routinely as part of their pregnancy care (screened once 
every trimester by registered nurse and again by health support workers at home visits) and it is 
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possible that the women are sensitized to the measure perhaps contributing to the lack of 
depression reported.  Finally, although the EPDS was higher for those with a history of 
depression (M=8.94) compared to those who did not (M=3.05) in the current study, there were 
no differences in vitamin D levels between these groups probably due to the lack depression 
severity even in those with a history of depression.  
Sleep Quality 
Sleep is a significant problem during pregnancy with reports insomnia rates in the third 
trimester of pregnancy as high as 60% (Sivertsen, Hysin, Dorheim, & Eberhard-Gran, 2015). 
Sleep issues have been reported to get worse as the pregnancy progresses due to normal 
physiological changes of pregnancy including an increasing size of the uterus, decreased 
respiratory capacity in a supine position, and increased incidence of nocturia and urinary 
frequency (King et al., 2015; Schuiling & Likis, 2015). A recent study of 2,427 pregnant women 
examined sleep quality across all months of pregnancy and reported that 100% of them had sleep 
disturbances (Mindell, Cook, & Nikolovski, 2014). Sleep disturbances during pregnancy have 
been reported to significantly impact the health and quality of life of the mother and contribute to 
poor birth outcomes (Volkovich, Tikotzky, & Manber, 2015; Okun et al., 2010; Chang, Pien, 
Duntley, & Macones, 2009; Skouteris et al., 2009; Tomfohr et al., 2015). For the current study, 
the Pittsburgh Sleep Quality Index (PSQI) was used to measure sleep quality. The mean global 
score for the sample was 6.3 with a score of ≤ 5 denoting good sleep quality. Therefore, sleep 
quality was poor in this study sample.  Notably, there was a statistically significantly difference 
in sleep quality between vitamin D groups (t(122) = 3.68, p < .001). Those who were vitamin D 
deficient had significantly worse sleep quality (PSQI global score, mean = 7.28) compared to 
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those who had sufficient vitamin D levels (PSQI global score, mean = 5.1).    
Several studies have reported that vitamin D may impact sleep quality in those who are 
not pregnant.  A cross-sectional study in Turkey that evaluated a cohort of men and women but 
predominantly women in their sample (n=102) assessed vitamin D status and its association with 
sleep quality (PSQI) and restless leg syndrome (International Restless Leg Syndrome Study 
Group (IRLSSG) symptom scale), which is commonly considered a sleep disordered condition 
(Cakir et al., 2015).  Their study resulted in a significant difference in PSQI global scores and 
restless leg syndrome scores between vitamin D groups based on IOM guidelines (20 ng/ml 
being sufficient, <20 ng/ml being deficient) (Cakir et al., 2015).  Therefore those that were in the 
vitamin D deficient group had higher PSQI and restless leg syndrome symptoms when compared 
with those in the vitamin D sufficient group. 
In addition, McCarty et al.(2013) indicated that those individuals being evaluated for a 
sleep disorder who had a deficient vitamin D levels (n=153) were more likely to be diagnosed 
with a sleep disorder and also had greater complaints of nonspecific musculoskeletal pain.  Their 
study also showed that African American participants were 50 times higher than White/Hispanic 
participants to be vitamin D deficient (McCarty et al., 2013).    
 The PSQI has several components (sleep duration, habitual sleep efficiency, use of 
sleeping medication, and daytime dysfunction).  Differences were found according to vitamin D 
status.  In the current study, those who were vitamin D deficient reported a mean 6.7 hours of 
sleep at night as compared to those with vitamin D sufficiency who reported 7.6 hours of 
nighttime sleep.  This finding is consistent with a study of vitamin D deficient elderly Korean 
people who reported shorter sleep duration ( 4 hours of sleep duration) than those who were 
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vitamin D sufficient despite controlling for significant covariates (Kim et al., 2014).  Another 
study that corroborated the relationship between vitamin D deficiency and shorter sleep duration 
was conducted on a predominantly Caucasian population (n=3048) assessing wrist actigraphy 
and total sleep time, sleep efficiency, and wake time after sleep onset based on vitamin D status 
(Massa et al., 2015).  Their results indicated that vitamin D deficient group had higher odds of 
short sleep duration (< 5 hours) (OR 2.15; 95% CI 1.21–3.79) (Massa et al., 2015). 
In contrast, a study of pregnant women at 36 weeks gestation (n= 92) resulted in no 
difference in PSQI global scores between vitamin D groups with sufficient being  20 ng/ml and 
deficient being < 20 ng/ml (Gunduz et al., 2015).  The mean PSQI global scores were similar to 
the current study (vitamin D deficient group mean PSQI score = 6.5 and the sufficient group 
mean PSQI score = 5.8) (Gunduz et al., 2015).  The difference in component 1 (subjective sleep 
quality) and component 3 (sleep duration) approached significance (p =.08 and p = .09 
respectively) between vitamin D groups (Gunduz et al., 2015). 
 There were items on the PSQI that validated the PSI symptoms, primarily in those related 
to urinary issues.  Sleep disturbances which are common in pregnancy especially with increasing 
gestational age and nocturia due to physiological nature of the uterus growing and less room for 
the bladder to expand.  This leads to “getting up in the middle of the night” (item 5 b of PSQI) 
and “have to get up to use the bathroom” (item5c of PSQI) (King et al., 2015).  Another common 
sleep disturbance universal to pregnant women is “feeling hot” (item 5g of PSQI) and that is 
related to the changes in pregnancy hormones and increased body mass in pregnancy (King et 
al., 2015).   
 In terms of sleeping medication use, the current study found that vitamin D deficient 
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pregnant women were more likely to need to use some sort of sleep medication on average once 
a week whereas those who were vitamin D sufficient had a mean < 1, which on average meant 
they did not need sleeping medication in the past month.  One randomized placebo controlled 
clinical trial examined Persian women (n=54) at 26 to 30 weeks gestation, seeking treatment for 
sleep disturbance at a psychiatric outpatient clinic (Khazaie, Ghadami, Knight, Emamian, & 
Tahmasian, 2013).  Pregnant women in the treatment group received Diphenhydramine HCl or 
Trazadone for insomnia versus the placebo group.  Objective sleep measures using wrist 
actigraphy and depressive symptom scores using the EPDS were measured.  The treatment group 
for insomnia had significantly lower depressive scores after 2 weeks (p= .037) and 6 weeks of 
treatment (p <.0001) (Khazaie et al., 2013).  This study was significant in that it showed that 
improvement of sleep in third trimester resulted in improved depressive symptoms which further 
supports the connection between poor sleep quality and depression. 
Overall, sleep is a major health issue for pregnant women and poor sleep quality can have 
deleterious effects on the pregnancy and postpartum (Siverstsen et al., 2015; Tham et al., 2016).  
In this study, women had overall poor sleep quality which could be reflective of the third 
trimester of pregnancy but there was a significant difference in impact of poor sleep quality 
based on vitamin D groups.  Those who were vitamin D deficient had significantly poorer sleep 
quality scores which provides further evidence that vitamin D status may indeed exacerbate poor 
sleep quality already prevalent in third trimester of pregnancy. 
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Functional Status 
Health-Promoting Lifestyle 
Practicing healthy behaviors during pregnancy enhances the pregnancy experience (King 
et al., 2015) and also improves health outcomes related to weight gain throughout and after 
pregnancy (Faucher & Barger, 2015).  For the current study, health-promoting behaviors were 
measured by the Health-promoting Lifestyle Profile v.2 which has six subscales including: 
physical activity, nutrition, health responsibility, interpersonal relations, spiritual growth, stress 
management.  The mean score of the global HPLP score for the entire sample was 2.59 (SD=0.4) 
which equates to practicing healthy behaviors “sometimes to often”.  Another study utilized the 
HPLP tool in assessing healthy behaviors of Mexican American (n=56) and African American 
(n=52) pregnant women.  They reported a mean score of 2.7(SD=0.4) for African American 
women and 2.3(SD=0.3) for Mexican American women (Esperat et al., 2007) which were similar 
to the current study. One distinct difference was that some of the Hispanic women were US 
immigrants and not all were English speaking in the current study in contrast to the Esperat et al. 
(2007) sample.   In the current study, the mean for patients who completed the Spanish version 
of the HPLP was 2.32 (SD=.26) as compared to 2.64 (SD=.44) for those who completed the 
English version.  This difference was statistically significant based on an independent samples t-
test (p = .002).  Overall, the current study sample practiced healthy behaviors sometimes to often 
in their pregnancy which could provide some insight into why the sample had such low 
depressive symptom scores and good birth outcomes. 
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General Health Perceptions 
Health of Pregnancy and Fetus 
 These were items that were created by the investigator and have not been used in the 
literature.  Thus, there may be limitations in these measures since validity and reliability were 
not previously established.   However, for women who were vitamin D deficient, 21% had rated 
their health perception of their pregnancy as “excellent” and 28% rated it as “very good” when 
compared with only 9.1% of vitamin D sufficient women who rated their pregnancy health as 
“excellent” and 40.4% rated the health of their pregnancy as “very good”.  Overall, there could 
be an inherent optimism in pregnancy and perceptions of health influenced by their spirituality or 
by their social support or receiving quality prenatal care resulting in a positive pregnancy 
experience.  Research indicates that those who have a poor health perception have poorer health 
outcomes, therefore since these participants had such positive health perceptions of their 
pregnancy, it is reflected in lower depressive scores and overall good birth outcomes (Maruish, 
2012).   
Quality of Life 
Promoting good quality of life during pregnancy is important to ensure the health of the 
mother and the unborn child.  For this study, quality of life was assessed using the SF-12.  In the 
current study the mean physical quality of life score was 45.2 (SD= 7.5).  Previous scores 
reported scores in the range of 40.51 to 52.7 in pregnant women (Lau, 2012; Ramirez-Velez, 
2011; Couto et al., 2009; Nicholson, Setse, Hill-Briggs, Cooper, Strobino, & Powe, 2006).  The 
most significant factors negatively impacting quality of life were physical back pain (76.7% of 
the sample reported this symptom) and hip/pelvic pain (71.9% of the sample reported this 
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symptom).  Differences in limitation on activities of daily living between vitamin D groups were 
significant.  Those who were vitamin D deficient had more limitation with back pain [t(97) = 
3.13, p = .002], and hip/pelvic pain [t(80) = 2.10, p = .039].  Consistent with literature in non-
pregnant women in regards to increased bodily pain, vitamin D deficient pregnant women had a 
mean 45.1 score for bodily pain and 50.3 score for women in the vitamin D sufficient group 
(Maruish, 2012).  However, in a sample of white pregnant women (n=125), quality of life was 
measured every three weeks throughout the pregnancy starting at 4-6 weeks gestation and 
physical quality of life subscales plateaued in the third trimester with significantly higher 
subscale scores at 29 weeks gestation of physical limitation (60), role limitation for physical 
(65), and bodily pain (52) (Hueston & Kasik-Miller, 1998).  The previous study is not  
comparable to the current study since it examined a predominantly White patient population, 
80% of sample was married or in stable relationship, and 61% of sample was employed outside 
of the home, however it does provide insight that physical quality of life could be impacted by 
race, social support and income.   
In direct contrast to the current study, another study examined an Australian pregnant 
patient population (n=363) using the SF-12 at 36 weeks gestation, 6 weeks postpartum and 12 
weeks postpartum (Emmanuel & Sun, 2014).  The sample was predominantly Caucasian 
pregnant women (n=292; 80.4%) and 88.2% of the sample was with their partner during 
pregnancy.  The mean physical health score was 55.13(SD=22.45), bodily pain was 
68.53(SD=23.63), role physical was 55.8(SD=22.67), therefore these scores are significantly 
better than those found in the current study (Emmanuel & Sun, 2014).  In addition, the mental 
health subscale scores were also significantly higher ranging from 70.25 to 79.28.  This is 
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significant, because despite not measuring vitamin D status in the study, it can be assumed that 
since a majority of the sample was Caucasian, that their vitamin D levels probably were not as 
deficient as those found in African American pregnant women.   
Supporting these findings in the significant in the current sample, was the correlation 
between physical component scores and pregnancy symptom total score (r = -0.31, p < .001) 
indicating that higher PSI total scores were associated with poorer physical health.  A meta-
analysis recently published investigating the impact that vitamin D supplementation had on 
generalized pain showed a significantly greater mean decrease in pain in those who were 
supplemented than those who were in the placebo group (Wu et al., 2016).  Wu et al. (2016) 
examined 19 randomized controlled trials and patient populations varied from healthy 
individuals with complaints of pain to those with rheumatoid arthritis, fibromyalgia, etc. 
Therefore the studies included were fairly heterogeneous with use of varying doses of vitamin D 
supplementation also.  Thus, the potential for vitamin D supplementation to alleviate back and/or 
hip pain are worthy of future study considering the impact on their physical quality of life.   
 In terms of mental well-being, the women in the current study reported a mean score of  
52.0 (SD= 8.6) with previous scores reported as 40.51 to 52.7 in pregnant women (Lau, 2012; 
Ramirez-Velez, 2011; Couto et al., 2009; Nicholson, Setse, Hill-Briggs, Cooper, Strobino, & 
Powe, 2006).  There was a significant correlation between mental component score and 
pregnancy symptom total score (r=0.32, p <.001) indicating that more symptoms were also 
associated with worse mental health.  The mental health scores were better than physical health 
scores in the current study and in other reported studies (Lau, 2012; Ramirez-Velez, 2011; Couto 
et al., 2009; Nicholson, Setse, Hill-Briggs, Cooper, Strobino, & Powe, 2006; Hueston & Kasik-
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Miller, 1998).  The reason for these findings may be due to the unusually high social support and 
spirituality scores of the current study population.  Research has shown that increased social 
support and higher levels of spirituality have a protective effect on psychological distress in 
pregnancy (Mann et al., 2010; Giurgescu et al., 2015; Feldman et al., 2010; Rini et al., 2006). 
Characteristics of the Environment 
Spirituality 
Spirituality and religiosity has been shown in the literature to have a positive effect on 
health outcomes both in pregnant and non-pregnant women (Koenig, 2012; Mann et al., 2010; 
Mann et al., 2008; Cheadle et al., 2015).  The current study population had elevated levels of 
spirituality as measured by the Spiritual Perspectives Scale.  The mean score of the SPS in this 
sample was 4.7, with a max score of 6.0.  The scores for the study sample were similar to other 
studies (3.64 for those without religious affiliation and 4.57 for those with a religious affiliation) 
that utilized a similar patient population and used the same measurement tool (Dailey & Stewart, 
2006).   
The current study was limited in that participants were not asked if they had a religious 
affiliation but due to the higher SPS scores, the assumption can be made that many of the 
participants did have a religious affiliation especially since the recruitment site was a faith based 
clinic.  Therefore, higher levels of spirituality among the study participants could be one of the 
explanations for lower depressive symptom scores.  This explanation is supported by a recent 
study of low income African American new mothers (n=702) that found that higher levels of 
spirituality and religiosity predicted lower levels of depressive symptoms (Cheadle et al., 2015).  
It is important to recognize that spirituality and religiosity is potentially an important social 
129 
 
 
support system for pregnant women which can contribute to better health outcomes and lower 
depressive and anxiety symptoms (Mann et al., 2010).  
Social Support  
Poor social support has been widely recognized as a risk factor for perinatal mood 
disorders, adverse birth outcomes and potentially influential factor with coping in pregnant 
women who have minimal amount of resources (Giurgescu et al., 2015; Rini et al., 2006; 
McKee, Cunningham, Jankowski, & Zayas, 2001; Collins, Dunkel-Schetter, Lobel, & 
Scrimshaw, 1993).  In the current study, social support was relatively high with a mean MSPSS 
score of 5.8, with 7 being the highest score of social support.  More importantly, significant other 
subscale for the study population was even higher with a mean score of 6.1.  The increased 
perceived social support in the current population could potentially account for the unusually low 
depressive symptom scores observed in this study.   There has been evidence to support these 
findings. Feldman et al. (2000) studied low income African American and Latina women with 
singleton pregnancy in the first trimester (n=247), which showed that that prenatal social support 
significantly predicted higher birth weight infants adjusted for gestational age.  
Discussion of Study Aims 
Aim 1 
To determine if there was a relationship between vitamin D status, pregnancy symptoms 
including depression and sleep disruption, health-promoting behaviors, and quality of life. 
The primary aim for the current study was to examine whether vitamin D status was a  
significant predictor for pregnancy total score, sleep quality, health-promoting behaviors and 
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quality of life.  In using a logistic regression model, the univariate analysis with vitamin D as a 
binary variable, only sleep quality and physical quality of life was predicted by vitamin D status.  
Therefore, pregnancy symptom total score, depressive symptoms, health-promoting behaviors 
and mental quality of life were not significantly predicted by vitamin D status.   
In regards to the current literature, there is no evidence of other studies that have 
examined pregnancy symptom total score and vitamin D status.  Therefore, the current study is 
the first to use the PSI tool as a total score and as described earlier in the chapter, it is not 
surprising that it was not significantly predicted by vitamin D.  The tool identifies many 
symptoms that currently do not have evidence regarding their association with vitamin D status.  
Specific measures of the symptoms previously discussed in chapter 2 such as depression, 
musculoskeletal pain, fatigue, and pelvic floor disorders have confirmed that it is predicted by 
vitamin D status.  Thus, a global tool like the PSI may not have been the best measure to capture 
pregnancy symptoms.    
The insignificant findings for vitamin D status predicting depressive symptom score was 
also not surprising considering the low EPDS scores (i.e. 32% of the sample scoring a zero). 
Most likely there were not enough people who had depressive symptoms to be able to see any 
effect of vitamin D status.  In other studies, almost a third of the participants had elevated 
depressive symptom scores which showed a positive predictive factor for vitamin D in pregnant 
women.  For example, Cassidy-Bushrow et al. (2012) had 41.6%, Brandenbarg et al. (2012) had 
28% whereas in the current study, only 6.4% (n=8) had elevated EPDS scores as measured by a 
score > 12.  Even one study that included predominantly Non-Hispanic white, married women 
with college or graduate degree pregnant women, had a 12.6% incidence of elevated depressive 
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symptom scores demonstrated a very modest association with lower vitamin D levels and 
depressive symptoms (Huang et al., 2014).  The variation in results could also be due to different 
instruments being used for assessment of depressive symptoms with Cassidy-Bushrow et al. 
(2012) using CES-D, Brandenbarg et al. (2012) using CES-D, and Huang et al. (2014) using the 
Patient Health Questionnaire-9 (PHQ-9).   
There is no evidence in the literature about healthy behaviors and vitamin D status in 
pregnant women, but there are some studies examining other patient populations. In a study 
examining determinants for vitamin D status among children, a representative sample of 2686 
children from 10-11 years of age were surveyed (Munasinghe, Willows, Yuan, & Veugelers, 
2015).  Healthy behaviors were measured by a physical activity instrument and nutrition by food 
frequency questionnaire.  It was found that adolescents who participated in higher levels of 
physical activity and whose parents completed college were more likely to take vitamin D 
supplements, which is interesting to note though the current study did not include pregnant 
women < 18 years of age (Munasinghe et al., 2015).  Other studies have examined physical 
activity alone as a healthy behavior and have shown an association of low vitamin D among 
those who practice low levels of physical activity (Brock et al., 2010; Man et al., 2015).   
However, healthy behaviors were not predicted by vitamin D status in the current study 
and more specifically physical activity was not different between vitamin D groups.  There is an 
assumption that if someone at risk for vitamin D deficiency is taking a vitamin D supplement, 
they are also practicing other healthy behaviors related to nutrition, health responsibility and 
stress management.  However that was not evident in the current study.  
Lastly, it is not surprising that mental quality of life was not predicted by vitamin D 
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status because both vitamin D groups had above average mental quality of life scores with 
vitamin D sufficient group with a mean of 51.5 and the vitamin D deficient group with a mean of 
52.4.  However, in contrast, physical quality of life was significantly predicted by vitamin D 
status.  Based on the logistic regression that controlled for pre-pregnancy BMI, EPDS depression 
score, sleep quality score, general health perceptions on pregnancy, and pregnancy symptom 
total score, vitamin D status was still a significant predictor.  There are no other studies that have 
examined quality of life with vitamin D status as the predictor in pregnant women.  This will 
provide further evidence to explore this association and whether vitamin D supplementation can 
improve physical quality of life in pregnant women particularly those at risk for vitamin D 
deficiency. 
The evidence between vitamin D status and sleep quality has been inconsistent with a 
majority of articles indicating an association between vitamin D deficiency and poor sleep 
quality but several lacking an association.  One study reported no association between vitamin D 
groups using  20 ng/ml as sufficient and < 20 ng/ml as deficient and sleep (PSQI) in pregnant 
women (n= 92) who were about 36 weeks gestation (Gunduz et al., 2015).  As noted in Appendix 
E, many studies have indicated a positive association with vitamin D deficiency and poor sleep 
quality but did not study pregnant women.  Since poor sleep quality is associated with increased 
incidence of depression (antenatal and postpartum) and anxiety and adverse birth outcomes, it is 
essential that research continue to explore these important relationships. 
One study examined a group of pregnant women with a history of adverse pregnancy 
outcomes (n=120) compared to a control group of pregnant women with no history of adverse 
pregnancy outcomes (n=120).  They were screened for depression and anxiety (with Hospital 
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Anxiety and Depression Scale (HADS) and quality of life (SF-36) (Couto et al., 2010).  Their 
study indicated that women with a history of adverse pregnancy outcomes had significantly 
higher depression and anxiety scores and poorer physical and mental quality of life (Couto et al., 
2010).  Their sample included a predominantly White patient population (70% control group to 
73% previous adverse pregnancy outcome group) and married (75 control group to 88% previous 
adverse pregnancy outcome group).  Therefore, the previous population is different from the 
current study population.  However, it is important to note because if these depressive and 
anxiety symptoms and poor quality of life are being seen in a White, upper socioeconomic, 
married patient population, then it is possible to see these trends in exacerbated in an African 
American, low socioeconomic patient population that already has a higher incidence of adverse 
pregnancy outcomes (Bodnar et al., 2010). 
Aim 2 
To determine if differences existed in pregnancy symptoms, sleep quality, depressive 
symptoms, health-promoting behaviors and quality of life between African American and 
Hispanic women. 
 The ethnic differences in vitamin D status and sleep quality found between African 
American and Hispanic pregnant women was expected since there is already great deal of 
literature showing African American women are more likely to be vitamin D deficient (Ginde et 
al., 2011; Hossein-Nezhad, & Holick, 2013).  However, no studies have investigated ethnic 
differences in sleep quality specifically between African American and Hispanic pregnant 
women.  However, the current study showed there was an ethnic difference in sleep quality 
between African American and Hispanic pregnant women, in that African American women has 
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significantly worse sleep quality (mean PSQI global score = 7.34) when compared to Hispanic 
pregnant women (mean PSQI global score = 5.33).  Consequently, since vitamin D deficiency 
has been correlated with poor sleep quality, it is not surprising that there was an ethnic difference 
in sleep quality as well since African American women had significantly lower vitamin D levels 
(mean = 17.02 ng/ml) when compared with Hispanic women (mean 21.13 ng/ml). 
 The ethnic difference in depressive symptoms found in the current study is inconsistent 
with the literature.  Blackmore, Groth, Chen, Gilchrist, O’Connor, & Moynihan, (2014) 
examined the differences in depressive symptoms and proinflammatory cytokines in African 
American pregnant women compared to non-African American pregnant women.  Their study 
indicated that African American pregnant women were not significantly more likely to have 
higher EPDS scores than non-African American pregnant women, but they were more likely to 
have higher levels of interleukin-6 (IL-6) across all four time points of 18 weeks gestation, 32 
weeks gestation, 6 weeks postpartum and 6 months postpartum.  However, this previous study 
did not compare African American pregnant women specifically with Hispanic women, as the 
comparison group, was classified as “non-African American”.  There is increasing evidence that 
increased inflammatory profiles can be correlated with increased depressive symptoms (Almond, 
2013), however interestingly in the Blackmore et al. (2014) study, this was not found to be the 
case.  Another study found African American pregnant women (n= 152) to have more depressive 
symptoms (mean CES-D = 16.9) with higher incidence of preterm birth and low birth weight 
babies as compared to White pregnant women (n= 200) with less depressive symptoms (mean 
CES-D = 9.9) (Mustillo, Krieger, Gunderson, Signey, McCreath, & Kiefe, 2004).   
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 Contrary to the current study, health-promoting behaviors have been reported to be 
significantly different between African American (n=50) and Mexican American pregnant 
women (n=56) (Esperat et al., 2007).  Mexican American pregnant women had lower HPLP total 
scores with a mean 2.3 (SD=0.3).  However, the current study grouped Hispanic women together 
with immigrant women and did not distinguish those who were Hispanic but American born.  
Therefore, results from the current study and Esperat et al. (2007) were not be comparable since 
immigrant Hispanic women may have different health-promoting behaviors than Mexian 
American pregnant women. 
 Ethnic differences in quality of life between African American and Hispanic women was 
not found in the current study.  However, one study showed that African American pregnant 
women (n=66) had poorer physical and mental quality of when compared with White women 
(n=66) and those of other ethnicities (n=21) (Nicholson et al., 2006).  Their study also showed 
that women who had depressive symptoms as measured by CES-D  16 had significantly poorer 
physical quality of life scores with subscale of role functioning physical dropping to 32 when 
compared to pregnant women without depressive symptomology who had a role functioning 
physical score of 62 (Nicholson et al., 2006).    
Exploratory Aim 
Do depressive symptoms mediate the relationship between vitamin D levels and sleep 
quality?  It was expected that depressive symptoms would not be a successful mediator of the 
relationship between vitamin D levels and sleep quality since there was a low incidence of high 
depressive symptom scores.  The second criterion for mediation is that the independent variable, 
in the current study was vitamin D levels would significantly predict the mediator, which was 
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depressive symptoms.  Based on univariate analyses as part of aim 1, it was already known that 
vitamin D status was not a significant predictor of depressive symptoms.  However, it would be 
interesting to examine if sleep quality mediates the relationship between vitamin D levels and 
physical quality of life which can be examined further in a future study. 
Study Strengths and Limitations 
 There were many strengths to the current study which included a large sample size, 
collection of self-report questionnaires with minimal missing data, reliable vitamin D serum 
levels on all participants, and strong reliability on instruments.  Due to the consistency of data 
collection performed by the same person, the protocol was accurately followed and 
questionnaires were reviewed with patients prior to providing the stipend in order to get 
clarifications if items were missing.  In addition, participants were very willing to enroll and 
were invested in the study which could be due to their provider encouraging them to participate, 
the investigator’s explanation of the importance of the study, and/or recruitment site staff being 
invested in recruitment.  However, interested participants could potentially introduce bias 
(Trochim & Donnelly, 2007).  
There were some limitations to the current study.  First, this was a cross-sectional study 
with only one time point of measurement.  Therefore only correlations could be conducted.   
Thus, if the study had multiple time points throughout the pregnancy to show trends and verify 
relationships of vitamin D status with sleep quality and physical quality of life, it would have 
been a stronger design.  However, due to the exploratory nature of the research question and 
limitations related to funding and time, only a cross-sectional study could be accomplished.  The 
results of the study do provide significant evidence for further investigation.  A pilot study to 
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examine if vitamin D supplementation improves sleep quality and physical quality of life would 
be a next logical step. 
 In addition, as mentioned above, only symptoms reflected in the literature to be 
correlated with vitamin D deficiency should have been assessed.  Because the PSI tool had a 
large variation of symptoms that do not relate to vitamin D status in any meaningful way, it 
potentially diminished the strength of the symptoms that were significantly related to vitamin D 
status.  Therefore, in a future study, symptoms common in pregnancy based on the current 
evidence that are correlated to vitamin D deficiency should be included.   
 Another important variable in the characteristics of environment related to depressive 
symptoms and adverse pregnancy outcomes is exposure to racism and neighborhood disorder 
(Giurgescu, McFarlin, Loma, Craddock, & Albrecht, 2011; Giurgescu et al., 2015; Sealy-
Jefferson et al., 2015; Dominguez, Dunkel-Schetter, Glynn, Hobel, & Sandman, 2008) was not 
assessed in this study.  The role of exposure to racism is still not well understood, but in one 
study, 72 African American postpartum women (24-72 hours after birth) were evaluated for 
psychological distress, neighborhood quality/environment, and perceived racial discrimination 
(Giurgescu et al., 2012).  This study found that pregnant women who had higher levels of 
perceived racial discrimination had higher psychological distress and those with objective 
physical disorder had higher risk for preterm birth (Giurgescu et al., 2012).  These characteristics 
of the environment were not measured in the current study and could have provided significant 
insight into understanding relationships found between vitamin D status and sleep quality and 
quality of life. 
It has been reported that racism has the potential to cause on a systemic inflammatory 
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response (Giurgescu et al., 2016).  One study found that among 96 African American pregnant 
women measured during their second trimester of pregnancy, racial discrimination was 
associated with higher cytokine levels (interleukin-4 and interleukin-6) even after controlling for 
covariates.  Vitamin D does play a role in inflammation as it has anti-inflammatory effects 
(Wagner et al., 2012).  Therefore, another limitation of the current study is that other physiologic 
markers other than vitamin D and hemoglobin were not measured in the study due to cost.  
Collection of the inflammatory markers could provide an interesting biological link between 
vitamin D and symptoms as other studies have reported these findings (Accortt et al., 2017; 
Garfield, Matthews, & Janusek, 2016). 
Another important factor as it relates to neighborhood disorder, is the fact that if women 
are living in a neighborhood with high crimes rates and violence, they will most likely not be 
spending significant amounts of time outside being exposed to sunshine.  However, exposure to 
sunlight for African American women has not typically been a significant predictor of vitamin D 
status (Freedman et al., 2013; Hossein-Nezhad & Holick, 2013) and therefore seasonality is 
usually not an important predictor in African Americans but it is in other ethnicities (Freedman 
et al., 2013). 
Lastly, the current study included a group of participants with high social support which 
is not reflective in other studies with similar demographics.  Thus, self-selection into the study 
with bias could contribute to these positive findings.  Therefore, those who did have severe 
depressive symptoms could have chosen not to participate in the study.  Therefore, this limits the 
generalizability of the results and highlights the need to explore those groups who do not have 
social support and may be depressed. 
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Nursing Implications 
Advanced Nurse Practitioners (APNs) provide prenatal care for a significant amount of 
pregnant women in the U.S., which include Family Nurse Practitioners (FNPs), Women’s Health 
Nurse Practitioners (WHNP), and Certified Nurse Midwives (CNMs) (Brooten et al., 2007).  
Therefore, APNs have an important role in providing education to pregnant women about 
vitamin D deficiency and its detrimental effects in pregnancy.  Pregnant women at risk need to 
be screened at their initial obstetric visit which is recommended by both American College of 
Obstetricians and Gynecologists (ACOG) and American College of Nurse Midwives (ACNM), 
the professional bodies that accredit obstetric physicians and nurse midwives (Committee 
opinion #495; King et al., 2015).  APNs have a central role in screening and educating women 
about their vitamin D levels and the potential role it may play in improved pregnancy 
complication and improve vitamin D status of their child. Registered nurses who are caring for 
pregnant women have a role in education, and incorporating the evidence about vitamin D needs 
in pregnancy is also very important, especially in the outpatient setting.  
Secondly, another important nursing implication from the current study is recognizing 
that physical symptoms in pregnancy can impact quality of life.  Discussing proactive 
suggestions for management or minimization of physical symptoms in pregnant women could 
alleviate some of these discomforts.  Physical activity during pregnancy has been shown to 
decrease musculoskeletal pain found in pregnant women (Mogren, 2005).  Another study 
reported that in 380 pregnant women, poor physical activity correlated with worse quality of life 
as measured by SF-36 which was the parent tool (Bahadoran & Mohamadirizi, 2015).  There has 
also been evidence that practicing physical activity can be protective against depressive 
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symptoms (Demissie, 2010; Battle, Abrantes, Schofield, & Kraines, 2015).  Notable criteria for 
physical activity for pregnant women should include low-to-moderate intensity, with gentle, 
gradual increases in activity, clear safety guidelines, and tips for preventing injury or 
overexertion (Battle et al., 2015). 
Another important nursing implication for the current study is the application of social 
support in caring for pregnant women.  Since there is some evidence that social support 
can positively impact quality of life, nurses have been on the forefront about promoting 
programs like Centering pregnancy that can increase the social support of pregnant women. 
Despite not seeing a difference in social support scores between routine care and centering 
pregnancy care, there is still a role for centering pregnancy care in improving the social networks 
of pregnant women.  
Another crucial component based on the results of this study is the impact of spirituality 
on depressive symptoms and mental quality of life.  This study did not find a significant 
relationship between vitamin D and each of the following: spirituality, depressive symptoms, and 
mental quality of life.  However, there is evidence that indicates vitamin D is associated with 
perinatal depression and it is important to assess spirituality as a potential protective factor 
(Cassidy-Bushrow et al., 2012; Brandenburg et al., 2012).  Nurses should continue to encourage 
communities of faith to be involved in healthcare and engage nurses to speak at churches and 
faith communities about health screening and disease management in vulnerable 
communities.  Engaging pregnant women who have little to no support in groups for education 
and/or encouragement and recognizing the importance of socialization during pregnancy can 
have a profound impact on pregnancy outcomes.   Increasing mental health resources for 
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pregnant women is another role for nursing to better care for at risk pregnant women.  Since 
vitamin D deficiency has been associated with depressive symptoms, it is essential that nurses 
and APNs screen for vitamin D status as evidence suggests its link to mental health. 
Nursing has the responsibility to be a fierce advocate for vulnerable patient populations 
and addressing the health disparity that exists and with the social justice charge given to nurses 
by the American Nurses Association code of ethics (ANA, 2001).  Nursing has a unique role to 
recognize and address the needs of pregnant women and to educate them about self-care and the 
importance of nutrients like vitamin D in pregnancy.   
Future Research 
 Based on the results of this descriptive study, future research needs to focus on validating 
the impact that vitamin D may have on sleep quality and quality of life in pregnant women.  
There seems to be some discrepancy in the literature about vitamin D status and sleep quality, 
therefore confirmatory studies to assess a correlation between vitamin D deficiency in pregnant 
women and poor sleep quality need to be conducted.   
 Ongoing clinical trials assessing vitamin D supplementation on depressive symptoms will 
provide clarity and confirmation that improvement of vitamin D status can positively impact 
mental health.  One example of a randomized control trial in type 2 diabetic women entitled 
“Sunshine 2 Study” funded by NINR (R01NR013906) is enrolling depressed women (CES-D 
score of > 16) in either a placebo (5,000 IU/week) dose or 50,000 IU/week) dose to determine 
the efficacy of vitamin D supplementation on mood symptoms, self-management of diabetes, and 
quality of life found on clinical trials.gov website (Penckofer, 2013, July 17).  This study is still 
recruiting participants but will provide evidence for the impact of vitamin D supplementation at 
142 
 
 
multiple time points (baseline, 3 months and 6 months) on treatment of depression.  Even though 
the study is not examining pregnant women, the study will provide much needed evidence about 
type 2 diabetic women who are more prone to depressive symptoms (Penckofer, Doyle, Byrn, & 
Lustman, 2014).  Although the current study only had 13.6% (n=17) of the sample diagnosed 
with GDM, there is a lot of evidence to indicate that women who are gestational diabetics double 
their risk for type 2 diabetes later in life (Laptook, Homko, & Biastre, 2013).  In addition, 
women with GDM have been reported to have more depressive symptoms (Byrn & Penckofer, 
2015), thus evaluating vitamin D would be especially important in this group. 
 Since type 2 diabetes is on the rise especially in Hispanic women and they are also at risk 
for vitamin D deficiency, it important to understand the impact that vitamin D supplementation 
can have in diabetic women (Castro & Penckofer, 2014).  In Europe, the DALI (vitamin D and 
Lifestyle Intervention) study is ongoing which will enroll pregnant women at risk of GDM from 
nine different European countries who will be randomized to different lifestyle interventions 
including vitamin D supplementation (Jelsma et al., 2013).  This study will provide important 
evidence for preventive measures that impact GDM development in at risk pregnant women and 
also provide much needed evidence for the role that vitamin D supplementation will have in 
potentially preventing GDM. 
 Medical University of South Carolina is also undergoing a major initiative for screening 
and treating all pregnant women who are vitamin D deficient in their university clinics.  
Therefore they will provide further evidence to the impact that vitamin D supplementation has in 
pregnancy (Hollis & Wagner, 2017).  In addition to evaluating the impact of vitamin D 
supplementation on birth outcomes and pregnancy complications, they will also be assessing the 
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impact that vitamin D supplementation can have on genomic mutations at an epigenetic level 
(Hollis & Wagner, 2017). 
 Another important area of research is understanding the role of inflammatory processes 
and its relationships between vitamin D status, depressive symptoms, poor sleep quality and 
quality of life.  Future studies should include these components to determine mechanics of action 
which may translate to ways to prevent adverse perinatal outcomes.  Vitamin D does seem to 
play a central role, but high quality supplementation trials need to be done to confirm these 
biologic relationships and demonstrate benefit on these outcomes. 
 The findings of this study provided exploratory evidence that vitamin D has a role in 
influencing symptoms such as poor sleep.  This study also contributed to the evidence in regards 
to the association of vitamin D status in pregnant women and its relationship to sleep quality 
burden and poorer physical quality of life.  In a sample of 125 pregnant women at risk for 
vitamin D deficiency, vitamin D status was predictive of poor sleep quality and poor physical 
quality of life.  It is important that populations who are at the greatest risk for vitamin D 
deficiency be studied.  The potential for a future study to examine whether supplementation can 
improve symptomology, quality of life and health outcomes is novel.  The beneficial effects of 
vitamin D supplementation to prevent pregnancy complications such as preterm birth and 
preeclampsia only further emphasizes the need to conduct well designed clinical trials.  In 
addition, the inclusion of diverse women who are at greatest risk for vitamin D deficiency cannot 
be ignored so future studies must target these at risk groups.  Finally the low cost for such an 
intervention could provide exponential benefit to many who suffer from health disparities 
emphasizing the need for further investigation.  
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APPENDIX A 
INSTRUMENTS (ENGLISH AND SPANISH)
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Demographic and Health History Information 
 
ID #____________ MRN#__________________ Date_________________ 
 
 
Pre-pregnancy weight: _____________________ 
 
Today’s weight: ____________ 
 
Today’s height: ____________ 
 
Estimated Due Date: __________________ 
 
Gestational age today: ______________ 
 
LCHC clinic site:   
 
o 3750 W. Ogden avenue 
o 3860 W. Ogden Avenue 
o Homan Square 
o Farragut 
o Archer 
o Breakthrough 
 
Please fill out the information below. 
 
1. Age: _______________ 
 
2. Ethnicity: (please circle one) 
o Hispanic 
o Non-Hispanic 
 
3. Race: (please circle one) 
o African American (Black) 
o Mixed please specify: ____________ 
o Other 
 
4. If Hispanic, which best describes you: (please check one box) 
o Born in the U.S. 
o From Mexico 
o From Latin America 
o From Spain 
o From the Carribean 
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o From Puerto Rico 
o From South America 
o Other ____________________ 
 
5. Language preference: (Please check one box) 
o English 
o Spanish 
 
6. Marital Status: (please circle one) 
o Married 
o Divorced 
o Separated 
o Single, and living with partner 
o Single, and not living with partner 
  
7. Education status: (please check highest level of education) 
o Grammar school 
o Middle school 
o High school 
o Associate’s degree/Technical college 
o Some college 
o College degree 
o Graduate degree 
 
8. Household income: (please check one box) 
o <$5,000 
o $5,000 to $14,999 
o $15,000 to $24,999 
o $25,000 to $39,999 
o $40,000 to $54,999 
o $55,000 to $64,999 
o >$65,000 
 
9. Employment status: (please check one box) 
o Full time 
o Part time 
o Unemployed 
o Laid off 
o Disability 
o Other________ 
 
10. What type of insurance? 
o Medicaid 
o Medicaid HMO (Family Health Network, Harmony) 
o Private insurance (BCBS, United, Aetna) 
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o Obamacare plan 
o No insurance 
  
11. Are you currently enrolled in the WIC (Women, Infants, Children) program? 
 
YES   NO 
 
12.  If you are enrolled, how many months pregnant did you enroll?  ______________ 
 
13.  Are you planning on breastfeeding?  YES  NO 
 
14. Was your current pregnancy planned?  YES   NO 
 
15. Please list any prescribed medications you are currently taking: 
 
______________________  ____________________ 
______________________  ____________________ 
______________________  ____________________ 
______________________  ____________________ 
 
Over the counter medications: 
 
______________________ ___________________ 
______________________ ___________________ 
 
16. Have you ever been diagnosed with depression?   YES   NO 
  
    IF YES when? ________________ 
        
             diagnosed with anxiety?  YES  NO 
 
    IF YES when? ________________ 
 
   diagnosed with any other MH illness __________________ 
 
17.  Please circle any of the following conditions you have been diagnosed with either in the past 
or in this pregnancy: 
o Asthma 
o Diabetes 
o Hypertension 
o Depression 
o Bipolar Disorder 
o Schizophrenia 
o Thyroid disorder 
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o Anemia 
o Other__________________ 
 
18. How many times have you been pregnant? _______________ 
 
19. How many of those pregnancies did you deliver a full term (after 37 weeks) 
baby? ___________ 
 
20. How many of those pregnancies did you deliver a preterm (between 20 and 37 
weeks) baby? ____________ 
 
21. How many miscarriages/abortions have you had? ___________________ 
 
22. How many living children do you have? ____________________ 
 
23. How many vaginal deliveries have you had? ________ 
 Complications:  (check all that apply) 
o Vacuum delivery 
o Forceps delivery 
o 3rd or 4th degree laceration 
o Other ________________ 
 
24. How many cesarean sections have you had? _______ 
 
25. Are you currently getting prenatal care through Centering Pregnancy?   YES    or     NO  
 
CONTACT INFORMATION 
1. What is your current address? 
Number and Street  
 
City  
 
State  
 
Zip  
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2. Contact information: 
Home phone number 
(please enter in format: 
###-###-####) 
 
 
Cell phone number 
(please enter in format: 
###-###-####) 
 
 
Email address 
(please enter in format: 
###-###-####) 
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Demografía y Salud Información Historia 
 
ID #____________ MRN#__________________ La fecha _________________ 
          Season ______________ 
  
       Código postal ____________ 
 
Peso antes del embarazo_____________________ 
 
Peso hoy: ____________ 
 
Altura de hoy: ____________ 
 
La fecha de nacimiento del bebé : __________________ 
 
Cuántas semanas estás hoy: ______________ 
 
Clinica lugares: 
 
o 3750 W. Ogden avenue 
o 3860 W. Ogden Avenue 
o Homan Square 
o Farragut 
o Archer 
o Breakthrough 
 
 
Por favor complete la información de abajo. 
 
1. Cuántos años tienes _________ 
 
2. Etnicidad: (por favor marque uno) 
 
o Hispanos 
o No Hispanos 
 
        3. Race: (please circle one) 
o Afroamericano 
o Mezclado   Por favor especifica: ____________ 
o Otros 
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4. Si Hispanos, Lo que te describe mejor: (por favor marque uno) 
o nacido en los Estados Unidos From Mexico 
o de américa latina  
o de Mexico 
o de España 
o del caribe  
o de Puerto Rico 
o Otro _______________ 
 
5. Preferencia: (por favor marque uno) 
o Ingles  
o Español 
 
6. Estado civil: 
o Casado 
o Divorciado 
o Separado 
o Sola, viviendo con pareja 
o Sola, no viviendo con pareja 
 
7. Estado de la educación:  (por favor marque más alto nivel de la educación) 
o Escuela primaria 
o Escuela secundaria 
o Grado asociado 
o Alguno colegio 
o Grado de la universidad 
o Título de posgrado 
 
8. los ingresos del hogar 
o <$5,000 
o $5,000 to $14,999 
o $15,000 to $24,999 
o $25,000 to $39,999 
o $40,000 to $54,999 
o $55,000 to $64,999 
o >$65,000 
 
9. Estado de Empleo: (por favor marque uno) 
o tiempo completo 
o medio tiempo 
o desempleados 
o Otro ___________________ 
 
10. Qué tipo de seguro de salud? 
o Seguro de enfermedad 
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o Seguro de enfermedad HMO (Family Health Network, Harmony) 
o Seguro private (BCBC, United, Aetna) 
o Obamacare plan 
o No seguro 
 
11. Estás inscrito en el programa WIC?   Sí  NO 
 
12. Si está inscrito, ¿cuántos meses de embarazo ha inscrito?   __________ 
 
13. ¿Está pensando en amamantar? Sí  NO 
 
14. Por favor, indique todos los medicamentos recetados que está tomando actualmente: 
 
______________________  ____________________ 
______________________  ____________________ 
______________________  ____________________ 
______________________  ____________________ 
 
La medicina sin receta: 
 
______________________ ___________________ 
______________________ ___________________ 
 
 
15. Alguna vez ha sido diagnosticado con depresión?  Sí  NO 
  
         Con ansiedad?   Sí  NO 
 
        otras enfermedades de salud mental?   _________________ 
 
16. Por favor marque cualquiera de las siguientes condiciones se le ha diagnosticado:  
o Asma 
o Diabetes 
o Hipertensión 
o Problema con su tiroides 
o Anemia 
o Otro _______________ 
 
17. Cuantas veces has estado embarazada? ______________ 
 
18. Cuántos bebés nacidos a término (después de las 37 semanas)?   ___________ 
 
19. Cuántos bebés nacidos a término prematuro (entre 20 y 36 semanas) __________ 
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20. ¿Cuántos abortos involuntarios / abortos han tenido? _____________ 
 
21. El número de hijos vivos tiene? ______________ 
 
22. ¿Cuántos nacimiento bebé vaginales? _____________ 
 
Complicaciones durante parto: 
 
o Parto vaginal ventosa 
o Parto con fórceps 
o Tercero o cuarto grado de laceración 
o Otro ____________________ 
 
23. Cuántas cesáreas ha tenido?   ________________ 
 
24. ¿Está recibiendo atención prenatal en grupo?    Sí  NO 
 
Información del contacto 
 
1. ¿Cual es tu dirección? 
Nombre y calle  
 
Ciudad  
 
Estado  
 
Código postal 
 
 
 
 
 
2. Número de teléfono 
Número de teléfono de 
casa 
 (escribir como este: 
###-###-####) 
 
 
Número Celular  
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 (escribir como este: 
###-###-####) 
  
Dirección de correo 
electrónico 
 (escribir como este: 
 
 
 ____@___.com 
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Pregnancy Symptom Inventory in Spanish, email author for copy of translation. 
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General Health Perceptions 
For each of the following questions, please mark an  in the one box that best 
describes your answer. 
 
1. In general, would you say your health in pregnancy is: 
2.  In general, would you say the health of your unborn baby is: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Excellent Very good Good Fair Poor 
    
   1    2    3    4    5 
Excellent Very good Good Fair Poor 
    
   1    2    3    4    5 
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Percepciones generales de salud 
 
Para cada una de las siguientes preguntas, por favor marque con una  la 
casilla que mejor describa su respuesta. 
 
1. En general, ¿diría que su salud durante el embarazo es: 
Excelente Muy buena Buena Pasable Mala 
    
   1    2    3    4    5 
 
 
2.  En general, ¿diría usted que la salud de su bebé por nacer es: 
Excelente Muy buena Buena Pasable Mala 
    
   1    2    3    4    5 
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Dear Ms. ________________  
Greetings.  My name is Jennifer Woo and I am a certified nurse midwife who 
previously worked at Lawndale Christian Health Center.  I am enrolled in the doctoral 
nursing program at Loyola University and studying pregnant women to determine 
whether the level of vitamin D in your blood is related to how you feel.  You will be 
asked to complete a questionnaire booklet that asks about pregnancy symptoms, mood, 
sleep, health behaviors, and quality of life.   You will also need to take a blood test so that 
we can know the level of vitamin D in your blood.    
 Research suggests that women who have low levels of vitamin D may be at 
greater risk for poor pregnancy and birth outcomes such as early delivery and diabetes in 
pregnancy.  There is also evidence to suggest that women who have lower levels of 
vitamin D are also at increased risk for common discomforts like musculoskeletal pain, 
sleep issues, depressive symptoms, and fatigue, but most the studies have not included 
pregnant women.    
 Therefore, we would like to study whether vitamin D levels are related to how 
you feel.   Pregnant women who are 24 to 32 weeks into gestation may participate.  If you 
are interested in participating in this study, please call me at XXX-XXX-XXXX.  I will 
ask questions to see if you meet the study inclusion criteria.   If you do, then I will 
schedule a time to meet you in the clinic at your next appointment.  At that time, we will 
review a document to make sure you understand the study.    You will be paid a small 
amount for your time with a $20 Target or Walmart gift card.  I thank you in advance for 
your willingness to review this letter and look forward to hearing from you!  
Sincerely, 
Jennifer Woo, CNM, WHNP 
Doctoral Nursing Student, Loyola University Chicago
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LOYOLA UNIVERSITY CHICAGO 
HEALTH SCIENCES DIVISION 
MAYWOOD, ILLINOIS 
DEPARTMENT OF  
MARCELLA NIEHOFF SCHOOL OF NURSING 
INFORMED CONSENT 
 
Participant’s Name __________________________________________________________ 
Medical Record number: ______________________________________________________ 
PROJECT TITLE: Vitamin D and pregnancy symptoms 
 
THE APPROVAL FOR THIS PROJECT EXPIRES ON XX/XX/XXXX 
 
Participant Information 
PRINICIPLES CONCERNING RESEARCH: You are being asked to take part in a 
research project.  It is important that you read and understand the principles that apply to all 
individuals who agree to participate in the research project described below: 
1. Taking part in the research is entirely voluntary 
2. We do not know if you will benefit from taking part in the research but the 
knowledge obtained may help others. 
3. You may withdraw from the study at any time without anyone objecting and without 
penalty or loss of any benefits to which you are otherwise entitled. 
The purpose of the research, how it is to be done, and what your part in the research will be is 
described below.  Also described are the risks, inconveniences, discomforts and other important 
information which you need to make a decision about whether or not you wish to participate.  
You are urged to discuss any questions you have about this research with the staff member. 
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PURPOSE OF RESEARCH:  You are being asked to participate in this study because you are 
pregnancy and are at risk for vitamin D deficiency.  There is evidence that shows that women 
who are African American and Hispanic are at greatest risk for having vitamin D deficiency. 
In addition, there are physiological changes that happen in pregnancy that can cause, some 
discomforts.  These are commonly called symptoms of pregnancy which may include increased 
urinary frequency, low back pain, and sleep problems.  These symptoms can cause significant 
discomfort to normal pregnancy and interfere with quality of life. 
Some observational studies have shown that many of the common discomforts of pregnancy like 
low back pain, sleep discomforts, urinary issues, are also associated with vitamin D deficiency 
but no one has looked at this association in pregnant women.  Therefore, it is important to see if 
there is a connection between vitamin D deficiency and pregnancy symptoms and how it impacts 
your quality of life. 
This purpose of this study is to see if y our vitamin D status is correlated with higher frequency 
of symptoms of pregnancy and what its impact is on your quality of life. 
This research is sponsored by Loyola University. Approximately 125 people will participate in 
this research. 
DESCRIPTION AND EXPLANATION OF PROCEDURES: If you agree to participate in 
this study, you will be required to provide a one time blood sample to measure your vitamin D 
level.  In addition, you will be required to fill out a packet of self-report questionnaires that 
describe your pregnancy symptoms, sleep quality, depressive symptoms, in addition to other 
demographical information.  Your healthcare provider at Lawndale Christian Health Center will 
be notified if you report having thoughts of harming yourself as reflected in question number 10 
on the Edinburgh Postnatal Depression Scale (EPDS). 
RISKS/DISCOMFORTS: Enrollment in the study, you will need to get your blood drawn and 
may experience some discomfort with this procedures.  You may also feel uncomfortable 
answering some of the survey questions or think more about your pregnancy symptoms.  
BENEFITS: You will not benefit from participating in this study. 
FINANCIAL INFORMATION: You or your insurance company will not be charged for the 
laboratory blood draw that you will have done in this study.  Insurance information will not even 
be collected, as the bill for the laboratory blood draw will be paid for by the investigator, 
Jennifer Woo.  You will receive $20 for participating in this study. 
RESEARCH RELATED INJURY:  In the event that you are injured or have side effects as a 
result of participating in this research project, your doctor will take the necessary steps to treat 
the problem.  There are no funds available from Loyola University Medical Center, Loyola 
University Health System or Loyola University Chicago to pay for the cost of care of the 
problem.  You will be financially responsible for the cost of care of any problems.  By signing 
this form, you are not giving up any legal rights to seek to obtain compensation of injury. 
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INFORMATION COLLECTED AND WHAT WILL HAPPEN TO IT:  In order to meet the 
goals of the research study (see Purpose of Research section of this consent), we will collect 
information on you, your tests results, and how you do from you and your Lawndale Christian 
Health Center medical records.  The information will be collected by Jennifer Woo who is a 
doctoral student at Loyola University Chicago. 
In this way, we will learn about the impact your vitamin D status may have on the frequency of 
pregnancy symptoms. 
The information we will collect and send includes: 
X  DEMOGRAPHIC INFORMATION (e.g., name, address, phone number) 
X  MEDICAL RECORD(including, but not limited to laboratory values, patient medical history) 
X  SELF-REPORTED QUESTIONNAIRES 
X  BLOOD SAMPLE 
We will collect and provide this information about you for the duration of the study. 
WITHDRAWAL OF CONSENT:  Your consent to use and disclose your medical information 
for the purpose of this research study is completely voluntary.  You can withdraw your consent 
for LUMC to use and disclose your information and your consent to participate in this study at 
any time without affecting your ability to receive care and treatment at LCHC unrelated to the 
research study.  Withdrawal means that all study procedures and follow-up will stop and we will 
not send any more information about you to the sponsor of this research or its designees.  
However, information already used and disclosed to the research sponsor prior to the time of 
your withdrawal from this study may continue to be used and disclosed by LUMC and the 
sponsor. 
If you withdraw from the study, we will ask that you sign the form attached to this consent and 
send it to Jennifer Woo.  Your withdrawal from the study will not have any affect on any actions 
by LCHC taken before the attached form is received by LUMC. 
Your study doctor, the Institutional Review Board, the regulatory authorities, or the sponsor, 
may terminate the study at any time with or without your consent. 
CONSENT 
I have fully explained to _____________________________ the nature and purpose of the 
above-described procedure and the risks that are involved in its performance.  I have answered 
and will answer all questions to the best of my ability.  I may be reached at 312-513-2214. 
______________________________________________ Date:___/ ___/ _____ 
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Jennifer Woo and Susan Penckofer, the principal investigator for this study, will be available to 
answer any questions you may have3.  Jennifer Woo can be reached at:  312-513-2214 
Although you have the right to revoke this authorization, you accept that such revocation will not 
apply to any uses and disclosures of your information that are described in the Loyola University 
Health System Notice of Privacy Practices or otherwise allowable under any Federal or State 
laws. 
You will receive a signed copy of this informed consent document. 
You have been fully informed of the above-described research program with its possible benefits 
and risks.  Your signature below indicates that you are willing to participate in this research 
study and agree to the use and disclosure of information about you as described above.  You do 
not give up any of your legal rights by signing this consent document. 
______________________________________________ Date:___/ ___/ _____ 
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LITERATURE REVIEW TABLES 
202 
 
 
Table 1 
Vitamin D and depression 
Authors/Title Year Design Sample 
characteristics 
Results 
Jaaskelainen et al. 
Higher serum 25-
hydroxyvitamin 
D concentrations 
are related to a 
reduced risk of 
depression 
2015 Cross-
sectional 
study men 
and women 
30-79 based 
on Health 
2000 survey 
which used 
self-report 
questionnair
es and 
comp-
rehensive 
health 
examination 
Finnish sample 
cohort 
N=5371 
Men–47% 
Women–53% 
Measures: 
Beck Depression 
Inventory (BDI) 
DSM-IV diagnosis 
code for major 
depressive disorder, 
dysthymic disorder, 
and anxiety disorder 
Lifestyle factors 
(BMI, physical 
activity, and tobacco 
and alcohol use) 
Metabolic health- 
related factors 
Dietary index 
VD method: 
Diasorin  RIA 
Logistic 
regression showed 
increased odds 
ratio of 0.65 (95% 
CI 0.46. 0.93) 
from highest to 
lowest quartiles of 
vitamin D and 
depression.  
Therefore, 
reduced risk of 
25% in those who 
had higher vitamin 
D levels even after 
adjustment for 
significant 
demographic, 
lifestyle and 
metabolic factors. 
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Kerr et al. 
Associations 
between vitamin 
D levels and 
depressive 
symptoms in 
healthy young 
adult women 
2015 Cross-
sectional 
study with 
sample for 
depressive 
symptoms 
weekly for 4 
weeks and 
vitamin D 
level at 
week 1 and 
week 5. 
U.S. college 
undergraduate 
women 
N=185 
Measures: 
CES-D, Season, 
BMI, 
Ethnicity, 
Physical activity, 
Time outside in 
daylight hours, 
Dietary intake of 
vitamin D, Anti-
depressant and 
multivitamin use 
VD method: LC-MS  
Multivariate 
prediction model 
which showed that 
lower Week 1 
vitamin D3 
predicted clinical 
significant 
depressive 
symptoms across 
Week 1–week 5 (β 
= -0.20, p < 0.05), 
controlling for 
season, BMI, 
race/ethnicity, 
diet, exercise, and 
time outside. 
Gowda et al. 
Vitamin D 
supplementation 
to reduce 
depression in 
adults: Meta-
analysis of 
randomized 
controlled trials 
 
2015 Meta-
analysis of 
randomized 
controlled 
trials which 
used vitamin 
D 
supplementa
tion to 
reduce 
depression 
or 
depressive 
symptoms 
RCTs that compared 
vitamin D only or 
vitamin D and 
vitamin D combined 
with other vitamins 
or antidepressants 
with a placebo 
included;  
Participants ≥ 18 
years of age 
Total of 9 studies 
included 
Final N=4923 
No significant 
reduction in 
depression was 
seen after vitamin 
D 
supplementation 
(standardized 
mean difference = 
0.2895% CI, -0.14 
to 0.69; P = 0.19); 
limitations–most 
of the studies 
included 
individuals with 
low levels of 
depression and 
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Vitamin D 
methodology varied 
with each study 
sufficient serum 
vitamin D at 
baseline.  The 
studies included 
used different 
vitamin D doses 
with variations in 
intervals of 
treatment 
Spedding, S./ 
Vitamin D and 
Depression: A 
Systematic 
Review and 
Meta-Analysis 
Comparing 
Studies with and 
without 
Biological Flaws 
2014 Meta-
analysis of 
randomized 
controlled 
trials using 
vitamin D 
supplementa
tion for 
depression. 
15 RCTs included in 
analysis; 7 studies 
did not have 
biological flaws and 
8 studies had 
biological flaws;  
 
Vitamin D 
methodology varied 
with each study 
7 studies with no 
biological flaws 
showed 
standardized mean 
difference (SMD) 
of 0.78 (CI 0.24, 
1.27); Cohen’s 
rule of thumb, 
SMD of 0.8 is 
considered a large 
effect so 
significant effect 
of vitamin D in 
improvement of 
depression;  
8 studies with 
biological flaws 
showed SMD of  
-1.1 (CI -0.7, -1.5) 
which showed a 
negative effect of 
vitamin D on 
depression 
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Anglin et al. 
Vitamin D 
deficiency and 
depression in 
adults: 
systematic review 
and meta-analysis 
 
2013 Meta-
analysis of 
published 
observationa
l and RCTs 
studying 
vitamin D 
and 
depression 
One case-control 
study, 10 cross-
sectional studies, 3 
cohort studies 
 
Vitamin D 
methodology varied 
with each study 
Lower vitamin D 
levels found in 
people with 
depression with 
SMD =0.60, 95% 
CI 0.23-0.97); 
Increased odds 
ratio of depression 
for the lowest to 
highest vitamin D 
groups with OR 
=1.31. 95% CI 
1.0-1.71; Cohort 
studies showed 
significant hazard 
ratio of depression 
for the lowest to 
highest vitamin D 
groups (HR = 
2.21, 95% CI 
1.40-3.49) 
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Table 2 
Vitamin D and perinatal depression 
Authors/Title Year Design Sample 
characteristics 
Results 
Miyake et al. 
Intake of dairy 
products and 
calcium and 
prevalence of 
depressive 
symptoms during 
pregnancy in 
japan: A cross-
sectional study 
2015 Cross-sectional 
study to evaluate 
the relationship 
between dietary 
vitamin D intake 
and depressive 
symptoms in 
pregnancy. 
Japan 
N=1745 
Measures: 
Dietary History 
Questionnaire 
(DHQ) 
CES-D for 
depressive sx 
VD method: not 
drawn, only 
based on dietary 
vitamin D intake 
Using logistic 
regression vitamin D 
intake in the highest 
quartile was 
significantly 
associated with lower 
prevalence of 
depressive symptoms 
with OR 0.52, 95% 
CI 0.30-0.89). 
Gould et al. 
Association of 
cord blood 
vitamin D at 
delivery with 
postpartum 
depression in 
Australian 
women 
2015 Cross-sectional 
study as part of a 
larger RCT grant 
looking at 
vitamin D status 
at delivery and 
subsequent risk 
of Postpartum 
depression (PPD) 
at 6 weeks and 6 
months 
postpartum 
Australia 
N=1040 
Caucasian 
N=919 
Non-Caucasian 
N=121 
Measures: 
EPDS 
VD method: 
LC/MS 
Adjusted Relative 
risk for VD status and 
PPD at 6 weeks PP 
was not significant 
(RR 0.92; 95% CI 
0.84-1.02, p=0.11) or 
at 6 months PP with 
RR 0.96 ; 95% CI 
0.88-1.05, p=0.41) 
However, only 8% of 
sample had VD level 
< 25 nmol/L;  
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Bobbitt et al. 
Early pregnancy 
vitamin D and 
patterns of 
antenatal 
inflammation in 
African-
American 
women 
2015 Cross-sectional 
study evaluating 
if vitamin D 
status and 
inflammatory 
markers are 
associated with 
antenatal 
depression in a 
cohort of AA 
pregnant women 
U.S. 
N=147 
VD measured in 
1st trimester 
Inflammatory 
markers 
measured in 2nd 
trimester along 
with CES-D 
Measures: 
CES-D, IL-6, 
IL-10, IL-1β, 
and TNF-α 
VD method: 
Chemiluminesce
nce 
immunoassay 
 
After adjusting for 
covariates, only IL-
1β was significantly 
associated with 
vitamin D status and 
depressive symptoms 
(p=0.032) 
Gur et al. 
Mid-pregnancy 
vitamin D levels 
and postpartum 
depression. 
 
2014 To examine if 
mid pregnancy 
vitamin D status 
had an impact on 
postpartum 
depressive 
symptoms at 1 
week, 6 weeks 
and 6 month 
postpartum 
Turkey 
N=189 after 1 
week PP 
N= 184 after 6 
week PP 
N=179 after 6 
mo PP 
Measures: 
EPDS 
VD method: 
 
Univariate ANOVA 
used to evaluate 
maternal depression 
(EPDS≥12) and 
vitamin D level and 
those with severe VD 
(<10ng/ml) had a 
P=0.002 in 1st week 
PP, in 6th week PP 
P=0.004 and in 6th 
month PP P=<0.001 
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Robinson et al. 
Low maternal 
serum vitamin D 
during 
pregnancy and 
the risk for 
postpartum 
depression 
symptoms 
2014 Prospective study 
examining if 
vitamin D status 
at 18 weeks is 
associated with 
postpartum 
depressive 
symptoms at 3 
days after birth 
Australia 
N = 796 
All Caucasian 
women 
Measures: 
EPDS 
VD Method: 
LCMS 
Logistic regression 
model showed 
women in the lowest 
quartile of VD levels 
(<47 nmol/L) were 
significantly more 
likely to report six or 
more depressive 
symptoms in the first 
days after birth (OR 
2.19, 95% CI, 1.26-
3.78) 
Huang et al. 
Association of 
serum vitamin D 
with symptoms 
of depression 
and anxiety in 
early pregnancy 
2014 Cross-sectional 
study to evaluate 
associations 
between early 
pregnancy VD 
and antepartum 
depression and 
anxiety 
symptoms at 20 
weeks gestation 
U.S. 
N=498 
Non-Hispanic 
white 
429/498(87%) 
Other 13% 
Mean vitamin D 
34.4 ng/ml 
Measures: 
Depression, 
Anxiety, and 
Stress Scales 
(DASS-21) 
Patient Health 
Questionnaire 
(PHQ-9) 
VD method: 
LC/MS 
Multivariate linear 
regression analysis 
showed a 1 ng/ml 
lower VD level was 
associated with 0.043 
and 0.40 higher 
DASS-21 and PHQ 9 
scores(P values 
=0.052 and p=0.029);  
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Nielsen et al. 
Vitamin D status 
during 
pregnancy and 
the risk of 
subsequent 
postpartum 
depression: A 
case-control 
study 
2013 Case-control 
study nested in 
the Danish 
National Birth 
Cohort to 
evaluate if low 
vitamin D in 
pregnancy 
increased the risk 
of postpartum 
depression 
Denmark 
N = 605 with 
PPD 
N = 875 control 
group 
Measures: 
Diagnosis of 
PPD (measured 
by women 
filling 
prescriptions for 
antidepressive 
medications) 
VD method: 
LC-MS 
 
Noted no association 
between low vitamin 
D status and risk of 
PPD.  With VD<15 
nmol/L(6 ng/ml) and 
risk of PPD, OR 1.35, 
95% CI (0.64, 2.85) 
** Noted an 
increased risk of PPD 
with VD >50 nmol/L 
(20 ng/ml) 
Cassidy-
Bushrow et al.  
Vitamin D 
nutritional status 
and antenatal 
depressive 
symptoms in 
African 
American 
women 
2012 Cross-sectional 
study to examine 
if there is a 
relationship 
between early 
pregnancy (1st 
trimester) 
vitamin D status 
and depressive 
symptoms in 2nd 
trimester. 
U.S. 
AA pregnant 
women 
N=178 
Measures: 
CES-D  
VD method: 
Chemiluminesce
nce 
immunoassay 
platform 
Logistic regression 
analysis with adjust-
ment for significant 
covariates showed an 
inverse relationship 
between VD and 
CES-D≥16 with OR 
0.54, 95% CI, 0.29-
0.99) 
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Brandenbarg et 
al. 
Maternal early-
pregnancy 
vitamin D status 
is associated 
with maternal 
depressive 
symptoms in the 
Amsterdam born 
children and 
their 
development 
cohort 
2012 Epidemiologic 
study to evaluate 
if vitamin D 
status impacted 
perinatal 
depressive 
symptom scores 
in a pregnant 
population. 
Netherlands 
N=4236 
VD measured in 
early pregnancy 
(median time 13 
weeks) and 
depressive 
symptoms 
measured at 16 
week gestation 
Measures: 
Center for 
Epidemiological 
Studies for 
Depression 
(CES-D) 
VD method:  
Enzyme 
immunoassay 
method 
Logistic regression 
with adjustment with 
significant covariates, 
vitamin D deficiency 
(VD < 29.9 nmol/l) 
had an OR 1.48, 95% 
CI, 1.13-1.95.  
Vitamin insufficiency 
as defined by 30 to 
49.9 nmol/l had an 
OR 1.44; 95% CI, 
1.12-1.85; 
Murphy et al. 
An exploratory 
study of 
postpartum 
depression and 
vitamin D 
2010 Cross-sectional 
study to 
determine if 
vitamin D status 
can predict 
presence of 
depressive 
symptoms in 
postpartum 
women. 
U.S. 
N=97 
White–43 
AA–30 
Hispanic–23 
Asian–1 
Measures: 
Demographic 
Using mixed model 
approach, used 
pooled t tests of 
unadjusted mean 
EPDS sum scores 
compared at each 
time point for 
insufficient (VD<32 
ng/ml) versus 
sufficient (VD>32 
ng/ml).  Adjusting for 
significant covariates, 
mothers with lower 
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Edinburgh 
Postnatal 
Depression 
Scale 
VD method: 
RIA 
 
levels of vitamin D 
had higher EPDS 
scores during first 7 
months postpartum 
(P=0.02).   
 
Table 3  
  Vitamin D and sleep 
Authors/Title Year Design Sample 
characteristics 
Results 
Cakir et al.  
An evaluation of 
sleep quality and 
prevalence of 
restless leg 
syndrome in 
vitamin D 
deficiency 
2015 Cross-sectional 
design with 2 
cohorts: group 1: 
VDD cohort 
(VD<20ng/ml) 
and group 2: 
vitamin D 
≥20ng/ml)  
Turkey 
N=102 
Group 1 = 57 (49 
women: 8men) 
Group 2 = 45 (41 
women: 4 men) 
Measures: 
PSQI 
IRLSSG 
symptom severity 
scale 
Ferritin 
Hemoglobin 
Iron 
Restless Leg syndrome is 
higher in group 1 (p=.03) 
than in group 2;  
PSQI scores worse in 
group 1 (p=0.046) than in 
group 2 
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Magnesium 
VD method: not 
stated 
 
**Gunduz et al. 
Sleep deprivation 
in the last 
trimester of 
pregnancy and 
inadequate 
vitamin D: is 
there a 
relationship? 
2015 Cross-sectional 
study with 
pregnant women 
recruited at 36 
weeks gestation  
Turkey 
N=92 
Measures: 
PSQI 
VD method: 
High performance 
liquid 
chromatography 
(LC) 
No association between 
vitamin D status and 
sleep quality based on 
PSQI global score or any 
of the subcomponents. 
 
Massa et al. 
Vitamin D and 
actigraphic sleep 
outcomes in older 
community-
dwelling men: the 
MrOS sleep study 
2015 Cross-sectional 
study with a 
large cohort of 
community 
dwelling men to 
evaluate the 
association 
between vitamin 
D status and 
sleep outcomes 
U.S. 
N = 3048 
84.1% Caucasian 
Measures: 
Wrist actigraphy 
worn for an 
average of 5 
consecutive days 
for 24 hours to 
assesse: 
Total sleep time, 
sleep efficiency, 
wake time after 
sleep onset 
(WASO) 
Logistic regression 
analysis adjusted for 
significant covariates 
showed that lower 
vitamin D levels had 
higher odds of short (< 5 
hours) sleep duration 
(OR 2.15 95% CI 1.21-
3.79) 
In addition, lower 
vitamin D levels had 
increased odds of sleep 
efficiency < 70% 
function (OR 1.45; 95% 
CI 0.97-2.18); No 
difference in WASO 
scores with vitamin D 
status. 
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VD Method: 
LC-MS  
Kim et al. 
Association 
between self-
reported sleep 
duration and 
serum vitamin D 
level in elderly 
Korean adults 
2014 Cross-sectional 
study examining 
association 
between self-
reported sleep 
duration and 
serum vitamin D 
levels in elderly 
Korean adults 
Korea 
N=1614 
M:F–748:866 
Measures: 
Self-reported 
sleep duration 
VD method: 
RIA  
Multiple linear 
regression, even after 
adjustment for 
confounders, vitamin D 
deficiency correlated 
with shorter sleep 
duration.  Women had 
significantly lower serum 
vitamin D levels than 
men. 
Huang et al. 
Improvement of 
pain, sleep, and 
quality of life in 
chronic pain 
patients with 
vitamin D 
supplementation 
2013 One arm 
intervention 
study 
Group 1: vitamin 
D insufficient 20 
ng/ml to 29 
ng/ml) 
Supplemented 
1200 IU/daily 
for 3 months 
Group 2: vitamin 
D deficient ≤ 20 
ng/ml  
Supplemented 
with 50,000 
IU/weekly for 3 
months 
U.S. veterans 
with chronic pain 
N=28 (all male) 
Group 1 =  11 
Group 2 = 7 
Group 1 = 9 AA 
males 
Group 2 = 11 AA 
males 
Measures: 
PSQI 
VR-36 (QOL 
measure) 
Pain score (0 to 
10) 
Noted improvements in 
pain score (p<0.0001), 
sleep latency (p=0.019), 
sleep duration (p=0.012), 
bodily pain (p=0.014), 
general health (p=0.006), 
vitality (p=0.048) and 
social functioning 
(p=0.017) from baseline 
to 3 month 
** vitamin D 
supplementation 
improved pain scores, 
sleep quality and various 
aspects of quality of life 
in patients with severe 
chronic pain. 
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VD method: 
LC/MS 
 
 
McCarty et al. 
Nonspecific pain 
is a marker for 
hypovitaminosis 
D in patients 
undergoing 
evaluation for  
sleep disorders: a 
pilot study 
 
2013 Cross-sectional 
study of patients 
being evaluated 
at a sleep 
disorder clinic 
who had 
concomitant 
complaints of 
nonspecific MS 
pain 
US 
N=153 
(76.5% women; 
23.5% men) 
(35% AA; 65% 
White) 
Complaints of 
nonspecific MS 
pain 
Mean vit D level: 
19.8 ng/ml 
Measures: 
Sleep dx: 
obstructive sleep 
apnea, hyper-
insomnia, restless 
leg syndrome, 
insomnia, other;  
VD method: 
immunoassay by 
Diasorin 
Noted: VDD more 
prevalent in patients 
diagnosed with sleep 
disorder 
Risk factors noted for 
VDD: 
Race, age < 60 yrs of 
age, and BMI 
McCarty et al. 
Vitamin D, Race, 
and Excessive 
2012 Cross-sectional 
study with 
patients being 
seen at a sleep 
U.S. sample 
N=81(77 women; 
24 men) 
When examining entire 
cohort, there was no 
significant correlations 
between vitamin D levels 
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Daytime 
Sleepiness 
 
medicine clinic 
who had 
complaints of 
MS pain  
(28 AA; 53 
White) 
Measures: 
Epworth 
Sleepiness Scale 
(ESS) 
VD method: 
Diasorin (RIA) 
and ESS; However, in 
the AA population (35%) 
who had significantly 
lower vitamin D levels 
also had significantly 
higher ESS scores. 
Balaban et 
al./Serum 25-
hydroxyvitamin 
D levels in 
restless legs 
syndrome patients 
2012  Prospective case-
control study to 
evaluate if 
people with 
Restless Leg 
Syndrome (RLS) 
have lower 
vitamin D levels 
compared to 
healthy control 
subjects without 
Restless Leg 
syndrome. 
Turkey 
N = 36 (patients 
with RLS)  
M:F–8:28 
N = 38 (control) 
M:F–11:27 
Measures:  
Idiopathic RLS 
Rating scale 
VD method: 
chemiluminescen
ce immunoasssay 
Significant inverse 
correlation between 
vitamin D levels and 
disease severity in 
females (p=0.01, r = -
0.47); therefore the lower 
the vitamin D level, the 
higher the RLS score. 
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Table 4  
Vitamin D and musculoskeletal pain/health 
Authors/Title Yea
r 
Design Sample 
characteristics 
Results 
Straube et al.  
Vitamin D for the 
treatment of 
chronic pain 
conditions in adults 
2015 Meta-
analysis 
using the 
Cochrane 
Central 
register of 
controlled 
trials, 
MEDLINE, 
and 
EMBASE to 
February 
2015 
10 studies included 
Adults > 15 years 
of age with all 
types of chronic 
pain conditions; 
vitamin D 
supplementation 
was given either 
PO or IV with a 
placebo or active 
comparator, with 
no restriction to 
type, dose or 
frequency of 
vitamin D 
treatment 
VD method: 
variable 
No consistent 
pattern that vitamin 
D treatment was 
associated with 
greater efficacy 
than placebo in any 
chronic painful 
condition (low 
quality of 
evidence). 
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Gendelman et al. 
A randomized 
double-blind 
placebo-controlled 
study adding high 
dose vitamin D to 
analgesic regimens 
in patients with 
musculoskeletal 
pain 
 
 
2015 Randomized, 
double-
blinded and 
placebo-
controlled 
study to test 
the effect of 
PO given 
4000 IU of 
vitamin D vs. 
placebo on 
different 
parameters of 
pain for 3 
months (time 
0, 6 weeks 
and at 12 
weeks) 
Israel pain clinic 
Male: 14 
Female: 60 
≥ 18 yrs of age 
Measures: 
Pain syndromes 
(eg. spinal pain, 
osteoarthritis, etc) 
Previous 
medications 
Visual Analogue 
Scale (VAS) 
McGill Pain 
Questionnaire 
(MPQ) 
Patient Global 
Perceived Effect 
(PGPE) 
Panel 
Inflammatory 
cytokines 
VD methodology: 
Diasorin RIA 
 
Using student t-
test, the group 
receiving vitamin 
D supplementation 
achieved 
statistically 
significant decline 
in their VAS scores 
from week 0 to 
week 12 (p< 
0.001), while the 
placebo group did 
not. 
The significant 
inflammatory 
cytokines that 
improved with 
vitamin D group 
include TNF-α , 
LTB4 and PGE. 
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Lodh et al. 
Assessment of 
Vitamin D status In 
Patients of Chronic 
Low Back 
Pain of Unknown 
Etiology 
2015 Cross-
sectional 
prospective 
study of 
patients at an 
orthopedic 
clinic with 
low back 
pain of 
unknown 
etiology 
India 
M:F ratio (54:146) 
200 control samples 
Measures: 
BMI 
Serum glucose, 
calcium, 
phosphorus, uric 
acid, rheumatoid 
factor, CRP, 
alkaline 
phosphatase, total 
protein and albumin 
VD method: 
ELISA 
Student t-tests 
showed women 
with lower vitamin 
D levels with 
chronic back pain 
compared to 
controls p valuen < 
0.0001;  
Maximum number 
of low back pain 
patients were in the 
age group of 31-50 
yrs; Calcium and 
alkaline 
phosphatase was 
positively 
correlated with 
vitamin D and 
glucose showed 
negative correlation 
with vitamin D 
**Bergstrom et al. 
Observational study 
of vitamin D levels 
and pain in 
immigrant pregnant 
women living in 
Sweden 
2014 Prospective 
longitudinal 
study cross-
sectional of 
pregnant 
women with 
MS pain at 
12 weeks 
gestation in 
pregnant and 
again at 6-12 
mos 
postpartum 
Sweden 
Immigrant women 
N=68 
Control group 
native Swedish 
pregnant women 
N=51 
Measures: 
Pain using VAS 
Parathyroid 
hormone (PTH) 
Significantly higher 
proportion (77.9%) 
of immigrant 
women had level of 
vit D < 25 nmol/l 
(10 ng/ml) 
compared with 
3.9% of controls; 
Pain via VAS 
significantly higher 
in immigrant 
women when 
compared with 
controls at 12th 
gestational week 
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Alkaline 
phosphatase (ALP) 
VD method: 
Competitive 
chemiluminiscence 
assay  
 
(p<0.001); An 
increase in vitamin 
D levels from 12 
weeks gestation to 
postpartum time 
point correlated to a 
decrease in pain 
(p<.01) using a t-
test. 
Von Kanel et al. 
Vitamin D and 
Central Hyper-
sensitivity in 
Patients with 
Chronic Pain 
2014 Cross-
sectional 
study to 
examine the 
relation 
between 
VDD and 
mechanical 
pain 
sensitivity 
Switzerland 
M:F (82:92) 
N = 174 
Measures of central 
hypersensitivity: 
Mechanical 
pressure pain 
sensitivity, 
Widespread Pain 
Index (WPI), 
Symptom Severity 
Score (SSS), 
fibromyalgia 
VD methodology: 
Chemiluminescent 
immunoassay 
Linear regression 
analysis to test for 
significant 
relationship 
between vitamin D 
and measures of 
central sensitivity 
including 
accounting for 
significant 
covariates; Results 
showed Lower 
vitamin D levels 
were related to 
greater symptom 
severity (r= -0.21. 
P= 0.008); mean ± 
standard error of 
the mean increase 
in pain intensity of 
0.61±0.25 for each 
25 nmol/L decrease 
in vitamin 
D(p=0.011) 
Le Goaziou et al. 
Vitamin D 
supplementation for 
2014 Prospective 
on armed 
study of 
Switzerland 
18-50 yrs of age 
Before treatment, 
mean vitamin D 
level of 23.7 
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diffuse 
musculoskeletal 
pain: Results of a 
before-and-after 
study 
patients with 
complaints of 
diffuse MS 
(DMS) and 
vitamin D 
deficiency.  
Supplementa
tion provided 
based on 
vitamin D 
level of 
200,000 IU 
in either one, 
two or three 
doses; with 
measures 
taken before 
treatment and 
45-60 days 
after 
treatment 
M:F - 14:35 
N = 49 
Patients received 
different doses of 
vitamin D 
supplementation 
based on their 
vitamin D level 
Measures:  
Demographics 
Mean pain 
evaluation score 
Quality of life 
(COOP-WONCA 
chart) 
VD method:  
Not stated 
 
nmol/L, mean pain 
evaluation score 
5.07 and a mean 
quality of life score 
3.55. Using 
ANOVA, after 
vitamin D 
supplementation, 
adjusted mean 
vitamin D increased 
to 118.8 nmol/l 
(p<0.001), mean 
quality of life score 
increased to 2.8 
(p<0.001), and 
mean pain 
evaluation score 
decreased to 2.8 
(p<0.001). 
Al-Jarallah et al. 
Musculoskeletal 
pain: should 
physicians test for 
vitamin D level? 
2013 Prospective 
case control 
study 
recruiting 
patients from 
rheumatolog
y clinic with 
complaints of 
MS pain. 
Kuwait 
N = 124 with MS 
pain 
M:F–77:118 
N= 82 age & sex 
matched controls 
Measures: 
Demographics 
Vitamin D levels 
were deficient in all 
patients (<50 
nmol/l); There was 
no statistical 
different (p=0.368) 
observed between 
the mean vitamin D 
values of patients 
and controls, 
27.6±13.06 nmol/L 
versus 25.82±15.06 
nmol/L. 
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Muscle and gait 
evaluation 
Symptoms related 
to MS pain 
Sun exposure 
Dietary habits 
Parity 
PTH 
Calcium 
Alkaline 
Phosphatase 
Albumin 
VD method: 
radioimmuno-assay 
Sinha et al. 
Improving the 
Vitamin D Status of 
Vitamin D 
Deficient Adults Is 
Associated With 
Improved 
Mitochondrial 
Oxidative Function 
in Skeletal Muscle 
2013 
 
Longitudinal 
study 
evaluating 
the 
mitochondria
l phoxidative 
function in 
skeletal 
muscles in 
symptomatic 
VDD 
patients with 
VD supp- 
lementation 
United Kingdom 
N=12 
M:F–7:5 
VDD patients with 
complaints of 
fatigue or muscle 
cramps (with 
exclusionary 
criteria for 
comorbid 
conditions) 
 
Linear regression 
model showed that 
decreasing vitamin 
D levels was 
associated with 
increasing 
mitochondrial 
oxidative function 
(r = -0.41, 
p=0.009). All 
patients report 
decrease in fatigue 
after treatment 
Schreuder et al. 2012 Semi-
crossover 
Netherlands Patients in vitamin 
D group were 
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Vitamin D 
Supplementation 
for Nonspecific 
Musculoskeletal 
Pain in Non-
Western 
Immigrants: 
A Randomized 
Controlled Trial 
randomized 
controlled 
trial in non-
Western 
immigrants 
who are 
VDD with 
VD supp- 
lementation 
for 3 months 
for MS pain 
N=84 
M:F–20:64 
Vitamin D < 50 
nmol/l 
Group 1–VD for 
entire 12 weeks 
Group 2 - VD for 6 
weeks; placebo 6 
weeks 
Group 3 - VD 
method: placebo for 
6 weeks; VD for 6 
weeks 
Measures: 
VAS for pain 
VD method: radio-
immunoassay 
 
significantly more 
likely than placebo 
group to experience 
pain relief after 6 
weeks of treatment 
(34/9% vs 19.5%, 
p=0.04); Significant 
difference in pain in 
VD-VD group 
when compared 
with placebo-VD 
group (p=0.005) 
 
Knutsen et al. 
Vitamin D status in 
patients with 
musculoskeletal 
pain, fatigue and 
headache: A cross-
sectional 
descriptive study in 
a multi-ethnic 
general practice in 
Norway 
2010 Cross-
sectional 
descriptive 
study to 
evaluate if 
patients with 
non-specific 
MS pain, 
headache and 
fatigue are 
more likely 
to be vitamin 
D deficient 
Norway 
Multi-ethnic 
population 
Norway 
N=249 
M:F–61:188 
Europe, America, 
SE Asia 
N=83 
85% of patients 
from Middle East, 
Africa, and South 
Asia had deficient 
vitamin D level 
with minimal 
seasonal variation; 
Logistic regression 
analysis showed 
headache was 
significantly 
associated with VD 
(OR 2.6; p=0.008) 
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M:F - 27:56 
Middle East, Arica, 
South Asia 
N = 240 
M:F–78:162 
Measures: 
Demographics 
International 
Classification of 
Primary Care codes 
(ICPC-2) 
VD method: 
HPLC-MS 
 
after adjustment for 
gender, season, 
geographic region 
of origin and age 
Heidari et al. 
Association 
between 
nonspecific skeletal 
pain and vitamin D 
deficiency 
2010 Cross-
sectional 
matched-
control 
design with 
patients with 
nonspecific 
skeletal pain 
compared 
with patients 
without pain 
with matched 
mean vitamin 
D levels 
Iran 
N = 276 in skeletal 
pain group 
M:F not provided 
N = matched 
controls 
M:F not provided 
Using logistic 
regression and 
adjusting for 
significant 
covariates, positive 
association between 
VDD and skeletal 
pain (OR 2.94; 95% 
CI = 1.1-4.3. 
p=0.0001); Greater 
positive 
associations in 
women compared 
with men (OR = 
2.1, 95% CI -=1.1-
4.3, p=0.001) 
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Houston et al. 
Association 
Between Vitamin D 
Status and Physical 
Performance: In 
CHIANTI Study 
2007 Secondary 
analysis of a 
population 
based study 
in a cross-
sectional 
design 
evaluating 
the 
association 
of vitamin D 
status and 
physical 
performance 
Italy 
N = 976 
M:F–not specified 
Measures: 
sociodemographic, 
physical 
performance battery 
(SPPB) test, 
handgrip strength, 
behavioral 
characteristics, 
BMI, cognition, 
health conditions, 
creatinine, 
hemoglobin, and 
albumin 
VD method: RIA 
 
Multiple linear 
regression analysis 
showed vitamin D 
levels were 
significantly 
associated with 
SPPB score in men 
(β coefficient [SE]: 
0.38[0.18], p = 
0.04) 
Men and women 
with VD levels < 
25 nmol/L had 
significantly lower 
SPPB scores 
whereas those with 
VD <50 nmol/L 
also had 
significantly lower 
handgrip strength 
(p<0.05). 
Lofti et al. 
Hypovitaminosis D 
in female patients 
with chronic 
low back pain 
2007 Cross-
sectional 
study to 
evaluate the 
association 
of VDD and 
low back 
pain in 
childbearing 
women 
compare to 
healthy age 
matched 
controls 
Egypt 
N=60 
Ages 20-50 years of 
age 
Control  
N=20 
Measures: 
Physical exam 
Pain assessment (1-
10) 
Stepwise multiple 
regression with 
adjustment with 
confounders, 
patients with LBP 
had significantly 
lower VD levels 
(p<0.05) and 
significantly higher 
PTH (p<0.05) and 
ALP (p<.001) than 
controls. 
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Risk factors for 
VDD questionnaire 
Ca, phosphate, 
ALP, PTH 
VD method: 
RIA by Diasorin  
Gerdhem et al. 
Association 
between 25-
hydroxy vitamin D 
levels, physical 
activity, 
muscle strength and 
fractures in the 
prospective 
population-based 
OPRA Study of 
Elderly Women 
 
2005 Prospective 
longitudinal 
study eval. 
any assocs 
between VD 
status and 
fall-
associated 
variables and 
fracture in 
ambulatory 
elderly 
women 
Sweden 
N=986 
Measures at 
baseline and 3 year 
follow up: 
Romberg test, gait 
speed, muscle 
strength, DEXA, X-
rays 
VD method: chemi-
luminescence 
Using Spearman 
rank’s test VD 
status correlated 
with gait speed(r = 
0.17, P <.001), 
Romberg balance 
test (r=0.14, P 
<0.001), self-
estimated activity 
level (r=0.15, 
P<0.001) and thigh 
muscle strength 
(r=0.08. P=0.02) 
Plotnikoff et al. 
Prevalence of 
severe hypo-
vitaminosis D in 
patients with 
persistent, 
nonspecific 
musculoskeletal 
pain 
2003 Cross-
sectional 
study to 
evaluate 
prevalence of 
VDD in 
patients with 
complaints of 
persistent, 
nonspecific 
MS pain. 
U.S. 
N=150 
M:F–44:106 
83 immigrant 
67 nonimmigrant 
Measures: 
VD method: 
RIA by Diasorin 
 
Immigrant patients: 
100% VDD with ≤ 
20 ng/ml; Severity 
of deficiency was 
disproportionate  by 
age for young 
women (P<0.001), 
and by race for 
African American 
patients (P=0.006); 
Season was not a 
significant factor in 
determining 
vitamin D serum 
levels (P=0.06) 
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Table 5 
Vitamin D and Pelvic Floor Disorders 
Authors/Title Year Design Sample 
characteristics 
Results 
Aydogmus et al. 
Association of 
antepartum vitamin 
D levels with 
postpartum pelvic 
floor muscle 
strength and 
symptoms 
2015 Cross-sectional 
study in pregnant 
women admitted to 
hospital in their 3rd 
trimester and 
compared with 
healthy nulliparous 
women. Serum 
samples collected 
in 3rd trimester (36 
weeks) and pelvic 
floor muscle 
strength measured 
at 8-10 weeks 
postpartum 
Turkish pregnant 
women 
Group I (vitamin D 
<15 ng/ml; normal 
delivery) 
N = 42 
Group II (vitamin D 
< 15ng/ml; 
cesarean delivery) 
N = 24 
Group III (vitamin 
D ≥15 ng/ml; 
normal delivery) 
N = 48 
Group IV (vitamin 
D ≥15 ng/ml; 
cesarean delivery) 
N = 34 
Total sample = 148 
Measures: 
Urinary Distress 
Inventory SF (UDI-
6) 
Using multivariate 
linear regression, 
women who were 
VDD had lower 
PFMS in women 
who had a vaginal 
delivery (p=0.001) 
and the relationship 
was not significant 
in women with 
cesarean delivery 
(p=0.258). 
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Incontinence 
impact 
questionnaire (IIQ-
7) 
Birth statistics 
Digital 
perineometer to test 
PFMS 
Vitamin D 
methodology: 
ELISA 
 
Parker-Autry et al. 
Vitamin D 
deficiency is 
associated with 
increased fecal 
incontinence 
symptoms 
2014 Retrospective chart 
review of case-
control study to 
assess if women 
being seen at 
gynecology clinic 
for fecal 
incontinence 
symptoms and 
those presenting for 
other gynecologic 
complaints and 
comparing their 
vitamin D levels. 
U.S. 
Case  
N=44 
Control group 
N = 103 
Measures: 
Fecal Incontinence 
Severity Index  
Manchester Health 
Questionnaire 
(MMHQ) 
VD method: liquid 
chromatography 
 
Case group vitamin 
D levels were 
significantly lower 
than those in the 
control group 
(p=0.04) with the 
odds of vitamin D 
deficiency almost 
threefold higher 
(OR2.77, 95% 
CI(1.08-7.09) in 
women with fecal 
incontinence when 
compared to 
controls. 
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Parker-Autry et al. 
Vitamin D status in 
women with pelvic 
floor disorder 
symptoms 
2012 Retrospective chart 
review of women 
who visited a 
urogynecology 
clinic to assess 
associations 
between vitamin D 
status and pelvic 
floor symptom 
distress (PFD) and 
quality of life 
U.S. 
N=268 (PFD 
group) 
225–Non-Hispanic 
White 
40–African 
American 
N = 126 (No PFD) 
Measures: 
CRADI-8 
(Colorectal Anal 
Distress Inventory) 
Incontiencen 
Impact 
Questionnaire (IIQ-
7) 
VD method: liquid 
chromotography 
Mean vitamin D 
levels were higher in 
women with no PFD 
(P<0.0001).  
CRADI-8 and IIQ-7 
scores were higher 
among women with 
vitamin D 
insufficiency 
(defined as 15 ng/ml 
to 29 ng/ml); Higher 
IIQ-7 scores were 
independently 
associated with 
vitamin D 
insufficiency 
(p<0.0001). 
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Vaughn et al. 
Vitamin D and 
Lower Urinary 
Tract Symptoms 
Among US Men: 
Results from the 
2005-2006 
National 
Health and 
Nutrition 
Examination 
Survey 
2011 Cross-sectional 
survey of US 
noninstitutionalized 
population from 
NHANES 2005-
2006 to evaluate 
the association of 
vitamin D level and 
lower urinary tract 
symptoms (LUTS) 
among US men 
N = 2837 
Men ≥ 20 years of 
age 
Measures: 
LUTS (nocturia, 
incomplete 
emptying, hesitancy 
and urinary 
incontinence) 
Age 
Race/ethnicity 
Education 
BMI 
Chronic diseases 
Self-reported health 
status 
Prior diagnosis of 
benign prostatic 
enlargement or 
prostate cancer 
Vitamin D 
methodology: 
Diasorin (RIA) 
 
Multivariable 
logistic regression 
analysis after 
adjusting for age and 
race norms, vitamin 
D deficiency was 
associated with the 
presence of 
moderate-serve UI 
(OR 1.8, 95% CI 
1.1, 3.0) and at least 
1 LUTS (OR 1.4, 
95% CI 1.0-2.0) 
Badalian et al. 
Vitamin D and 
pelvic floor 
disorders in 
women: Results 
2010 Cross-sectional 
survey of 
nonpregnant 
women based on 
NHANES data 
from 2005-2006 to 
N = 1881 
U.S. women ≥ 20 
years of age 
Measures:  
Adjusted logistic 
regression models, 
decreased risk of 
pelvic floor 
disorders with 
increasing vitamin D 
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from the national 
health and nutrition 
examination survey 
estimate prevalence 
of vitamin D 
deficiency in 
women with pelvic 
floor disorders 
Incontinence 
severity index of 
both urinary and 
fecal incontinence 
 
levels in all women 
(OR 0.94, 95% CI, 
0.88-0.99); In 
women >50 yrs and 
older (OR 0.92; 95% 
CI 0.85-0.99)  
Likelihood of 
urinary incontinence 
was significantly 
reduced in women > 
50yrs with vitamin 
D levels >30 ng/ml 
(OR 0.55; 95% CI 
0.34-0.91) 
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